,words,labels,sentence_id,full sentence
412,Current,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
413,breeding,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
414,programs,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
415,based,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
416,on,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
417,the,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
418,traditional,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
419,quantitative,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
420,approach,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
421,have,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
422,achieved,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
423,appreciable,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
424,genetic,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
425,gains,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
426,for,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
427,milk,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
428,yield,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
429,.,O,12.0,Current breeding programs based on the traditional quantitative approach have achieved appreciable genetic gains for milk yield .
612,Thus,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
613,",",O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
614,a,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
615,new,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
616,milk,B-AG.01.e,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
617,product,I-AG.01.e,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
618,with,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
619,a,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
620,higher,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
621,calcium,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
622,content,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
623,and,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
624,lower,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
625,contents,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
626,of,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
627,protein,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
628,",",O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
629,phosphorus,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
630,",",O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
631,and,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
632,energy,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
633,was,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
634,developed,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
635,.,O,20.0,"Thus , a new milk product with a higher calcium content and lower contents of protein , phosphorus , and energy was developed ."
680,Short,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
681,-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
682,term,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
683,consumption,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
684,of,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
685,the,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
686,product,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
687,significantly,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
688,lowered,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
689,24,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
690,-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
691,h,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
692,urinary,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
693,calcium,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
694,excretion,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
695,by,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
696,approximately,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
697,0.65,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
698,+,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
699,/-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
700,0.19,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
701,mmol,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
702,/,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
703,d,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
704,(,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
705,means,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
706,+,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
707,/-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
708,SEM,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
709,",",O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
710,p,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
711,less,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
712,than,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
713,0.001,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
714,),O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
715,.,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
716,The,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
717,ratio,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
718,of,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
719,fasting,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
720,urinary,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
721,hydroxyproline,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
722,to,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
723,creatinine,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
724,did,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
725,not,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
726,decrease,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
727,",",O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
728,indicating,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
729,no,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
730,significant,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
731,reduction,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
732,of,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
733,bone,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
734,resorption,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
735,in,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
736,our,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
737,subjects,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
738,.,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
929,Polyphenols,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
930,may,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
931,also,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
932,enhance,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
933,insulin,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
934,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
935,dependent,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
936,glucose,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
937,uptake,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
938,",",O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
939,activate,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
940,5,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
941,',O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
942,adenosine,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
943,monophosphate,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
944,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
945,activated,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
946,protein,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
947,kinase,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
948,(,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
949,AMPK,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
950,),O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
951,",",O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
952,modify,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
953,the,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
954,microbiome,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
955,and,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
956,have,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
957,anti,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
958,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
959,inflammatory,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
960,effects,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
961,.,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
997,Overweight,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
998,and,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
999,obesity,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1000,constitute,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1001,a,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1002,global,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1003,pandemic,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1004,with,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1005,devastating,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1006,consequences,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1007,that,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1008,affect,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1009,>,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1010,2,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1011,billion,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1012,people,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1013,.,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1154,Type,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1155,2,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1156,diabetes,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1157,is,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1158,another,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1159,global,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1160,health,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1161,threat,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1162,closely,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1163,associated,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1164,with,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1165,obesity,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1166,that,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1167,boosts,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1168,the,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1169,risk,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1170,of,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1171,cancer,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1172,driven,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1173,by,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1174,high,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1175,BMI,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1176,.,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1377,This,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1378,review,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1379,summarized,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1380,recent,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1381,studies,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1382,on,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1383,some,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1384,spices,B-AG.01.l.03,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1385,for,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1386,prevention,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1387,and,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1388,treatment,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1389,of,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1390,cancers,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1391,",",O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1392,and,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1393,special,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1394,attention,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1395,was,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1396,paid,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1397,to,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1398,bioactive,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1399,components,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1400,and,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1401,mechanisms,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1402,of,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1403,action,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1404,.,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1522,Levels,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1523,of,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1524,isoflavones,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1525,in,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1526,fermented,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1527,soybean,B-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1528,products,I-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1529,",",O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1530,miso,B-AG.01.n.02,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1531,(,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1532,bean,B-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1533,paste,I-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1534,),O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1535,and,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1536,natto,B-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1537,(,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1538,fermented,B-AG.01.h.02.g,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1539,soybeans,I-AG.01.h.02.g,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1540,),O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1541,",",O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1542,were,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1543,38.5,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1544,to,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1545,229.1,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1546,micrograms,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1547,/,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1548,g,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1549,food,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1550,for,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1551,genistein,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1552,and,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1553,71.7,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1554,to,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1555,492.8,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1556,micrograms,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1557,/,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1558,g,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1559,food,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1560,for,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1561,genistin,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1562,.,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1640,On,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1641,the,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1642,basis,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1643,of,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1644,these,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1645,data,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1646,for,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1647,average,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1648,annual,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1649,consumption,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1650,of,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1651,soybeans,B-AG.01.h.02.g,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1652,and,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1653,related,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1654,products,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1655,",",O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1656,daily,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1657,intake,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1658,of,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1659,genistein,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1660,and,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1661,genistin,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1662,by,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1663,the,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1664,Japanese,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1665,is,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1666,calculated,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1667,to,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1668,be,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1669,1.5,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1670,-,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1671,4.1,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1672,and,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1673,6.3,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1674,-,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1675,8.3,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1676,mg,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1677,/,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1678,person,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1679,",",O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1680,respectively,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1681,.,O,51.0,"On the basis of these data for average annual consumption of soybeans and related products , daily intake of genistein and genistin by the Japanese is calculated to be 1.5 - 4.1 and 6.3 - 8.3 mg / person , respectively ."
1996,Results,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1997,from,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1998,this,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1999,large,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2000,prospective,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2001,observational,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2002,study,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2003,are,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2004,consistent,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2005,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2006,previous,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2007,case,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2008,-,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2009,control,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2010,studies,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2011,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2012,support,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2013,the,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2014,hypothesis,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2015,that,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2016,total,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2017,fruit,B-AG.01.h.01,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2018,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2019,vegetable,B-AG.01.h.02,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2020,intake,B-X,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2021,is,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2022,associated,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2023,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2024,reduced,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2025,risk,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2026,of,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2027,head,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2028,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2029,neck,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2030,cancer,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2031,.,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2252,The,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2253,present,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2254,study,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2255,aimed,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2256,to,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2257,examine,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2258,whether,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2259,the,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2260,antiobesity,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2261,effect,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2262,of,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2263,ginger,B-AG.01.l.03,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2264,is,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2265,associated,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2266,with,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2267,energy,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2268,metabolism,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2269,.,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2514,At,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2515,the,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2516,geographic,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2517,level,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2518,",",O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2519,intake,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2520,maps,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2521,closely,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2522,onto,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2523,the,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2524,distribution,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2525,of,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2526,lactase,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2527,persistence,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2528,(,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2529,LP,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2530,),O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2531,",",O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2532,a,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2533,genetic,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2534,trait,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2535,that,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2536,allows,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2537,milk,B-AG.01.e,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2538,to,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2539,be,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2540,consumed,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2541,beyond,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2542,the,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2543,weaning,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2544,period,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2545,without,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2546,gastrointestinal,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2547,side,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2548,effects,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2549,.,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
3116,The,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3117,test,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3118,beverages,B-AG.01.y,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3119,(,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3120,except,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3121,water,B-AG.01.z,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3122,),O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3123,each,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3124,contained,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3125,12,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3126,g,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3127,digestible,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3128,carbohydrate,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3129,.,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3130,Plasma,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3131,glucose,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3132,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3133,insulin,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3134,concentrations,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3135,were,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3136,measured,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3137,from,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3138,blood,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3139,obtained,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3140,pre-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3141,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3142,post,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3143,-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3144,meal,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3145,at,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3146,30,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3147,-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3148,min,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3149,intervals,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3150,for,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3151,4,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3152,h,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3153,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3154,incremental,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3155,areas,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3156,under,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3157,the,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3158,curve,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3159,(,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3160,AUC,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3161,),O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3162,were,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3163,computed,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3164,.,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3405,),O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3406,",",O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3407,Dongchimi,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3408,(,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3409,a,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3410,kind,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3411,of,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3412,kimchi,B-AG.01.n.09,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3413,prepared,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3414,with,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3415,radish,B-AG.01.h.02.a,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3416,and,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3417,a,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3418,large,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3419,quantity,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3420,of,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3421,salt,B-AG.01.l.01,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3422,water,I-AG.01.l.01,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3423,),O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3424,and,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3425,cooked,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3426,spinach,B-AG.01.h.02.c,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3427,.,O,106.0,") , Dongchimi ( a kind of kimchi prepared with radish and a large quantity of salt water ) and cooked spinach ."
3599,Clinical,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3600,status,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3601,and,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3602,changes,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3603,in,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3604,milk,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3605,production,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3606,and,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3607,composition,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3608,were,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3609,compared,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3610,in,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3611,the,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3612,four,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3613,groups,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3614,.,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3615,In,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3616,a,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3617,second,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3618,study,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3619,",",O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3620,8,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3621,cows,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3622,received,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3623,bST,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3624,or,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3625,vehicle,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3626,7,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3627,d,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3628,before,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3629,bacterial,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3630,challenge,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3631,.,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3880,Golden,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3881,-,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3882,Syrian,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3883,hamsters,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3884,were,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3885,fed,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3886,a,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3887,nonpurified,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3888,(,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3889,6.25,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3890,g/100,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3891,g,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3892,fat,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3893,),O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3894,diet,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3895,containing,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3896,an,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3897,additional,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3898,10,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3899,g/100,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3900,g,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3901,experimental,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3902,fat,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3903,and,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3904,0.1,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3905,g/100,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3906,g,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3907,cholesterol,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3908,for,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3909,6,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3910,wk,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3911,.,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
4118,We,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4119,describe,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4120,a,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4121,method,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4122,for,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4123,the,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4124,direct,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4125,determination,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4126,of,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4127,stilbenes,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4128,in,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4129,several,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4130,red,B-AG.01.y.01.a,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4131,wines,I-AG.01.y.01.a,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4132,using,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4133,high,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4134,-,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4135,performance,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4136,liquid,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4137,chromatography,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4138,with,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4139,UV,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4140,detection,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4141,.,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4426,Street,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4427,food,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4428,is,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4429,popular,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4430,in,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4431,Eastern,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4432,Europe,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4433,",",O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4434,but,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4435,its,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4436,diversity,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4437,and,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4438,nutritional,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4439,value,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4440,are,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4441,unknown,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4442,.,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4980,About,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4981,25,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4982,days,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4983,after,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4984,diet,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4985,change,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4986,",",O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4987,mice,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4988,that,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4989,consumed,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4990,the,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4991,corn,B-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4992,oil,I-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4993,diet,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4994,stopped,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4995,gaining,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4996,weight,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4997,",",O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4998,whereas,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
4999,the,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5000,mice,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5001,that,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5002,consumed,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5003,the,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5004,canola,B-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5005,oil,I-AG.01.f,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5006,diet,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5007,continued,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5008,normal,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5009,weight,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5010,gain,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5011,.,O,158.0,"About 25 days after diet change , mice that consumed the corn oil diet stopped gaining weight , whereas the mice that consumed the canola oil diet continued normal weight gain ."
5049,Epigenetic,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5050,therapy,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5051,induced,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5052,by,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5053,dietary,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5054,components,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5055,has,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5056,become,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5057,a,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5058,strong,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5059,interest,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5060,in,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5061,the,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5062,field,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5063,of,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5064,cancer,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5065,prevention,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5066,.,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5188,The,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5189,effect,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5190,of,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5191,olive,B-AG.01.f,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5192,oil,I-AG.01.f,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5193,on,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5194,epigenetic,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5195,alterations,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5196,was,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5197,examined,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5198,by,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5199,detecting,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5200,promoter,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5201,methylation,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5202,with,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5203,MS,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5204,-,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5205,HRM,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5206,and,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5207,dysregulation,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5208,of,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5209,miRNA,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5210,by,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5211,TaqMan,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5212,MicroRNA,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5213,Assay,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5214,.,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5236,Olive,B-AG.01.f,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5237,oil,I-AG.01.f,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5238,markedly,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5239,decreased,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5240,the,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5241,expression,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5242,of,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5243,inflammatory,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5244,and,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5245,angiogenic,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5246,markers,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5247,and,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5248,restored,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5249,the,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5250,expression,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5251,of,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5252,pro,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5253,-,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5254,apoptotic,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5255,markers,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5256,in,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5257,DMH,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5258,-,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5259,treated,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5260,rats,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5261,.,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5340,Epidemiological,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5341,studies,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5342,suggest,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5343,that,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5344,milk,B-AG.01.e,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5345,consumption,B-X,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5346,and,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5347,dietary,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5348,intake,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5349,of,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5350,dairy,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5351,proteins,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5352,are,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5353,inversely,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5354,related,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5355,to,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5356,the,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5357,risk,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5358,for,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5359,hypertension,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5360,.,O,171.0,Epidemiological studies suggest that milk consumption and dietary intake of dairy proteins are inversely related to the risk for hypertension .
5381,Milk,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5382,peptides,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5383,are,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5384,formed,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5385,from,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5386,milk,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5387,proteins,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5388,by,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5389,enzymatic,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5390,breakdown,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5391,by,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5392,digestive,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5393,enzymes,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5394,or,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5395,by,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5396,the,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5397,proteinases,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5398,formed,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5399,by,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5400,lactobacilli,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5401,during,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5402,the,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5403,fermentation,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5404,of,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5405,milk,B-AG.01.e,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5406,.,O,173.0,Milk peptides are formed from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinases formed by lactobacilli during the fermentation of milk .
5443,Milk,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5444,peptides,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5445,may,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5446,also,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5447,have,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5448,other,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5449,additional,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5450,mechanisms,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5451,to,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5452,lower,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5453,blood,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5454,pressure,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5455,such,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5456,as,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5457,opioid,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5458,-,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5459,like,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5460,activities,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5461,and,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5462,mineral,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5463,-,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5464,binding,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5465,and,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5466,antithrombotic,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5467,properties,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5468,.,O,176.0,Milk peptides may also have other additional mechanisms to lower blood pressure such as opioid - like activities and mineral - binding and antithrombotic properties .
5716,The,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5717,water,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5718,intake,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5719,-,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5720,bladder,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5721,cancer,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5722,association,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5723,also,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5724,seemed,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5725,to,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5726,be,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5727,modified,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5728,by,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5729,daytime,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5730,urination,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5731,frequency,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5732,with,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5733,significant,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5734,inverse,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5735,association,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5736,among,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5737,subjects,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5738,who,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5739,urinated,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5740,>,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5741,or,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5742,=,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5743,6,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5744,times,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5745,/,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5746,day,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5747,(,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5748,p,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5749,for,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5750,trend,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5751,=,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5752,0.015,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5753,),O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5754,",",O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5755,but,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5756,not,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5757,among,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5758,those,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5759,who,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5760,urinated,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5761,less,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5762,frequently,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
5763,.,O,185.0,"The water intake - bladder cancer association also seemed to be modified by daytime urination frequency with significant inverse association among subjects who urinated > or = 6 times / day ( p for trend = 0.015 ) , but not among those who urinated less frequently ."
6090,Consumption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6091,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6092,tomato,B-AG.01.h.02.f,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6093,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6094,tomato,B-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6095,-,I-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6096,based,I-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6097,products,I-AG.01.n.09,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6098,contribute,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6099,to,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6100,the,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6101,absorption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6102,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6103,carotenoids,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6104,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6105,lycopenes,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6106,in,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6107,human,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6108,serum,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6109,.,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6399,Evidence,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6400,shows,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6401,that,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6402,compared,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6403,to,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6404,nonconsumers,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6405,",",O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6406,those,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6407,who,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6408,consume,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6409,100,B-AG.01.ab,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6410,%,I-AG.01.ab,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6411,fruit,I-AG.01.ab,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6412,juice,I-AG.01.ab,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6413,come,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6414,closer,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6415,to,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6416,meeting,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6417,daily,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6418,fruit,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6419,needs,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6420,and,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6421,have,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6422,better,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6423,diet,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6424,quality,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6425,.,O,208.0,"Evidence shows that compared to nonconsumers , those who consume 100 % fruit juice come closer to meeting daily fruit needs and have better diet quality ."
6623,The,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6624,literature,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6625,was,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6626,extensively,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6627,examined,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6628,to,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6629,provide,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6630,an,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6631,objective,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6632,overview,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6633,of,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6634,the,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6635,most,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6636,significant,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6637,achievements,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6638,on,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6639,the,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6640,subject,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6641,.,O,215.0,The literature was extensively examined to provide an objective overview of the most significant achievements on the subject .
6703,These,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6704,include,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6705,nutrition,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6706,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6707,particularly,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6708,calcium,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6709,and,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6710,protein,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6711,intake,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6712,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6713,physical,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6714,activity,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6715,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6716,endocrine,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6717,status,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6718,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6719,as,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6720,well,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6721,as,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6722,exposure,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6723,to,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6724,a,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6725,wide,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6726,variety,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6727,of,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6728,risk,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6729,factors,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6730,.,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
7141,The,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7142,espresso,B-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7143,coffee,I-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7144,sample,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7145,was,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7146,found,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7147,to,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7148,contain,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7149,the,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7150,highest,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7151,level,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7152,of,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7153,MG,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7154,at,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7155,230.9,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7156,microM.,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7157,The,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7158,bold,B-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7159,coffee,I-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7160,roast,I-AG.01.ad,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7161,had,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7162,the,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7163,2nd,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7164,highest,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7165,amount,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7166,of,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7167,MG,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7168,",",O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7169,followed,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7170,by,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7171,the,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7172,mild,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7173,and,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7174,decaffeinated,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7175,varieties,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7176,.,O,236.0,"The espresso coffee sample was found to contain the highest level of MG at 230.9 microM. The bold coffee roast had the 2nd highest amount of MG , followed by the mild and decaffeinated varieties ."
7341,Serum,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7342,samples,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7343,of,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7344,136,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7345,patients,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7346,with,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7347,well,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7348,-,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7349,documented,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7350,",",O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7351,clinically,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7352,relevant,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7353,",",O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7354,immediate,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7355,-,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7356,type,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7357,hypersensitivity,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7358,against,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7359,latex,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7360,proteins,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7361,were,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7362,analyzed,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7363,for,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7364,IgE,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7365,antibodies,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7366,against,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7367,a,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7368,panel,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7369,of,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7370,different,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7371,fruits,B-AG.01.h.01,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7372,.,O,243.0,"Serum samples of 136 patients with well - documented , clinically relevant , immediate - type hypersensitivity against latex proteins were analyzed for IgE antibodies against a panel of different fruits ."
7795,There,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7796,was,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7797,no,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7798,indication,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7799,of,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7800,an,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7801,effect,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7802,of,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7803,alcohol,B-AG.01.y.01,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7804,in,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7805,either,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7806,sex,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7807,or,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7808,of,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7809,beer,B-AG.01.y.01.b,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7810,in,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7811,males,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
7812,.,O,258.0,There was no indication of an effect of alcohol in either sex or of beer in males .
8008,Macronutrient,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8009,analysis,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8010,revealed,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8011,that,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8012,25.4,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8013,%,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8014,of,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8015,the,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8016,products,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8017,could,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8018,be,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8019,labeled,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8020,as,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8021,a,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8022,source,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8023,of,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8024,fiber,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
8025,.,O,267.0,Macronutrient analysis revealed that 25.4 % of the products could be labeled as a source of fiber .
9615,One,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9616,FT,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9617,homolog,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9618,",",O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9619,GmFT7,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9620,showed,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9621,strong,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9622,expression,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9623,during,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9624,soybean,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9625,floral,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9626,transition,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9627,.,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9811,Brain,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9812,-,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9813,derived,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9814,cell,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9815,cultures,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9816,from,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9817,rats,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9818,were,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9819,prepared,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9820,and,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9821,grown,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9822,for,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9823,about,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9824,2,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9825,weeks,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9826,.,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9827,Cell,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9828,cultures,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9829,were,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9830,treated,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9831,with,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9832,glutamate,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9833,(,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9834,100,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9835,μM,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9836,),O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9837,for,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9838,24,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9839,h,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9840,",",O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9841,and,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9842,the,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9843,effect,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9844,of,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9845,extracts,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9846,was,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9847,determined,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9848,on,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9849,cells,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9850,subjected,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9851,to,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9852,this,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9853,excitotoxicity,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9854,.,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
10067,Excessive,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10068,alcohol,B-AG.01.y.01,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10069,consumption,B-X,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10070,among,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10071,smokers,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10072,appears,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10073,to,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10074,be,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10075,associated,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10076,with,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10077,an,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10078,elevated,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10079,risk,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10080,of,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10081,cancers,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10082,of,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10083,the,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10084,oral,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10085,cavity,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10086,",",O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10087,esophagus,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10088,",",O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10089,larynx,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10090,",",O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10091,and,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10092,respiratory,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10093,tract,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10094,.,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10095,Interim,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10096,dietary,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10097,guidelines,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10098,to,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10099,reduce,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10100,the,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10101,risk,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10102,of,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10103,cancer,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10104,were,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10105,proposed,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10106,in,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10107,accordance,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10108,with,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10109,these,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10110,conclusions,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10111,.,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10178,This,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10179,risk,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10180,assessment,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10181,covers,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10182,edible,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10183,parts,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10184,of,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10185,potato,B-AG.01.h.02.a,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10186,plants,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10187,and,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10188,other,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10189,food,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10190,plants,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10191,containing,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10192,GAs,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10193,",",O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10194,in,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10195,particular,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10196,",",O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10197,tomato,B-AG.01.h.02.f,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10198,and,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10199,aubergine,B-AG.01.h.02.f,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10200,.,O,342.0,"This risk assessment covers edible parts of potato plants and other food plants containing GAs , in particular , tomato and aubergine ."
10535,The,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10536,plant,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10537,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10538,based,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10539,emulsions,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10540,are,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10541,directed,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10542,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10543,prevent,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10544,diet,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10545,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10546,related,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10547,chronic,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10548,diseases,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10549,including,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10550,diabetes,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10551,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10552,cardiovascular,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10553,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10554,obesity,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10555,and,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10556,other,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10557,disorders,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10558,due,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10559,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10560,the,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10561,presence,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10562,of,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10563,healthy,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10564,long,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10565,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10566,chain,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10567,unsaturated,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10568,fatty,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10569,acids,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10570,as,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10571,compared,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10572,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10573,bovine,B-AG.01.e,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10574,milk,I-AG.01.e,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10575,.,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10604,The,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10605,review,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10606,aims,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10607,to,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10608,summarize,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10609,the,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10610,four,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10611,different,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10612,groups,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10613,of,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10614,plant,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10615,sources,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10616,(,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10617,nuts,B-AG.01.h.01.f,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10618,",",O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10619,cereals,B-AG.01.i,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10620,",",O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10621,seeds,B-AG.01,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10622,and,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10623,legumes,B-AG.01.h.02.g,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10624,),O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10625,used,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10626,for,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10627,the,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10628,preparation,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10629,of,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10630,plant,B-AG.01,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10631,-,I-AG.01,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10632,based,I-AG.01,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10633,milk,I-AG.01,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10634,beverages,I-AG.01,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10635,.,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10958,In,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10959,conclusion,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10960,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10961,glucose,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10962,tolerance,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10963,status,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10964,did,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10965,not,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10966,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10967,in,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10968,general,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10969,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10970,affect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10971,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10972,predictive,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10973,effect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10974,of,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10975,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10976,dietary,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10977,patterns,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10978,.,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
11106,Our,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11107,objective,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11108,was,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11109,to,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11110,evaluate,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11111,the,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11112,association,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11113,between,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11114,the,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11115,substitution,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11116,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11117,a,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11118,serving,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11119,per,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11120,day,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11121,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11122,water,B-AG.01.z,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11123,for,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11124,another,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11125,beverage,B-AG.01.y,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11126,(,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11127,or,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11128,group,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11129,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11130,them,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11131,),O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11132,and,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11133,the,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11134,incidence,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11135,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11136,obesity,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11137,and,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11138,weight,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11139,change,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11140,in,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11141,a,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11142,Mediterranean,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11143,cohort,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11144,",",O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11145,using,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11146,mathematical,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11147,models,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11148,.,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11394,Components,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11395,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11396,the,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11397,Mediterranean,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11398,diet,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11399,associated,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11400,with,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11401,better,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11402,cardiovascular,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11403,health,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11404,include,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11405,low,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11406,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11407,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11408,meat,B-AG.01.d,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11409,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11410,meat,B-AG.01.d,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11411,products,I-AG.01.d,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11412,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11413,moderate,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11414,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11415,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11416,ethanol,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11417,(,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11418,mostly,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11419,from,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11420,wine,B-AG.01.y.01.a,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11421,),O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11422,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11423,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11424,high,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11425,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11426,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11427,vegetables,B-AG.01.h.02,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11428,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11429,fruits,B-AG.01.h.01,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11430,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11431,nuts,B-AG.01.h.01.f,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11432,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11433,legumes,B-AG.01.h.02.g,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11434,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11435,fish,B-AG.01.d.07,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11436,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11437,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11438,olive,B-AG.01.f,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11439,oil,I-AG.01.f,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11440,.,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11571,In,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11572,addition,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11573,a,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11574,group,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11575,of,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11576,45,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11577,female,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11578,control,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11579,workers,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11580,matched,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11581,by,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11582,sex,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11583,",",O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11584,age,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11585,",",O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11586,and,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11587,smoking,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11588,habit,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11589,were,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11590,also,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11591,studied,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11592,.,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11624,Increased,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11625,IgE,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11626,serum,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11627,levels,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11628,were,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11629,found,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11630,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11631,36.8,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11632,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11633,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11634,exposed,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11635,and,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11636,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11637,9.7,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11638,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11639,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11640,the,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11641,control,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11642,workers,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11643,(,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11644,P,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11645,less,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11646,than,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11647,0.01,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11648,),O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11649,.,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11650,The,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11651,prevalence,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11652,of,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11653,chronic,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11654,respiratory,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11655,symptoms,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11656,was,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11657,significantly,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11658,higher,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11659,in,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11660,the,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11661,exposed,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11662,workers,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11663,than,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11664,in,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11665,the,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11666,control,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11667,workers,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11668,(,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11669,P,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11670,less,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11671,than,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11672,0.01,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11673,),O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11674,.,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
12731,The,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12732,possible,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12733,population,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12734,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12735,preventable,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12736,fraction,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12737,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12738,modifying,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12739,diet,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12740,in,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12741,relation,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12742,to,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12743,fruit,B-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12744,and,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12745,vegetable,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12746,consumption,B-X,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12747,was,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12748,calculated,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12749,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12750,well,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12751,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12752,an,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12753,overall,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12754,statement,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12755,about,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12756,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12757,degree,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12758,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12759,evidence,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12760,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12761,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12762,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12763,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12764,preventive,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12765,effect,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12766,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12767,fruit,B-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12768,and,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12769,vegetable,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12770,consumption,B-X,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12771,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12772,each,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12773,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12774,site,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12775,.,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12850,Applying,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12851,this,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12852,range,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12853,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12854,risk,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12855,difference,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12856,to,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12857,the,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12858,range,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12859,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12860,prevalence,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12861,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12862,low,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12863,intake,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12864,",",O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12865,the,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12866,preventable,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12867,fraction,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12868,for,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12869,low,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12870,fruit,B-AG.01.h,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12871,and,I-AG.01.h,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12872,vegetable,I-AG.01.h,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12873,intake,B-X,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12874,would,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12875,fall,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12876,into,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12877,the,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12878,range,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12879,of,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12880,5,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12881,-,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12882,12,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12883,%,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
12884,.,O,428.0,"Applying this range of risk difference to the range of prevalence of low intake , the preventable fraction for low fruit and vegetable intake would fall into the range of 5 - 12 % ."
13299,Postprandial,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13300,serum,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13301,insulin,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13302,concentration,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13303,AUC,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13304,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13305,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13306,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13307,during,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13308,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13309,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13310, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13311,+,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13312, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13313,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13314,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13315,compared,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13316,with,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13317,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13318,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13319,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13320,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13321,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13322, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13323,=,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13324, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13325,0·001,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13326,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13327,and,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13328,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13329,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13330,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13331,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13332,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13333, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13334,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13335, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13336,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13337,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13338,",",O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13339,which,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13340,in,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13341,turn,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13342,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13343,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13344,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13345,than,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13346,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13347,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13348,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13349,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13350,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13351, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13352,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13353, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13354,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13355,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13356,.,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13559,Dietary,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13560,intake,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13561,was,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13562,recorded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13563,daily,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13564,for,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13565,seven,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13566,consecutive,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13567,days,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13568,in,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13569,pre,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13570,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13571,coded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13572,food,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13573,records,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13574,supplemented,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13575,with,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13576,open,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13577,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13578,answer,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13579,possibilities,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13580,.,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13623,Boys,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13624,had,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13625,a,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13626,higher,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13627,intake,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13628,of,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13629,energy,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13630,(,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13631,P,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13632, ,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13633,≤,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13634, ,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13635,0·0001,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13636,),O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13637,and,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13638,all,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13639,types,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13640,of,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13641,gluten,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13642,",",O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13643,except,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13644,for,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13645,barley,B-AG.01.i,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13646,(,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13647,P,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13648, ,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13649,≤,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13650, ,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13651,0·87,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13652,),O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13653,.,O,454.0,"Boys had a higher intake of energy ( P   ≤   0·0001 ) and all types of gluten , except for barley ( P   ≤   0·87 ) ."
13743,Plant,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13744,lipid,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13745,transfer,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13746,proteins,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13747,",",O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13748,a,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13749,widespread,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13750,family,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13751,of,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13752,proteins,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13753,",",O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13754,have,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13755,been,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13756,recently,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13757,identified,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13758,as,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13759,important,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13760,food,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13761,allergens,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13762,.,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
27684,Plausible,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27685,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27686,was,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27687,based,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27688,on,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27689,strong,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27690,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27691,from,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27692,prospective,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27693,cohort,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27694,studies,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27695,only,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27696,.,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27757,Three,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27758,guidelines,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27759,on,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27760,vegetables,B-AG.01.h.02,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27761,",",O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27762,fruits,B-AG.01.h.01,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27763,",",O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27764,fish,B-AG.01.d.07,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27765,and,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27766,alcoholic,B-AG.01.y.01,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27767,beverages,I-AG.01.y.01,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27768,have,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27769,been,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27770,sharpened,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27771,",",O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27772,and,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27773,the,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27774,2006,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27775,guideline,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27776,on,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27777,salt,B-AG.01.l.01,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27778,stayed,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27779,the,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27780,same,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27781,.,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
29402,Adults,O,997.0,Adults often consume more fat than is recommended .
29403,often,O,997.0,Adults often consume more fat than is recommended .
29404,consume,O,997.0,Adults often consume more fat than is recommended .
29405,more,O,997.0,Adults often consume more fat than is recommended .
29406,fat,O,997.0,Adults often consume more fat than is recommended .
29407,than,O,997.0,Adults often consume more fat than is recommended .
29408,is,O,997.0,Adults often consume more fat than is recommended .
29409,recommended,O,997.0,Adults often consume more fat than is recommended .
29410,.,O,997.0,Adults often consume more fat than is recommended .
29948,We,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29949,analyzed,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29950,22,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29951,sera,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29952,from,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29953,patients,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29954,with,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29955,the,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29956,mugwort,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29957,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29958,birch,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29959,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29960,celery,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29961,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29962,spice,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29963,syndrome,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29964,for,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29965,IgE,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29966,binding,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29967,to,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29968,the,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29969,spices,B-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29970,pepper,I-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29971,and,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29972,paprika,B-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29973,by,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29974,immunoblotting,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29975,.,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
30251,Particular,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30252,concerns,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30253,center,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30254,on,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30255,free,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30256,-,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30257,roaming,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30258,chickens,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30259,",",O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30260,given,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30261,their,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30262,proximity,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30263,to,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30264,children,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30265,in,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30266,rural,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30267,settings,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30268,",",O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30269,but,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30270,findings,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30271,to,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30272,date,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30273,have,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30274,been,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30275,inconclusive,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30276,.,O,1024.0,"Particular concerns center on free - roaming chickens , given their proximity to children in rural settings , but findings to date have been inconclusive ."
30844,The,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30845,vegetable,B-AG.01.h.02,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30846,mixture,I-AG.01.h.02,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30847,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30848,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30849,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30850,2,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30851,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30852,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30853,consisted,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30854,of,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30855,the,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30856,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30857,individual,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30858,vegetables,B-AG.01.h.02,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30859,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30860,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30861,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30862,5,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30863,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30864,8,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30865,:,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30866,cauliflower,B-AG.01.h.02.d,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30867,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30868,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30869,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30870,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30871,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30872,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30873,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30874,carrots,B-AG.01.h.02.a,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30875,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30876,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30877,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30878,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30879,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30880,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30881,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30882,peas,B-AG.01.h.02.g,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30883,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30884,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30885,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30886,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30887,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30888,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30889,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30890,and,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30891,onions,B-AG.01.h.02.e,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30892,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30893,10,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30894,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30895,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30896,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30897,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30898,.,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
31017,These,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31018,genes,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31019,are,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31020,of,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31021,particular,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31022,interest,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31023,because,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31024,they,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31025,were,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31026,consistently,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31027,affected,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31028,and,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31029,could,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31030,be,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31031,involved,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31032,in,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31033,the,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31034,prevention,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31035,of,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31036,CRC,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31037,by,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31038,vegetable,B-AG.01.h.02,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31039,consumption,B-X,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31040,.,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31078,Experimental,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31079,studies,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31080,on,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31081,animals,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31082,or,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31083,cultured,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31084,human,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31085,cell,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31086,lines,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31087,support,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31088,a,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31089,role,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31090,of,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31091,polyphenols,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31092,in,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31093,the,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31094,prevention,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31095,of,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31096,cardiovascular,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31097,diseases,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31098,",",O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31099,cancers,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31100,",",O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31101,neurodegenerative,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31102,diseases,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31103,",",O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31104,diabetes,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31105,",",O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31106,or,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31107,osteoporosis,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31108,.,O,1051.0,"Experimental studies on animals or cultured human cell lines support a role of polyphenols in the prevention of cardiovascular diseases , cancers , neurodegenerative diseases , diabetes , or osteoporosis ."
31109,However,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31110,",",O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31111,it,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31112,is,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31113,very,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31114,difficult,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31115,to,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31116,predict,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31117,from,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31118,these,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31119,results,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31120,the,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31121,effects,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31122,of,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31123,polyphenol,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31124,intake,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31125,on,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31126,disease,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31127,prevention,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31128,in,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31129,humans,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31130,.,O,1052.0,"However , it is very difficult to predict from these results the effects of polyphenol intake on disease prevention in humans ."
31573,The,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31574,evidence,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31575,regarding,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31576,black,B-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31577,tea,I-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31578,is,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31579,less,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31580,clear,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31581,",",O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31582,with,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31583,some,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31584,indication,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31585,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31586,a,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31587,risk,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31588,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31589,colon,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31590,or,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31591,rectal,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31592,cancer,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31593,associated,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31594,with,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31595,regular,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31596,use,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31597,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31598,black,B-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31599,tea,I-AG.01.ac,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31600,.,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31643,From,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31644,the,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31645,limited,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31646,studies,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31647,that,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31648,suggest,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31649,a,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31650,favorable,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31651,effect,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31652,from,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31653,tea,B-AG.01.ac,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31654,",",O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31655,it,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31656,is,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31657,likely,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31658,that,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31659,benefits,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31660,are,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31661,restricted,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31662,to,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31663,high,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31664,intakes,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31665,in,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31666,high,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31667,-,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31668,risk,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31669,populations,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31670,.,O,1073.0,"From the limited studies that suggest a favorable effect from tea , it is likely that benefits are restricted to high intakes in high - risk populations ."
31690,This,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31691,report,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31692,examines,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31693,associations,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31694,of,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31695,various,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31696,food,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31697,groups,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31698,with,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31699,colon,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31700,cancer,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31701,in,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31702,African,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31703,-,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31704,Americans,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31705,and,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31706,Caucasians,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31707,from,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31708,a,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31709,case,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31710,-,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31711,control,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31712,study,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31713,.,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31796,Controls,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31797,generally,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31798,reported,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31799,higher,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31800,consumption,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31801,(,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31802,daily,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31803,amount,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31804,and,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31805,weekly,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31806,frequency,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31807,),O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31808,of,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31809,fruits,B-AG.01.h.01,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31810,",",O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31811,vegetables,B-AG.01.h.02,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31812,and,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31813,dark,B-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31814,green,I-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31815,",",I-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31816,deep,I-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31817,yellow,I-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31818,fruits,I-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31819,/,I-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31820,vegetables,I-AG.01.h,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31821,",",O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31822,whereas,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31823,cases,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31824,consumed,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31825,more,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31826,refined,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31827,carbohydrates,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31828,and,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31829,fats,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31830,",",O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31831,oils,B-AG.01.f,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31832,and,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31833,snacks,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31834,.,O,1079.0,"Controls generally reported higher consumption ( daily amount and weekly frequency ) of fruits , vegetables and dark green , deep yellow fruits / vegetables , whereas cases consumed more refined carbohydrates and fats , oils and snacks ."
31835,Regardless,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31836,of,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31837,ethnic,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31838,group,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31839,or,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31840,energy,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31841,adjustment,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31842,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31843,high,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31844,and,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31845,frequent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31846,vegetable,B-AG.01.h.02,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31847,consumption,B-X,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31848,(,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31849,particularly,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31850,dark,B-AG.01.h.02,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31851,green,I-AG.01.h.02,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31852,vegetables,I-AG.01.h.02,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31853,),O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31854,was,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31855,protective,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31856,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31857,consistent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31858,with,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31859,20,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31860,-,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31861,50,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31862,%,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31863,reductions,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31864,in,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31865,risk,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31866,.,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
32213,It,O,1093.0,It has been grown since at least 1000 BC in China .
32214,has,O,1093.0,It has been grown since at least 1000 BC in China .
32215,been,O,1093.0,It has been grown since at least 1000 BC in China .
32216,grown,O,1093.0,It has been grown since at least 1000 BC in China .
32217,since,O,1093.0,It has been grown since at least 1000 BC in China .
32218,at,O,1093.0,It has been grown since at least 1000 BC in China .
32219,least,O,1093.0,It has been grown since at least 1000 BC in China .
32220,1000,O,1093.0,It has been grown since at least 1000 BC in China .
32221,BC,O,1093.0,It has been grown since at least 1000 BC in China .
32222,in,O,1093.0,It has been grown since at least 1000 BC in China .
32223,China,O,1093.0,It has been grown since at least 1000 BC in China .
32224,.,O,1093.0,It has been grown since at least 1000 BC in China .
32412,The,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32413,trypsin,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32414,inhibitors,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32415,isolated,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32416,from,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32417,buckwheat,B-AG.01.i,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32418,seeds,I-AG.01.i,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32419,are,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32420,heat,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32421,stable,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32422,and,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32423,can,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32424,cause,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32425,poor,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32426,digestion,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32427,if,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32428,they,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32429,are,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32430,not,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32431,suitably,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32432,cooked,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32433,before,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32434,consumption,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32435,.,O,1102.0,The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption .
32506,Methods,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32507,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32508,exploit,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32509,buckwheat,B-AG.01.i,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32510,seeds,I-AG.01.i,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32511,and,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32512,flour,B-AG.01.k,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32513,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32514,produce,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32515,highly,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32516,effective,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32517,nutraceuticals,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32518,are,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32519,also,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32520,reviewed,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32521,.,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
33621,Livers,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33622,from,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33623,rats,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33624,fed,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33625,the,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33626,coconut,B-AG.01.f,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33627,oil,I-AG.01.f,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33628,diet,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33629,had,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33630,more,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33631,saturated,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33632,phospholipid,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33633,fatty,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33634,acids,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33635,than,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33636,those,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33637,from,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33638,rats,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33639,fed,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33640,the,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33641,corn,B-AG.01.f,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33642,oil,I-AG.01.f,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33643,diet,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
33644,.,O,1147.0,Livers from rats fed the coconut oil diet had more saturated phospholipid fatty acids than those from rats fed the corn oil diet .
35006,Purchase,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35007,intent,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35008,of,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35009,all,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35010,flavored,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35011,products,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35012,also,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35013,significantly,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35014,increased,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35015,once,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35016,consumers,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35017,had,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35018,been,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35019,given,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35020,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35021,information,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35022,about,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35023,potential,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35024,health,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35025,benefits,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35026,associated,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35027,with,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35028,RBO,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35029,and,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35030,SPC,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35031,in,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35032,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35033,spreads,B-AG.01,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35034,.,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35330,Researchers,O,1204.0,Researchers do not understand what causes ovarian cancer .
35331,do,O,1204.0,Researchers do not understand what causes ovarian cancer .
35332,not,O,1204.0,Researchers do not understand what causes ovarian cancer .
35333,understand,O,1204.0,Researchers do not understand what causes ovarian cancer .
35334,what,O,1204.0,Researchers do not understand what causes ovarian cancer .
35335,causes,O,1204.0,Researchers do not understand what causes ovarian cancer .
35336,ovarian,O,1204.0,Researchers do not understand what causes ovarian cancer .
35337,cancer,O,1204.0,Researchers do not understand what causes ovarian cancer .
35338,.,O,1204.0,Researchers do not understand what causes ovarian cancer .
35559, ,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35560,Using,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35561,the,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35562,case,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35563,control,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35564,data,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35565,",",O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35566,others,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35567,found,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35568,an,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35569,increased,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35570,risk,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35571,for,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35572,total,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35573,lactose,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35574,intake,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35575,in,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35576,women,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35577,who,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35578,never,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35579,used,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35580,oral,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35581,contraceptives,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35582,(,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35583,OCs,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35584,),O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35585,.,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35632, ,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35633,2,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35634,studies,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35635,showed,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35636,that,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35637,low,B-AG.01.e,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35638,fat,I-AG.01.e,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35639,milk,I-AG.01.e,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35640,was,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35641,associated,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35642,with,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35643,decreased,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35644,risk,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35645,",",O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35646,even,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35647,though,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35648,both,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35649,milks,B-AG.01.e,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35650,have,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35651,the,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35652,same,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35653,lactose,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35654,content,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35655,.,O,1218.0,"  2 studies showed that low fat milk was associated with decreased risk , even though both milks have the same lactose content ."
35940,A,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35941,strong,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35942,negative,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35943,correlation,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35944,was,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35945,identified,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35946,between,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35947,mammary,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35948,vascular,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35949,permeability,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35950,and,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35951,milk,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35952,perchlorate,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35953,concentrations,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35954,in,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35955,LPS,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35956,-,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35957,infused,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35958,glands,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
35959,.,O,1232.0,A strong negative correlation was identified between mammary vascular permeability and milk perchlorate concentrations in LPS - infused glands .
36015,The,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36016,overall,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36017,finding,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36018,that,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36019,mastitis,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36020,results,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36021,in,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36022,lower,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36023,milk,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36024,perchlorate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36025,concentrations,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36026,suggests,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36027,that,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36028,changes,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36029,in,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36030,udder,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36031,health,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36032,do,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36033,not,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36034,necessitate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36035,increased,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36036,screening,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36037,of,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36038,milk,B-AG.01.e,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36039,for,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36040,perchlorate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36041,.,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36607,Cancer,O,1251.0,Cancer is increasing worldwide .
36608,is,O,1251.0,Cancer is increasing worldwide .
36609,increasing,O,1251.0,Cancer is increasing worldwide .
36610,worldwide,O,1251.0,Cancer is increasing worldwide .
36611,.,O,1251.0,Cancer is increasing worldwide .
36675,Epidemiology,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36676,identifies,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36677,associations,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36678,between,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36679,aspects,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36680,of,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36681,diet,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36682,",",O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36683,nutrition,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36684,",",O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36685,and,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36686,physical,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36687,activity,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36688,with,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36689,one,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36690,or,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36691,more,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36692,cancers,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36693,;,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36694,there,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36695,is,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36696,evidence,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36697,for,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36698,plausible,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36699,mechanisms,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36700,that,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36701,imply,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36702,that,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36703,these,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36704,are,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36705,causal,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36706,.,O,1255.0,"Epidemiology identifies associations between aspects of diet , nutrition , and physical activity with one or more cancers ; there is evidence for plausible mechanisms that imply that these are causal ."
36974,Many,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36975,herbal,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36976,medicines,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36977,are,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36978,used,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36979,in,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36980,traditional,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36981,medicine,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36982,for,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36983,their,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36984,protective,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36985,and,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36986,therapeutic,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36987,properties,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36988,against,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36989,liver,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36990,diseases,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36991,.,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
37200,Individual,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37201,NOAELs,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37202,and,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37203,LOAELs,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37204,were,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37205,obtained,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37206,from,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37207,clinical,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37208,challenges,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37209,of,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37210,food,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37211,-,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37212,allergic,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37213,subjects,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37214,.,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37215,Statistical,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37216,dose,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37217,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37218,distribution,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37219,models,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37220,(,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37221,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37222,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37223,normal,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37224,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37225,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37226,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37227,logistic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37228,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37229,Weibull,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37230,),O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37231,were,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37232,applied,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37233,to,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37234,the,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37235,individual,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37236,NOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37237,and,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37238,LOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37239,for,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37240,each,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37241,allergenic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37242,food,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37243,.,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37244,The,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37245,Reference,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37246,Doses,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37247,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37248,in,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37249,terms,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37250,of,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37251,mg,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37252,of,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37253,total,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37254,protein,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37255,from,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37256,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37257,allergenic,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37258,food,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37259,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37260,were,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37261,based,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37262,upon,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37263,either,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37264,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37265,ED01,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37266,(,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37267,for,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37268,peanut,B-AG.01.h.01.f,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37269,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37270,cow,B-AG.01.e,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37271,'s,I-AG.01.e,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37272,milk,I-AG.01.e,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37273,),O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37274,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37275,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37276,95,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37277,%,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37278,lower,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37279,confidence,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37280,interval,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37281,of,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37282,the,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37283,ED05,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37284,(,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37285,for,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37286,wheat,B-AG.01.i,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37287,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37288,soybean,B-AG.01.h.02.g,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37289,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37290,cashew,B-AG.01.h.01.f,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37291,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37292,shrimp,B-AG.01.d.07,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37293,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37294,sesame,B-AG.01,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37295,seed,I-AG.01,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37296,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37297,mustard,B-AG.01.l.03,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37298,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37299,and,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37300,lupine,B-AG.01.h.02.g,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37301,),O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37302,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37303,or,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37304,both,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37305,(,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37306,egg,B-AG.01.g,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37307,",",O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37308,hazelnut,B-AG.01.h.01.f,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37309,),O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37310,using,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37311,all,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37312,appropriate,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37313,statistical,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37314,dose,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37315,-,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37316,distribution,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37317,models,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37318,.,O,1275.0,"The Reference Doses , in terms of mg of total protein from the allergenic food , were based upon either the ED01 ( for peanut , cow 's milk ) , the 95 % lower confidence interval of the ED05 ( for wheat , soybean , cashew , shrimp , sesame seed , mustard , and lupine ) , or both ( egg , hazelnut ) using all appropriate statistical dose - distribution models ."
37341,Reference,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37342,Doses,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37343,were,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37344,not,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37345,established,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37346,for,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37347,fish,B-AG.01.d.07,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37348,or,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37349,celery,B-AG.01.h.02.b,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37350,due,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37351,to,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37352,poor,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37353,model,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37354,fits,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37355,with,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37356,existing,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37357,data,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37358,.,O,1277.0,Reference Doses were not established for fish or celery due to poor model fits with existing data .
37691,The,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37692,hypothesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37693,that,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37694,meat,B-AG.01.d,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37695,intake,B-X,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37696,can,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37697,increase,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37698,fecal,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37699,NOC,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37700,levels,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37701,and,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37702,colon,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37703,carcinogenesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37704,was,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37705,tested,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37706,in,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37707,175,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37708,Fischer,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37709,344,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37710,rats,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37711,.,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37745,Promotion,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37746,was,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37747,assessed,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37748,by,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37749,the,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37750,multiplicity,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37751,of,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37752,ACF,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37753,(,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37754,crypts,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37755,per,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37756,ACF,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37757,),O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37758,in,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37759,rats,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37760,given,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37761,experimental,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37762,diets,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37763,for,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37764,100,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37765,days,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37766,starting,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37767,7,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37768,days,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37769,after,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37770,an,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37771,azoxymethane,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37772,injection,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37773,.,O,1294.0,Promotion was assessed by the multiplicity of ACF ( crypts per ACF ) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection .
37886,Rats,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37887,fed,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37888,a,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37889,diet,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37890,based,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37891,on,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37892,beef,B-AG.01.d.03,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37893,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37894,pork,B-AG.01.d.05,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37895,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37896,or,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37897,chicken,B-AG.01.d.06,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37898,meat,I-AG.01.d.06,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37899,had,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37900,less,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37901,fecal,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37902,NOC,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37903,than,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37904,controls,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37905,(,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37906,most,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37907,p,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37908,<,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37909,0.01,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37910,),O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37911,.,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
38390,Separate,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38391,analyses,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38392,relating,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38393,alcohol,B-AG.01.y.01,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38394,consumption,B-X,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38395,to,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38396,mortality,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38397,from,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38398,all,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38399,causes,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38400,showed,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38401,similar,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38402,effects,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38403,except,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38404,that,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38405,the,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38406,reduction,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38407,in,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38408,mortality,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38409,for,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38410,males,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38411,was,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38412,much,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38413,less,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38414,.,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38605,We,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38606,did,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38607,not,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38608,notice,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38609,a,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38610,relationship,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38611,between,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38612,the,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38613,total,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38614,phenolic,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38615,content,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38616,and,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38617,the,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38618,antioxidant,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38619,capacity,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38620,with,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38621,antiproliferative,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38622,effect,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38623,.,O,1327.0,We did not notice a relationship between the total phenolic content and the antioxidant capacity with antiproliferative effect .
38694,We,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38695,examined,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38696,the,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38697,association,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38698,of,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38699,alcohol,B-AG.01.y.01,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38700,consumption,B-X,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38701,and,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38702,lung,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38703,cancer,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38704,risk,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38705,in,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38706,a,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38707,large,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38708,pooled,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38709,international,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38710,sample,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38711,",",O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38712,minimizing,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38713,potential,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38714,confounding,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38715,of,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38716,tobacco,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38717,consumption,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38718,by,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38719,restricting,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38720,analyses,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38721,to,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38722,never,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38723,smokers,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
38724,.,O,1332.0,"We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample , minimizing potential confounding of tobacco consumption by restricting analyses to never smokers ."
39005,Confounding,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39006,in,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39007,relation,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39008,to,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39009,the,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39010,non,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39011,-,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39012,drinker,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39013,reference,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39014,category,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39015,may,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39016,be,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39017,of,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39018,particular,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39019,importance,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39020,.,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
40109,Differences,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40110,induced,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40111,by,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40112,the,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40113,dietary,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40114,perturbations,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40115,in,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40116,LDL,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40117,content,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40118,of,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40119,beta,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40120,-,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40121,cryptoxanthin,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40122,",",O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40123,lutein,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40124,/,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40125,zeaxanthin,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40126,",",O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40127,lycopene,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40128,",",O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40129,alpha,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40130,-,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40131,carotene,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40132,or,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40133,beta,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40134,-,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40135,carotene,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40136,",",O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40137,and,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40138,LDL,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40139,particle,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40140,size,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40141,were,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40142,not,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40143,related,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40144,to,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40145,resistance,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40146,of,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40147,LDL,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40148,to,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40149,oxidation,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40150,.,O,1376.0,"Differences induced by the dietary perturbations in LDL content of beta - cryptoxanthin , lutein / zeaxanthin , lycopene , alpha - carotene or beta - carotene , and LDL particle size were not related to resistance of LDL to oxidation ."
40697,The,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40698,effects,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40699,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40700,the,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40701,type,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40702,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40703,dietary,B-AG.01.f,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40704,fat,I-AG.01.f,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40705,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40706,180,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40707,g,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40708,/,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40709,kg,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40710,diet,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40711,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40712,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40713,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40714,calcium,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40715,phosphate,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40716,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40717,CaHPO4,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40718,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40719,supplementation,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40720,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40721,25,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40722,vs.,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40723,225,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40724,mmol,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40725,/,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40726,kg,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40727,diet,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40728,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40729,on,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40730,luminal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40731,solubility,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40732,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40733,fatty,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40734,acids,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40735,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40736,bile,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40737,acids,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40738,",",O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40739,cytotoxicity,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40740,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40741,fecal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40742,water,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40743,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40744,intestinal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40745,epitheliolysis,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40746,were,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40747,studied,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40748,in,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40749,rats,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40750,.,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40920,Intestinal,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40921,epitheliolysis,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40922,measured,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40923,as,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40924,alkaline,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40925,phosphatase,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40926,activity,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40927,in,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40928,fecal,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40929,water,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40930,was,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40931,lowered,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40932,comparably,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40933,to,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40934,the,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40935,reduction,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40936,in,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40937,cytotoxicity,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40938,by,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40939,supplemental,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40940,calcium,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40941,phosphate,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40942,.,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
41404,Glycemic,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41405,indices,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41406,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41407,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41408,rice,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41409,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41410,38,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41411,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41412,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41413,6,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41414,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41415,and,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41416,almond,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41417,meals,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41418,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41419,55,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41420,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41421,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41422,7,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41423,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41424,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41425,less,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41426,than,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41427,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41428,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41429,potato,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41430,meal,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41431,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41432,94,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41433,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41434,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41435,11,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41436,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41437,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41438,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41439,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41440,0.003,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41441,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41442,",",O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41443,as,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41444,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41445,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41446,postprandial,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41447,areas,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41448,under,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41449,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41450,insulin,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41451,concentration,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41452,time,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41453,curve,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41454,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41455,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41456,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41457,0.001,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41458,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41459,.,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41800,Flavonoid,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41801,consumption,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41802,was,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41803,not,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41804,associated,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41805,with,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41806,diabetes,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41807,risk,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41808,after,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41809,multivariable,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41810,adjustment,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41811,.,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
42274,The,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42275,purpose,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42276,of,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42277,this,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42278,study,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42279,was,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42280,to,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42281,assess,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42282,the,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42283,effect,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42284,of,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42285,garlic,B-AG.01.h.02.e,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42286,on,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42287,the,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42288,liver,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42289,phosphatidate,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42290,phosphohydrolase,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42291,(,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42292,PAP,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42293,),O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42294,activity,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42295,",",O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42296,plasma,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42297,lipid,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42298,levels,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42299,",",O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42300,malondialdehyde,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42301,(,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42302,MDA,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42303,),O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42304,and,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42305,plasma,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42306,antioxidant,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42307,in,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42308,rats,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42309,fed,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42310,either,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42311,by,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42312,normal,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42313,or,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42314,high,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42315,-,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42316,lipogenic,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42317,diet,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42318,with,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42319,or,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42320,without,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42321,garlic,B-AG.01.h.02.e,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42322,.,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42323,Male,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42324,Wistar,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42325,rats,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42326,were,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42327,fed,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42328,by,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42329,standard,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42330,pellet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42331,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42332,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42333,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42334,I,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42335,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42336,",",O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42337,standard,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42338,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42339,supplemented,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42340,with,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42341,4,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42342,%,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42343,garlic,B-AG.01.h.02.e,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42344,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42345,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42346,II,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42347,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42348,",",O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42349,lipogenic,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42350,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42351,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42352,containing,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42353,sunflower,B-AG.01.f,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42354,oil,I-AG.01.f,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42355,",",O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42356,cholesterol,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42357,and,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42358,ethanol,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42359,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42360,plus,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42361,4,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42362,%,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42363,garlic,B-AG.01.h.02.e,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42364,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42365,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42366,III,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42367,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42368,and,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42369,only,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42370,lipogenic,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42371,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42372,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42373,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42374,IV,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42375,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42376,.,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
43364,More,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43365,studies,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43366,are,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43367,required,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43368,powered,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43369,for,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43370,primary,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43371,clinical,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43372,outcomes,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43373,together,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43374,with,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43375,the,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43376,development,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43377,of,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43378,standardized,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43379,product,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43380,formulations,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43381,that,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43382,optimize,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43383,the,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43384,dose,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43385,of,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43386,polyphenols,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43387,within,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43388,a,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43389,palatable,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43390,and,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43391,energy,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43392,-,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43393,restricted,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43394,product,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43395,.,O,1489.0,More studies are required powered for primary clinical outcomes together with the development of standardized product formulations that optimize the dose of polyphenols within a palatable and energy - restricted product .
43881,Of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43882,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43883,tree,B-AG.01.h.01.f,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43884,nuts,I-AG.01.h.01.f,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43885,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43886,walnuts,B-AG.01.h.01.f,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43887,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43888,pecans,B-AG.01.h.01.f,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43889,and,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43890,chestnuts,B-AG.01.h.01.f,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43891,have,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43892,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43893,highest,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43894,contents,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43895,of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43896,antioxidants,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43897,.,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43983,Hazard,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43984,ratio,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43985,was,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43986,0.89,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43987,(,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43988,CI,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43989,=,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43990,0.81,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43991,-,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43992,0.97,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43993,),O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43994,and,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43995,0.81,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43996,(,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43997,CI,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43998,=,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
43999,0.75,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44000,-,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44001,0.88,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44002,),O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44003,for,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44004,nut,B-AG.01.h.01.f,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44005,/,I-AG.01.h.01.f,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44006,peanut,I-AG.01.h.01.f,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44007,butter,I-AG.01.h.01.f,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44008,intake,B-X,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44009,once,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44010,per,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44011,week,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44012,and,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44013,1,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44014,-,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44015,4,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44016,times,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44017,per,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44018,week,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44019,",",O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44020,respectively,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
44021,.,O,1515.0,"Hazard ratio was 0.89 ( CI = 0.81 - 0.97 ) and 0.81 ( CI = 0.75 - 0.88 ) for nut / peanut butter intake once per week and 1 - 4 times per week , respectively ."
45398,We,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45399,computed,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45400,the,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45401,odds,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45402,ratios,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45403,(,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45404,ORs,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45405,),O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45406,of,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45407,melanoma,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45408,and,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45409,the,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45410,corresponding,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45411,95,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45412,%,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45413,confidence,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45414,intervals,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45415,(,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45416,CIs,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45417,),O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45418,according,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45419,to,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45420,tertiles,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45421,of,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45422,daily,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45423,intake,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45424,of,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45425,each,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45426,food,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45427,item,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45428,",",O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45429,using,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45430,multiple,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45431,logistic,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45432,regression,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45433,models,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45434,adjusted,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45435,for,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45436,major,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45437,confounding,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45438,factors,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45439,.,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45495,etc,O,1573.0,etc .
45496,.,O,1573.0,etc .
45497,",",O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45498,(,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45499,OR,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45500,=,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45501,1.51,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45502,;,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45503,95,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45504,%,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45505,CI,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45506,1.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45507,-,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45508,2.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45509,),O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45510,and,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45511,cabbages,B-AG.01.h.02.d,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45512,(,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45513,OR,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45514,=,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45515,1.51,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45516,;,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45517,95,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45518,%,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45519,CI,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45520,1.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45521,-,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45522,2.09,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45523,),O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
45524,.,O,1574.0,", ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) and cabbages ( OR = 1.51 ; 95 % CI 1.09 - 2.09 ) ."
46104,Prevention,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46105,is,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46106,a,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46107,more,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46108,effective,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46109,strategy,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46110,than,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46111,is,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46112,treatment,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46113,of,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46114,chronic,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46115,diseases,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46116,.,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46523,Resolution,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46524,of,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46525,these,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46526,issues,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46527,is,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46528,needed,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46529,to,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46530,provide,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46531,optimal,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46532,guidance,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46533,regarding,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46534,healthy,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46535,diets,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46536,",",O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46537,and,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46538,the,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46539,newly,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46540,funded,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46541,Adventist,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46542,Health,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46543,Study,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46544,will,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46545,contribute,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46546,importantly,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46547,in,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46548,this,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46549,effort,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46550,.,O,1609.0,"Resolution of these issues is needed to provide optimal guidance regarding healthy diets , and the newly funded Adventist Health Study will contribute importantly in this effort ."
46580,We,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46581,examined,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46582,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46583,Barilla,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46584,Center,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46585,for,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46586,Food,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46587,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46588,Nutrition,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46589,'s,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46590,double,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46591,pyramid,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46592,to,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46593,describe,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46594,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46595,carbon,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46596,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46597,water,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46598,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46599,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46600,ecological,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46601,footprints,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46602,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46603,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46604,components,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46605,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46606,a,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46607,cardio,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46608,-,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46609,protective,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46610,diet,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46611,.,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
47043,Nine,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47044,healthy,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47045,subjects,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47046,aged,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47047,between,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47048,26,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47049,and,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47050,59,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47051,(,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47052,one,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47053,male,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47054,and,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47055,eight,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47056,females,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47057,),O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47058,took,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47059,part,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47060,in,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47061,3,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47062,study,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47063,days,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47064,.,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47781,The,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47782,',O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47783,prudent,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47784,',O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47785,diet,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47786,did,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47787,not,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47788,show,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47789,a,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47790,significant,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47791,trend,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47792,with,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47793,cardiovascular,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47794,outcomes,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47795,or,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47796,mortality,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47797,.,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
48082,The,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48083,AAN,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48084,area,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48085,response,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48086,was,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48087,approximately,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48088,twofold,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48089,greater,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48090,following,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48091,ingestion,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48092,of,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48093,cottage,B-AG.01.e,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48094,cheese,I-AG.01.e,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48095,compared,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48096,with,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48097,egg,B-AG.01.g,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48098,white,I-AG.01.g,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48099,.,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48109,When,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48110,protein,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48111,was,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48112,ingested,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48113,with,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48114,glucose,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48115,",",O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48116,the,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48117,AAN,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48118,area,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48119,responses,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48120,were,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48121,additive,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48122,.,O,1663.0,"When protein was ingested with glucose , the AAN area responses were additive ."
48533,Eleven,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48534,trained,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48535,panelists,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48536,evaluated,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48537,the,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48538,snacks,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48539,and,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48540,found,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48541,eight,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48542,significantly,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48543,different,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48544,attributes,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48545,for,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48546,potato,B-AG.01.n.09,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48547,chips,I-AG.01.n.09,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48548,and,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48549,seven,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48550,significantly,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48551,different,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48552,attributes,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48553,for,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48554,puffed,B-AG.01.n.10,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48555,rice,I-AG.01.n.10,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48556,.,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
49273,A,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49274,longitudinal,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49275,study,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49276,was,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49277,conducted,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49278,to,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49279,assess,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49280,to,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49281,what,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49282,extent,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49283,intramammary,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49284,infection,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49285,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49286,IMI,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49287,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49288,with,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49289,non,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49290,-,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49291,aureus,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49292,staphylococci,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49293,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49294,NAS,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49295,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49296,within,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49297,the,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49298,first,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49299,4,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49300,d,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49301,after,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49302,calving,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49303,in,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49304,dairy,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49305,heifers,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49306,affects,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49307,quarter,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49308,milk,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49309,yield,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49310,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49311,qMY,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49312,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49313,and,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49314,quarter,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49315,milk,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49316,somatic,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49317,cell,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49318,count,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49319,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49320,qSCC,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49321,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49322,during,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49323,the,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49324,first,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49325,4,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49326,mo,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49327,of,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49328,lactation,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49329,.,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49565,The,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49566,main,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49567,operators,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49568,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49569,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49570,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49571,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49572,sector,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49573,are,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49574,continuously,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49575,involved,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49576,in,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49577,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49578,development,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49579,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49580,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49581,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49582,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49583,mechanical,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49584,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49585,process,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49586,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49587,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49588,common,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49589,aim,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49590,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49591,increasing,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49592,both,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49593,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49594,quality,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49595,and,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49596,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49597,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49598,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49599,yield,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49600,coupled,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49601,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49602,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49603,potential,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49604,enhancement,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49605,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49606,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49607,working,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49608,efficiency,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49609,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49610,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49611,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49612,mill,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49613,.,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49975,Total,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49976,plasma,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49977,cholesterol,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49978,(,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49979,TPC,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49980,),O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49981,",",O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49982,LDL,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49983,-,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49984,C,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49985,",",O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49986,and,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49987,HDL,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49988,-,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49989,C,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49990,distributions,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49991,were,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49992,determined,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49993,by,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49994,high,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49995,-,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49996,performance,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49997,gel,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49998,filtration,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49999,chromatography,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50000,",",O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50001,while,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50002,aortic,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50003,total,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50004,cholesterol,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50005,(,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50006,TC,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50007,),O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50008,and,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50009,cholesteryl,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50010,ester,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50011,(,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50012,CE,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50013,),O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50014,were,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50015,determined,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50016,by,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50017,gas,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50018,liquid,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50019,chromatography,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50020,.,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50154,It,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50155,has,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50156,been,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50157,reported,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50158,that,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50159,miso,B-AG.01.n.02,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50160,soup,I-AG.01.n.02,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50161,was,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50162,one,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50163,of,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50164,the,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50165,major,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50166,sources,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50167,of,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50168,daily,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50169,salt,B-AG.01.l.01,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50170,intake,B-X,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50171,in,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50172,Japanese,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50173,people,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
50174,.,O,1730.0,It has been reported that miso soup was one of the major sources of daily salt intake in Japanese people .
52095,The,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52096,mean,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52097,FA,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52098,content,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52099,of,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52100,bread,B-AG.01.n.11,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52101,was,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52102,2020,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52103,+,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52104,/-,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52105,940,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52106,micro,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52107,g,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52108,/,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52109,kg,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52110,.,O,1786.0,The mean FA content of bread was 2020 + /- 940 micro g / kg .
52900,All,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52901,spices,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52902,exhibited,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52903,inhibitory,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52904,activity,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52905,against,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52906,selected,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52907,Ruminococcus,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52908,species,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
52909,.,O,1817.0,All spices exhibited inhibitory activity against selected Ruminococcus species .
53200,The,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53201,latter,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53202,GI,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53203,also,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53204,differed,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53205,considerably,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53206,from,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53207,its,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53208,predicted,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53209,value,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53210,of,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53211,103,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53212,",",O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53213,which,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53214,was,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53215,based,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53216,on,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53217,the,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53218,individual,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53219,GI,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53220,of,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53221,the,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53222,components,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53223,of,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53224,the,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53225,meal,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53226,.,O,1829.0,"The latter GI also differed considerably from its predicted value of 103 , which was based on the individual GI of the components of the meal ."
53853,Water,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53854,scarcity,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53855,is,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53856,currently,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53857,affecting,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53858,many,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53859,areas,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53860,of,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53861,the,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53862,world,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53863,",",O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53864,reaching,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53865,worrying,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53866,levels,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53867,in,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53868,drought,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53869,areas,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53870,such,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53871,as,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53872,southern,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53873,Spain,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
53874,.,O,1855.0,"Water scarcity is currently affecting many areas of the world , reaching worrying levels in drought areas such as southern Spain ."
54083,Hazard,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54084,ratios,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54085,for,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54086,dietary,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54087,factors,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54088,were,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54089,calculated,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54090,by,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54091,Cox,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54092,'s,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54093,proportional,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54094,hazards,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54095,model,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54096,.,O,1865.0,Hazard ratios for dietary factors were calculated by Cox 's proportional hazards model .
54587,Using,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54588,case,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54589,-,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54590,cohort,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54591,analysis,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54592,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54593,the,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54594,authors,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54595,calculated,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54596,rate,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54597,ratios,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54598,and,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54599,95,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54600,%,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54601,confidence,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54602,intervals,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54603,adjusted,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54604,for,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54605,age,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54606,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54607,alcohol,B-AG.01.y.01,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54608,intake,B-X,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54609,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54610,and,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54611,family,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54612,history,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54613,of,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54614,colorectal,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54615,cancer,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54616,.,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54636,However,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54637,",",O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54638,among,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54639,women,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54640,",",O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54641,an,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54642,inverse,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54643,association,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54644,was,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54645,observed,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54646,with,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54647,vegetables,B-AG.01.h,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54648,and,I-AG.01.h,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54649,fruits,I-AG.01.h,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54650,combined,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54651,(,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54652,for,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54653,the,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54654,highest,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54655,quintile,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54656,vs.,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54657,the,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54658,lowest,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54659,",",O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54660,the,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54661,rate,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54662,ratio,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54663,was,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54664,0.66,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54665,(,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54666,95,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54667,%,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54668,confidence,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54669,interval,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54670,:,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54671,0.44,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54672,",",O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54673,1.01,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54674,),O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54675,),O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54676,.,O,1887.0,"However , among women , an inverse association was observed with vegetables and fruits combined ( for the highest quintile vs. the lowest , the rate ratio was 0.66 ( 95 % confidence interval : 0.44 , 1.01 ) ) ."
54864,Among,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54865,the,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54866,spices,B-AG.01.l.03,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54867,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54868,fenugreek,B-AG.01.l.03,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54869,seeds,I-AG.01.l.03,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54870,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54871,Trigonella,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54872,foenumgraecum,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54873,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54874,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54875,garlic,B-AG.01.h.02.e,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54876,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54877,Allium,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54878,sativum,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54879,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54880,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54881,onion,B-AG.01.l.03,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54882,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54883,Allium,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54884,cepa,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54885,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54886,",",O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54887,and,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54888,turmeric,B-AG.01.l.03,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54889,(,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54890,Curcuma,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54891,longa,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54892,),O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54893,have,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54894,been,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54895,experimentally,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54896,documented,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54897,to,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54898,possess,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54899,antidiabetic,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54900,potential,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
54901,.,O,1896.0,"Among the spices , fenugreek seeds ( Trigonella foenumgraecum ) , garlic ( Allium sativum ) , onion ( Allium cepa ) , and turmeric ( Curcuma longa ) have been experimentally documented to possess antidiabetic potential ."
55253,Besides,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55254,",",O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55255,anthocyanins,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55256,exhibited,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55257,anti,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55258,-,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55259,diabetic,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55260,properties,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55261,by,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55262,reducing,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55263,blood,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55264,glucose,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55265,and,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55266,HbA1c,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55267,levels,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55268,or,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55269,the,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55270,improvement,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55271,of,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55272,insulin,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55273,secretion,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55274,and,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55275,resistance,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55276,.,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55277,The,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55278,structure,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55279,-,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55280,activity,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55281,relationship,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55282,of,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55283,polyphenols,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55284,as,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55285,anti,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55286,-,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55287,diabetic,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55288,agents,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55289,in,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55290,humans,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55291,has,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55292,been,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55293,rarely,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55294,reported,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55295,.,O,1911.0,The structure - activity relationship of polyphenols as anti - diabetic agents in humans has been rarely reported .
55748,The,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55749,incidence,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55750,of,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55751,allergic,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55752,diarrhoea,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55753,induced,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55754,by,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55755,oral,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55756,administration,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55757,of,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55758,ovalbumin,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55759,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55760,systemically,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55761,immunised,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55762,mice,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55763,was,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55764,lower,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55765,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55766,mice,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55767,fed,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55768,Yukihikari,B-AG.01.i,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55769,",",O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55770,albeit,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55771,with,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55772,no,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55773,difference,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55774,in,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55775,serum,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55776,antibodies,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55777,specific,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55778,to,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55779,ovalbumin,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55780,.,O,1927.0,"The incidence of allergic diarrhoea induced by oral administration of ovalbumin in systemically immunised mice was lower in mice fed Yukihikari , albeit with no difference in serum antibodies specific to ovalbumin ."
55835,These,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55836,data,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55837,indicate,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55838,that,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55839,changes,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55840,in,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55841,the,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55842,gut,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55843,microbiota,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55844,of,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55845,mice,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55846,fed,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55847,Yukihikari,B-AG.01.i,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55848,could,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55849,be,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55850,advantageous,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55851,in,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55852,the,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55853,prevention,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55854,of,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55855,food,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55856,allergy,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
55857,.,O,1930.0,These data indicate that changes in the gut microbiota of mice fed Yukihikari could be advantageous in the prevention of food allergy .
56375,Oxidized,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56376,starches,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56377,have,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56378,been,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56379,utilized,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56380,in,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56381,many,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56382,coating,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56383,applications,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56384,for,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56385,their,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56386,adhesion,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56387,ability,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56388,.,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56675,Conversely,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56676,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56677,potato,B-AG.01.n.09,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56678,products,I-AG.01.n.09,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56679,are,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56680,less,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56681,known,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56682,for,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56683,their,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56684,contribution,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56685,of,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56686,key,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56687,micronutrients,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56688,(,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56689,vitamin,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56690,C,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56691,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56692,potassium,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56693,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56694,magnesium,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56695,),O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56696,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56697,fiber,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56698,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56699,and,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56700,phytochemicals,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56701,(,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56702,phenolics,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56703,and,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56704,carotenoids,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56705,),O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56706,.,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56707,More,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56708,recent,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56709,insight,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56710,into,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56711,the,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56712,nutritional,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56713,value,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56714,of,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56715,potatoes,B-AG.01.h.02.a,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56716,and,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56717,the,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56718,potential,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56719,of,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56720,potato,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56721,phytochemicals,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56722,to,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56723,modulate,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56724,oxidative,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56725,and,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56726,inflammatory,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56727,stress,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56728,as,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56729,well,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56730,as,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56731,the,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56732,potential,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56733,to,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56734,alter,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56735,glycemic,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56736,response,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56737,has,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56738,resulted,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56739,in,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56740,increased,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56741,interest,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56742,in,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56743,strategies,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56744,to,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56745,improve,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56746,and,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56747,leverage,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56748,the,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56749,nutritional,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56750,quality,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56751,of,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56752,processed,B-AG.01.n.09,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56753,potatoes,I-AG.01.n.09,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56754,.,O,1958.0,More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes .
56916,In,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56917,view,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56918,of,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56919,the,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56920,available,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56921,evidence,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56922,",",O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56923,it,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56924,has,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56925,become,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56926,acceptable,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56927,to,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56928,emphasize,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56929,the,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56930,role,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56931,of,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56932,optimum,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56933,nutrition,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56934,to,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56935,maintain,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56936,arterial,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56937,and,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56938,CV,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56939,health,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
56940,.,O,1964.0,"In view of the available evidence , it has become acceptable to emphasize the role of optimum nutrition to maintain arterial and CV health ."
57115,However,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57116,",",O,1972.0,"However , the way red meat is cooked and preserved matters ."
57117,the,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57118,way,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57119,red,B-AG.01.d,1972.0,"However , the way red meat is cooked and preserved matters ."
57120,meat,I-AG.01.d,1972.0,"However , the way red meat is cooked and preserved matters ."
57121,is,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57122,cooked,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57123,and,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57124,preserved,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57125,matters,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57126,.,O,1972.0,"However , the way red meat is cooked and preserved matters ."
57499,As,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57500,is,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57501,known,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57502,",",O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57503,diet,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57504,plays,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57505,an,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57506,important,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57507,role,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57508,in,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57509,the,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57510,management,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57511,of,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57512,diabetes,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57513,.,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57582,Anthropometric,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57583,measurements,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57584,were,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57585,taken,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57586,and,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57587,blood,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57588,parameters,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57589,were,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57590,measured,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
57591,.,O,1993.0,Anthropometric measurements were taken and blood parameters were measured .
58166,The,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58167,control,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58168,meal,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58169,consisted,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58170,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58171,50,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58172,g,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58173,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58174,available,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58175,carbohydrate,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58176,",",O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58177,whereas,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58178,all,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58179,other,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58180,test,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58181,meals,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58182,contained,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58183,additional,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58184,25,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58185,g,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58186,of,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58187,protein,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58188,.,O,2005.0,"The control meal consisted of 50 g of available carbohydrate , whereas all other test meals contained additional 25 g of protein ."
58254,The,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58255,four,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58256,test,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58257,meals,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58258,studied,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58259,showed,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58260,varying,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58261,effects,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58262,",",O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58263,with,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58264,RWT,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58265,showing,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58266,the,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58267,greatest,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58268,reduction,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58269,in,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58270,glycaemic,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58271,response,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58272,.,O,2009.0,"The four test meals studied showed varying effects , with RWT showing the greatest reduction in glycaemic response ."
58602,Addressing,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58603,intake,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58604,of,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58605,liquid,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58606,UPF,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58607,and,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58608,processed,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58609,meats,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58610,may,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58611,help,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58612,in,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58613,managing,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58614,hypertension,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58615,in,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58616,LMIC,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58617,.,O,2023.0,Addressing intake of liquid UPF and processed meats may help in managing hypertension in LMIC .
58836,Diets,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58837,high,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58838,in,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58839,glycaemic,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58840,index,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58841,(,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58842,GI,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58843,),O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58844,and,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58845,glycaemic,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58846,load,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58847,(,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58848,GL,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58849,),O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58850,have,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58851,been,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58852,associated,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58853,with,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58854,a,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58855,higher,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58856,diabetes,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58857,risk,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58858,.,O,2033.0,Diets high in glycaemic index ( GI ) and glycaemic load ( GL ) have been associated with a higher diabetes risk .
58992,Stepwise,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58993,linear,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58994,regression,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58995,identified,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58996,contribution,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58997,to,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58998,inter,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
58999,-,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59000,individual,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59001,variation,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59002,in,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59003,dietary,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59004,GI,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59005,and,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59006,GL,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59007,.,O,2040.0,Stepwise linear regression identified contribution to inter - individual variation in dietary GI and GL .
59082,In,O,2045.0,"In conclusion , beer is a high - GI food ."
59083,conclusion,O,2045.0,"In conclusion , beer is a high - GI food ."
59084,",",O,2045.0,"In conclusion , beer is a high - GI food ."
59085,beer,B-AG.01.y.01.b,2045.0,"In conclusion , beer is a high - GI food ."
59086,is,O,2045.0,"In conclusion , beer is a high - GI food ."
59087,a,O,2045.0,"In conclusion , beer is a high - GI food ."
59088,high,O,2045.0,"In conclusion , beer is a high - GI food ."
59089,-,O,2045.0,"In conclusion , beer is a high - GI food ."
59090,GI,O,2045.0,"In conclusion , beer is a high - GI food ."
59091,food,O,2045.0,"In conclusion , beer is a high - GI food ."
59092,.,O,2045.0,"In conclusion , beer is a high - GI food ."
59355,A,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59356,decrease,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59357,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59358,D,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59359,-,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59360,ROMS,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59361,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59362,the,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59363,RD,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59364,and,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59365,an,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59366,increase,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59367,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59368,albumin,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59369,and,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59370,an,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59371,increased,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59372,tendency,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59373,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59374,cytotoxicity,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59375,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59376,the,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59377,TD,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59378,were,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59379,observed,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59380,.,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59696,Strongly,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59697,depending,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59698,on,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59699,the,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59700,individual,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59701,fecal,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59702,inoculum,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59703,",",O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59704,colonic,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59705,digestion,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59706,of,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59707,beef,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59708,resulted,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59709,in,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59710,significantly,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59711,higher,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59712,concentrations,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59713,of,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59714,the,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59715,NOC,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59716,-,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59717,specific,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59718,DNA,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59719,adduct,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59720,O(6)-carboxymethyl,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59721,-,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59722,guanine,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59723,compared,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59724,to,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59725,chicken,B-AG.01.d.06,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59726,and,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59727,pork,B-AG.01.d.05,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59728,",",O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59729,whereas,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59730,nitrite,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59731,curing,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59732,had,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59733,no,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59734,significant,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59735,effect,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59736,.,O,2066.0,"Strongly depending on the individual fecal inoculum , colonic digestion of beef resulted in significantly higher concentrations of the NOC - specific DNA adduct O(6)-carboxymethyl - guanine compared to chicken and pork , whereas nitrite curing had no significant effect ."
59737,This,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59738,study,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59739,confirms,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59740,previously,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59741,reported,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59742,evidence,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59743,that,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59744,heme,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59745,-,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59746,Fe,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59747,is,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59748,involved,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59749,in,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59750,the,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59751,epidemiological,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59752,association,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59753,between,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59754,red,B-AG.01.d,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59755,meat,I-AG.01.d,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59756,consumption,B-X,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59757,and,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59758,colorectal,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59759,cancer,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59760,",",O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59761,but,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59762,questions,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59763,the,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59764,role,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59765,of,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59766,nitrite,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59767,curing,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59768,in,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59769,this,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59770,association,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59771,.,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
60120,When,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60121,omnivorous,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60122,individuals,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60123,change,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60124,to,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60125,a,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60126,plant,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60127,-,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60128,based,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60129,diet,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60130,",",O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60131,diet,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60132,quality,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60133,as,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60134,measured,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60135,by,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60136,the,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60137,Alternate,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60138,Healthy,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60139,Eating,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60140,Index,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60141,improves,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60142,",",O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60143,and,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60144,the,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60145,risk,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60146,of,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60147,these,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60148,health,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60149,problems,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60150,diminishes,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60151,.,O,2081.0,"When omnivorous individuals change to a plant - based diet , diet quality as measured by the Alternate Healthy Eating Index improves , and the risk of these health problems diminishes ."
60942,After,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60943,calving,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60944,",",O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60945,body,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60946,condition,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60947,score,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60948,(,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60949,BCS,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60950,),O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60951,decrease,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60952,was,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60953,greater,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60954,for,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60955,control,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60956,compared,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60957,with,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60958,treated,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60959,cows,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60960,.,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
61093,However,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61094,",",O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61095,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61096,molecular,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61097,mechanisms,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61098,responsible,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61099,for,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61100,this,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61101,preventive,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61102,activity,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61103,and,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61104,whether,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61105,cocoa,B-AG.01,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61106,exerts,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61107,potential,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61108,beneficial,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61109,effects,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61110,on,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61111,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61112,insulin,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61113,signaling,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61114,pathway,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61115,in,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61116,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61117,liver,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61118,remain,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61119,largely,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61120,unknown,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61121,.,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61326,These,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61327,findings,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61328,suggest,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61329,that,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61330,cocoa,B-AG.01,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61331,has,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61332,the,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61333,potential,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61334,to,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61335,alleviate,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61336,both,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61337,hyperglycemia,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61338,and,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61339,hepatic,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61340,insulin,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61341,resistance,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61342,in,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61343,type,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61344,2,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61345,diabetic,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61346,ZDF,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61347,rats,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61348,.,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61537,There,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61538,was,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61539,no,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61540,credible,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61541,evidence,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61542,linking,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61543,sugar,B-AG.01.l.02,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61544,with,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61545,attention,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61546,-,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61547,deficit,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61548,",",O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61549,dementia,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61550,",",O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61551,or,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61552,depression,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61553,.,O,2136.0,"There was no credible evidence linking sugar with attention - deficit , dementia , or depression ."
61748,The,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61749,main,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61750,pharmacological,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61751,actions,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61752,of,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61753,ginger,B-AG.01.l.03,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61754,and,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61755,compounds,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61756,isolated,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61757,therefrom,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61758,include,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61759,immuno,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61760,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61761,modulatory,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61762,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61763,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61764,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61765,tumorigenic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61766,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61767,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61768,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61769,inflammatory,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61770,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61771,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61772,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61773,apoptotic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61774,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61775,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61776,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61777,hyperglycemic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61778,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61779,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61780,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61781,lipidemic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61782,and,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61783,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61784,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61785,emetic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61786,actions,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61787,.,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
62071,Therefore,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62072,",",O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62073,we,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62074,were,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62075,interested,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62076,in,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62077,the,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62078,relation,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62079,with,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62080,extended,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62081,follow,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62082,-,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62083,up,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62084,",",O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62085,also,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62086,focusing,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62087,on,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62088,single,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62089,subtypes,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62090,and,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62091,a,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62092,variety,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62093,of,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62094,intake,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62095,of,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62096,fruit,B-AG.01.h.01,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62097,and,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62098,vegetables,B-AG.01.h.02,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62099,.,O,2152.0,"Therefore , we were interested in the relation with extended follow - up , also focusing on single subtypes and a variety of intake of fruit and vegetables ."
62228,Variety,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62229,in,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62230,consumption,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62231,of,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62232,fruits,B-AG.01.h.01,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62233,and,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62234,vegetables,B-AG.01.h.02,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62235,was,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62236,not,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62237,associated,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62238,with,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62239,a,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62240,lower,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62241,risk,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62242,of,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62243,colon,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62244,or,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62245,rectal,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62246,cancer,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62247,.,O,2159.0,Variety in consumption of fruits and vegetables was not associated with a lower risk of colon or rectal cancer .
62314,Radioallergosorbent,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62315,testing,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62316,(,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62317,RAST,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62318,),O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62319,of,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62320,sera,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62321,from,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62322,subjects,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62323,sensitized,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62324,to,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62325,wheat,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62326,and,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62327,rye,B-AG.01.k,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62328,flour,I-AG.01.k,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62329,indicated,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62330,that,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62331,there,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62332,is,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62333,significant,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62334,reaction,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62335,with,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62336,seed,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62337,extracts,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62338,of,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62339,12,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62340,cereals,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62341,(,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62342,wheat,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62343,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62344,durum,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62345,wheat,I-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62346,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62347,triticale,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62348,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62349,cereal,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62350,rye,I-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62351,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62352,barley,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62353,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62354,rye,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62355,grass,I-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62356,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62357,oats,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62358,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62359,canary,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62360,grass,I-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62361,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62362,rice,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62363,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62364,maize,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62365,",",O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62366,sorghum,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62367,and,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62368,Johnson,B-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62369,grass,I-AG.01.i,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62370,),O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62371,.,O,2162.0,"Radioallergosorbent testing ( RAST ) of sera from subjects sensitized to wheat and rye flour indicated that there is significant reaction with seed extracts of 12 cereals ( wheat , durum wheat , triticale , cereal rye , barley , rye grass , oats , canary grass , rice , maize , sorghum and Johnson grass ) ."
62418,Much,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62419,higher,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62420,RAST,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62421,uptakes,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62422,were,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62423,obtained,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62424,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62425,sera,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62426,from,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62427,four,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62428,asthmatic,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62429,bakers,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62430,when,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62431,tested,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62432,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62433,wheat,B-AG.01.i,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62434,and,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62435,its,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62436,close,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62437,relatives,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62438,",",O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62439,but,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62440,there,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62441,was,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62442,still,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62443,reasonably,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62444,high,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62445,reactivity,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62446,with,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62447,more,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62448,distantly,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62449,related,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62450,cereals,B-AG.01.i,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62451,.,O,2165.0,"Much higher RAST uptakes were obtained with sera from four asthmatic bakers when tested with wheat and its close relatives , but there was still reasonably high reactivity with more distantly related cereals ."
62551,Food,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62552,extracts,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62553,for,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62554,diagnostic,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62555,purposes,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62556,often,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62557,lack,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62558,sufficient,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62559,activity,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62560,and,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62561,consistency,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62562,.,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62563,Biologically,O,2171.0,Biologically standardized food extracts are not available on the market .
62564,standardized,O,2171.0,Biologically standardized food extracts are not available on the market .
62565,food,O,2171.0,Biologically standardized food extracts are not available on the market .
62566,extracts,O,2171.0,Biologically standardized food extracts are not available on the market .
62567,are,O,2171.0,Biologically standardized food extracts are not available on the market .
62568,not,O,2171.0,Biologically standardized food extracts are not available on the market .
62569,available,O,2171.0,Biologically standardized food extracts are not available on the market .
62570,on,O,2171.0,Biologically standardized food extracts are not available on the market .
62571,the,O,2171.0,Biologically standardized food extracts are not available on the market .
62572,market,O,2171.0,Biologically standardized food extracts are not available on the market .
62573,.,O,2171.0,Biologically standardized food extracts are not available on the market .
62836,Since,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62837,all,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62838,parameters,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62839,were,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62840,tested,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62841,in,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62842,model,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62843,experiments,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62844,with,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62845,either,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62846,human,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62847,or,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62848,murine,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62849,IgE,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62850,",",O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62851,their,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62852,relevance,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62853,has,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62854,to,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62855,be,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62856,proven,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62857,in,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62858,further,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62859,clinical,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62860,investigations,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62861,.,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
63264,During,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63265,"2,193,751",O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63266,person,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63267,years,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63268,of,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63269,follow,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63270,-,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63271,up,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63272,",",O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63273,103,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63274,participants,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63275,were,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63276,diagnosed,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63277,with,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63278,ESCC,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63279,and,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63280,213,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63281,participants,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63282,with,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63283,EAC,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63284,.,O,2196.0,"During 2,193,751 person years of follow - up , 103 participants were diagnosed with ESCC and 213 participants with EAC ."
63592,The,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63593,rapidly,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63594,digestible,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63595,starch,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63596,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63597,RDS,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63598,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63599,content,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63600,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63601,estimated,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63602,glycemic,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63603,index,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63604,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63605,eGI,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63606,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63607,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63608,as,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63609,cooking,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63610,temperature,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63611,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63612,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63613,the,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63614,ratio,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63615,of,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63616,water,B-AG.01.z,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63617,to,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63618,rice,B-AG.01.i,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63619,increased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63620,.,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63760,Therefore,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63761,",",O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63762,preparation,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63763,of,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63764,an,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63765,instant,B-AG.01.n.10,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63766,rice,I-AG.01.n.10,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63767,product,I-AG.01.n.10,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63768,with,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63769,a,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63770,lower,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63771,GI,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63772,would,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63773,ensure,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63774,the,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63775,product,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63776,was,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63777,beneficial,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63778,to,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63779,a,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63780,wider,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63781,range,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63782,of,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63783,the,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63784,population,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63785,.,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63832,Food,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63833,intake,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63834,",",O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63835,assessed,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63836,by,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63837,a,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63838,FFQ,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63839,",",O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63840,was,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63841,aggregated,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63842,into,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63843,thirty,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63844,-,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63845,four,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63846,separate,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63847,food,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63848,groups,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63849,.,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63878,The,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63879,Bland,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63880,Altman,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63881,plots,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63882,were,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63883,used,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63884,as,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63885,an,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63886,alternative,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63887,and,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63888,new,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63889,method,O,2219.0,The Bland Altman plots were used as an alternative and new method .
63890,.,O,2219.0,The Bland Altman plots were used as an alternative and new method .
64264,The,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64265,evidence,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64266,reviewed,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64267,provides,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64268,additional,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64269,support,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64270,for,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64271,increased,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64272,consumption,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64273,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64274,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64275,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64276,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64277,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64278,vegetables,B-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64279,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64280,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64281,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64282,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64283,dark,B-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64284,-,I-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64285,green,I-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64286,leafy,I-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64287,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64288,cruciferous,B-AG.01.h.02.d,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64289,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64290,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64291,deep,B-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64292,-,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64293,yellow,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64294,-,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64295,orange,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64296,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64297,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64298,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64299,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64300,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64301,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64302,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64303,fruits,B-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64304,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64305,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64306,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64307,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64308,citrus,B-AG.01.h.01.a,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64309,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64310,deep,B-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64311,-,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64312,yellow,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64313,-,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64314,orange,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64315,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64316,.,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64436,Our,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64437,hypothesis,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64438,was,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64439,that,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64440,cold,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64441,milk,B-AG.01.e,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64442,drunk,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64443,at,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64444,high,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64445,speed,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64446,would,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64447,cause,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64448,insufficient,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64449,closure,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64450,of,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64451,the,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64452,esophageal,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64453,groove,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64454,and,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64455,hence,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64456,milk,B-AG.01.e,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64457,in,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64458,the,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64459,rumen,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64460,.,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64461,Fifteen,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64462,Norwegian,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64463,Red,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64464,calves,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64465,",",O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64466,9,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64467,to,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64468,27,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64469,d,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64470,of,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64471,age,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64472,",",O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64473,weighing,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64474,between,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64475,45.5,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64476,and,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64477,71.0,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64478,kg,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64479,",",O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64480,were,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64481,tested,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64482,according,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64483,to,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64484,the,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64485,response,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64486,surface,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64487,pathway,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64488,design,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64489,.,O,2241.0,"Fifteen Norwegian Red calves , 9 to 27 d of age , weighing between 45.5 and 71.0 kg , were tested according to the response surface pathway design ."
64726,The,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64727,fractionation,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64728,of,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64729,heavy,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64730,metals,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64731,also,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64732,has,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64733,been,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64734,studied,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64735,in,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64736,all,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64737,treated,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64738,soils,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64739,.,O,2251.0,The fractionation of heavy metals also has been studied in all treated soils .
64984,Cases,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64985,(,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64986,399,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64987,),O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64988,and,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64989,a,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64990,corresponding,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64991,number,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64992,of,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64993,controls,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64994,",",O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64995,matched,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64996,for,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64997,age,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64998,and,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
64999,sex,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65000,",",O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65001,were,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65002,included,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65003,",",O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65004,the,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65005,controls,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65006,being,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65007,selected,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65008,from,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65009,patients,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65010,undergoing,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65011,functional,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65012,re,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65013,-,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65014,education,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65015,for,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65016,injuries,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65017,or,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65018,trauma,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65019,which,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65020,reduced,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65021,their,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65022,mobility,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65023,.,O,2262.0,"Cases ( 399 ) and a corresponding number of controls , matched for age and sex , were included , the controls being selected from patients undergoing functional re - education for injuries or trauma which reduced their mobility ."
65159,The,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65160,low,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65161,rate,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65162,of,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65163,coronary,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65164,heart,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65165,disease,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65166,(,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65167,CHD,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65168,),O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65169,in,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65170,France,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65171,compared,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65172,with,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65173,other,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65174,developed,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65175,countries,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65176,with,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65177,comparable,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65178,dietary,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65179,intake,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65180,has,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65181,been,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65182,called,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65183,the,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65184,French,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65185,paradox,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65186,.,O,2269.0,The low rate of coronary heart disease ( CHD ) in France compared with other developed countries with comparable dietary intake has been called the French paradox .
65231,France,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65232,had,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65233,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65234,highest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65235,wine,B-AG.01.y.01.a,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65236,intake,B-X,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65237,and,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65238,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65239,highest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65240,total,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65241,alcohol,B-AG.01.y.01,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65242,intake,B-X,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65243,",",O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65244,and,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65245,the,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65246,second,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65247,lowest,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65248,CHD,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65249,mortality,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65250,rate,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65251,.,O,2272.0,"France had the highest wine intake and the highest total alcohol intake , and the second lowest CHD mortality rate ."
65406,Although,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65407,corn,B-AG.01.i,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65408,is,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65409,often,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65410,cited,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65411,as,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65412,an,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65413,allergenic,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65414,food,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65415,",",O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65416,very,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65417,few,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65418,studies,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65419,have,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65420,been,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65421,devoted,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65422,to,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65423,the,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65424,identification,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65425,of,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65426,corn,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65427,allergens,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65428,and,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65429,corn,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65430,allergy,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65431,has,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65432,been,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65433,rarely,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65434,confirmed,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65435,by,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65436,double,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65437,-,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65438,blind,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65439,",",O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65440,placebo,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65441,-,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65442,controlled,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65443,food,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65444,challenge,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65445,(,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65446,DBPCFC,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65447,),O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65448,.,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65474,One,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65475,of,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65476,these,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65477,",",O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65478,corresponding,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65479,to,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65480,corn,B-AG.01.i,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65481,Lipid,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65482,Transfer,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65483,Protein,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65484,(,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65485,LTP,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65486,),O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65487,",",O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65488,appeared,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65489,to,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65490,be,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65491,the,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65492,major,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65493,one,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65494,.,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65686,In,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65687,age-,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65688,and,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65689,energy,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65690,-,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65691,adjusted,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65692,models,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65693,for,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65694,all,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65695,centers,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65696,combined,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65697,",",O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65698,the,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65699,odds,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65700,ratio,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65701,(,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65702,OR,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65703,),O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65704,for,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65705,the,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65706,highest,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65707,quintile,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65708,of,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65709,total,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65710,alcohol,B-AG.01.y.01,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65711,intake,B-X,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65712,was,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65713,0.89,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
65714,.,O,2290.0,"In age- and energy - adjusted models for all centers combined , the odds ratio ( OR ) for the highest quintile of total alcohol intake was 0.89 ."
66302,Epidemiological,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66303,studies,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66304,have,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66305,noted,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66306,a,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66307,consistent,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66308,association,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66309,between,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66310,the,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66311,consumption,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66312,of,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66313,diets,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66314,rich,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66315,in,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66316,fruits,B-AG.01.h.01,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66317,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66318,vegetables,B-AG.01.h.02,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66319,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66320,a,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66321,lower,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66322,risk,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66323,for,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66324,chronic,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66325,diseases,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66326,including,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66327,cancer,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66328,and,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66329,cardiovascular,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66330,disease,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66331,.,O,2314.0,Epidemiological studies have noted a consistent association between the consumption of diets rich in fruits and vegetables and a lower risk for chronic diseases including cancer and cardiovascular disease .
66332,There,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66333,is,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66334,accumulating,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66335,evidence,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66336,that,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66337,much,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66338,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66339,the,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66340,health,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66341,-,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66342,promoting,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66343,potential,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66344,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66345,these,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66346,plant,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66347,foods,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66348,may,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66349,come,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66350,from,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66351,phytochemicals,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66352,",",O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66353,bioactive,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66354,compounds,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66355,not,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66356,designated,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66357,as,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66358,traditional,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66359,nutrients,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66360,.,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66394,Antioxidants,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66395,help,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66396,lower,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66397,risk,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66398,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66399,cardiovascular,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66400,events,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66401,by,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66402,inhibition,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66403,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66404,LDL,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66405,-,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66406,cholesterol,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66407,oxidation,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66408,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66409,promotion,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66410,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66411,plaque,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66412,stability,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66413,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66414,improved,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66415,vascular,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66416,endothelial,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66417,function,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66418,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66419,and,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66420,decreased,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66421,tendency,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66422,for,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66423,thrombosis,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66424,.,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66826,Men,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66827,who,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66828,consumed,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66829,more,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66830,than,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66831,one,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66832,drink,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66833,per,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66834,month,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66835,had,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66836,a,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66837,small,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66838,increased,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66839,risk,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66840,of,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66841,prostate,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66842,cancer,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66843,(,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66844,hazard,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66845,ratio,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66846,",",O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66847,HR,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66848,=,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66849,1.20,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66850,;,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66851,95,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66852,%,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66853,confidence,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66854,interval,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66855,",",O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66856,CI,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66857,=,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66858,1.02,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66859,-,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66860,1.40,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66861,),O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66862,compared,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66863,with,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66864,men,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66865,who,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66866,drank,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66867,no,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66868,alcohol,B-AG.01.y.01,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66869,or,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66870,less,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66871,than,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66872,one,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66873,drink,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66874,per,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66875,month,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66876,.,O,2334.0,"Men who consumed more than one drink per month had a small increased risk of prostate cancer ( hazard ratio , HR = 1.20 ; 95 % confidence interval , CI = 1.02 - 1.40 ) compared with men who drank no alcohol or less than one drink per month ."
66956,Limited,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66957,research,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66958,exists,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66959,on,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66960,how,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66961,different,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66962,oil,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66963,types,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66964,and,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66965,time,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66966,of,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66967,addition,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66968,affect,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66969,starch,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66970,digestibility,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66971,of,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66972,rice,B-AG.01.i,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66973,.,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
67106,Red,B-AG.01.i,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67107,rice,I-AG.01.i,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67108,cooked,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67109,using,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67110,ghee,B-AG.01.e.01,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67111,showed,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67112,the,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67113,lowest,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67114,amount,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67115,of,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67116,glucose,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67117,release,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67118,during,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67119,in,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67120,vitro,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67121,digestion,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67122,.,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
68553,A,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68554,100,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68555,mg,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68556,increase,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68557,of,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68558,dietary,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68559,cholesterol,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68560,per,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68561,4184,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68562,kJ,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68563,(,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68564,or,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68565,1000,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68566,kcal,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68567,),O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68568,was,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68569,associated,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68570,with,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68571,a,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68572,14,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68573,%,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68574,increase,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68575,in,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68576,the,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68577,risk,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68578,of,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68579,diabetes,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68580,(,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68581,HR,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68582,1·14,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68583,;,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68584,95,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68585,%,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68586,CI,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68587,1·02,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68588,",",O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68589,1·26,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68590,),O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68591,.,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68617,In,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68618,the,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68619,absence,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68620,of,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68621,a,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68622,clear,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68623,underlying,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68624,mechanism,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68625,and,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68626,potential,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68627,residual,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68628,confounding,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68629,",",O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68630,these,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68631,results,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68632,should,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68633,be,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68634,interpreted,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68635,with,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68636,caution,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68637,.,O,2394.0,"In the absence of a clear underlying mechanism and potential residual confounding , these results should be interpreted with caution ."
68638,Over,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68639,one,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68640,third,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68641,of,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68642,Australians,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68643,',O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68644,daily,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68645,energy,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68646,intake,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68647,is,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68648,from,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68649,discretionary,B-AG.01,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68650,foods,I-AG.01,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68651,and,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68652,drinks,B-AG.01.y,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68653,.,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68975,The,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68976,results,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68977,demonstrate,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68978,that,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68979,small,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68980,reductions,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68981,in,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68982,discretionary,B-AG.01,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68983,food,I-AG.01,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68984,consumption,B-X,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68985,are,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68986,likely,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68987,to,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68988,have,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68989,substantial,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68990,health,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68991,benefits,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68992,at,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68993,the,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68994,population,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68995,level,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68996,.,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
69244,These,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69245,test,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69246,meals,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69247,were,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69248,randomly,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69249,assigned,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69250,using,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69251,a,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69252,three,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69253,factor,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69254,experiment,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69255,design,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69256,.,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69517,In,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69518,Northern,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69519,Nigeria,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69520,(,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69521,where,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69522,the,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69523,Hausas,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69524,and,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69525,Fulanis,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69526,are,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69527,the,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69528,dominant,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69529,ethnic,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69530,groups,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69531,),O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69532,",",O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69533,grains,B-AG.01.i,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69534,such,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69535,as,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69536,sorghum,B-AG.01.i,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69537,",",O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69538,millet,B-AG.01.i,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69539,form,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69540,the,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69541,main,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69542,diet,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69543,;,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69544,these,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69545,are,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69546,served,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69547,with,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69548,palm,B-AG.01.n.02,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69549,oil,I-AG.01.n.02,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69550,based,I-AG.01.n.02,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69551,soup,I-AG.01.n.02,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69552,made,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69553,with,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69554,tomatoes,B-AG.01.h.02.f,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69555,and,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69556,okra,B-AG.01.h.02,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69557,.,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69618,The,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69619,proposed,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69620,long,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69621,-,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69622,term,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69623,measure,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69624,by,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69625,the,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69626,Federal,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69627,government,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69628,of,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69629,Nigeria,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69630,for,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69631,the,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69632,resolution,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69633,of,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69634,these,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69635,various,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69636,types,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69637,of,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69638,malnutrition,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69639,is,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69640,dietary,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69641,diversification,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69642,.,O,2427.0,The proposed long - term measure by the Federal government of Nigeria for the resolution of these various types of malnutrition is dietary diversification .
69767,The,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69768,ability,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69769,of,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69770,L.,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69771,monocytogenes,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69772,to,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69773,grow,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69774,at,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69775,refrigeration,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69776,temperatures,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69777,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69778,coupled,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69779,with,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69780,appearance,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69781,of,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69782,the,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69783,pathogen,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69784,in,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69785,raw,B-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69786,and,I-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69787,processed,I-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69788,meats,I-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69789,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69790,as,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69791,well,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69792,as,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69793,poultry,B-AG.01.d.06,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69794,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69795,vegetables,B-AG.01.h.02,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69796,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69797,and,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69798,seafood,B-AG.01.d.07,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69799,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69800,makes,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69801,this,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69802,bacterium,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69803,a,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69804,serious,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69805,threat,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69806,to,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69807,susceptible,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69808,consumers,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69809,and,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69810,to,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69811,the,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69812,entire,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69813,food,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69814,industry,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69815,.,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69816,Yersinia,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69817,enterocolitica,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69818,",",O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69819,another,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69820,psychrotrophic,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69821,food,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69822,-,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69823,borne,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69824,pathogen,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69825,of,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69826,recent,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69827,concern,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69828,",",O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69829,was,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69830,linked,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69831,to,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69832,several,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69833,outbreaks,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69834,of,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69835,yersiniosis,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69836,associated,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69837,with,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69838,consumption,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69839,of,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69840,both,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69841,raw,B-AG.01.e,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69842,and,I-AG.01.e,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69843,pasteurized,I-AG.01.e,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69844,milk,I-AG.01.e,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69845,",",O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69846,as,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69847,well,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69848,as,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69849,contaminated,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69850,water,B-AG.01.z,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
69851,.,O,2433.0,"Yersinia enterocolitica , another psychrotrophic food - borne pathogen of recent concern , was linked to several outbreaks of yersiniosis associated with consumption of both raw and pasteurized milk , as well as contaminated water ."
70790,Additional,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70791,study,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70792,of,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70793,lactose,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70794,and,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70795,ovarian,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70796,cancer,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70797,risk,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70798,involving,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70799,careful,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70800,control,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70801,for,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70802,confounding,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70803,is,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70804,needed,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70805,.,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70976,The,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70977,multivariate,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70978,RR,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70979,(,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70980,95,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70981,%,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70982,CI,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70983,),O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70984,",",O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70985,comparing,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70986,highest,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70987,to,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70988,lowest,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70989,quintiles,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70990,of,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70991,cumulative,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70992,average,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70993,intake,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70994,",",O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70995,was,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70996,0.94,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70997,(,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70998,0.72,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
70999,",",O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71000,1.22,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71001,;,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71002,p,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71003,-,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71004,value,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71005,for,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71006,test,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71007,of,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71008,trend=0.54,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71009,),O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71010,for,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71011,sum,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71012,of,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71013,flavonol,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71014,-,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71015,rich,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71016,foods,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71017,.,O,2473.0,"The multivariate RR ( 95 % CI ) , comparing highest to lowest quintiles of cumulative average intake , was 0.94 ( 0.72 , 1.22 ; p - value for test of trend=0.54 ) for sum of flavonol - rich foods ."
71382,Studies,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71383,on,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71384,the,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71385,association,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71386,between,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71387,dietary,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71388,patterns,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71389,and,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71390,bone,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71391,mineral,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71392,density,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71393,(,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71394,BMD,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71395,),O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71396,have,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71397,reported,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71398,inconsistent,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71399,findings,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71400,.,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
72255,The,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72256,study,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72257,included,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72258,192,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72259,CRC,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72260,patients,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72261,with,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72262,available,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72263,EORTC,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72264,QLQ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72265,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72266,C30,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72267,data,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72268,before,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72269,and,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72270,12,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72271, ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72272,months,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72273,post,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72274,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72275,surgery,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72276,and,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72277,food,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72278,frequency,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72279,questionnaire,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72280,data,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72281,at,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72282,12,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72283, ,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72284,months,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72285,post,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72286,-,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72287,surgery,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72288,.,O,2513.0,The study included 192 CRC patients with available EORTC QLQ - C30 data before and 12   months post - surgery and food frequency questionnaire data at 12   months post - surgery .
72876,Reduced,B-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72877,fat,I-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72878,milk,I-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72879,was,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72880,the,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72881,most,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72882,commonly,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72883,consumed,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72884,dairy,B-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72885,product,I-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72886,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72887,235,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72888,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72889,200,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72890,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72891,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72892,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72893,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72894,",",O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72895,followed,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72896,by,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72897,whole,B-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72898,milk,I-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72899,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72900,63,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72901,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72902,128,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72903,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72904,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72905,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72906,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72907,and,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72908,yoghurt,B-AG.01.e,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72909,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72910,53,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72911,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72912,66,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72913,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72914,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72915,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72916,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72917,.,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
73202,In,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73203,addition,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73204,",",O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73205,the,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73206,biological,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73207,availability,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73208,of,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73209,garlic,B-AG.01,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73210,products,I-AG.01,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73211,is,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73212,of,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73213,importance,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73214,",",O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73215,which,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73216,was,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73217,omitted,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73218,in,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73219,many,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73220,studies,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73221,.,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73333,We,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73334,aimed,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73335,to,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73336,investigate,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73337,associations,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73338,of,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73339,total,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73340,and,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73341,different,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73342,types,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73343,of,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73344,dairy,B-AG.01.e,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73345,products,I-AG.01.e,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73346,with,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73347,markers,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73348,of,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73349,adiposity,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73350,",",O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73351,and,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73352,body,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73353,fat,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73354,and,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73355,lean,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73356,mass,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73357,distribution,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73358,.,O,2547.0,"We aimed to investigate associations of total and different types of dairy products with markers of adiposity , and body fat and lean mass distribution ."
73907,Preconception,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73908,food,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73909,frequency,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73910,data,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73911,were,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73912,collected,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73913,retrospectively,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73914,in,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73915,309,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73916,women,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73917,.,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
74601,Only,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74602,one,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74603,patient,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74604,with,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74605,clinical,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74606,allergy,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74607,to,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74608,latex,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74609,and,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74610,positive,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74611,skin,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74612,tests,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74613,to,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74614,fruits,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74615,had,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74616,a,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74617,history,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74618,of,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74619,clinical,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74620,symptoms,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74621,after,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74622,ingestion,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74623,of,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74624,kiwi,B-AG.01.h.01,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74625,and,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74626,orange,B-AG.01.h.01.a,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74627,.,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
75031,The,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75032,objective,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75033,of,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75034,this,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75035,study,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75036,was,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75037,to,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75038,investigate,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75039,the,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75040,characteristics,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75041,",",O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75042,antioxidative,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75043,properties,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75044,",",O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75045,and,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75046,hepatoprotective,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75047,effects,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75048,of,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75049,Maillard,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75050,reaction,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75051,products,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75052,(,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75053,MRP,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75054,),O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75055,from,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75056,milk,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75057,protein,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75058,reacted,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75059,with,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75060,sugars,B-AG.01.l.02,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75061,.,O,2608.0,"The objective of this study was to investigate the characteristics , antioxidative properties , and hepatoprotective effects of Maillard reaction products ( MRP ) from milk protein reacted with sugars ."
75170,The,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75171,modification,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75172,sites,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75173,induced,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75174,by,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75175,MR,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75176,of,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75177,milk,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75178,protein,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75179,were,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75180,monitored,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75181,by,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75182,matrix,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75183,-,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75184,assisted,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75185,laser,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75186,desorption,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75187,/,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75188,ionization,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75189,time,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75190,-,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75191,of,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75192,-,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75193,flight,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75194,mass,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75195,spectrometry,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75196,analysis,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75197,of,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75198,tryptic,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75199,-,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75200,digested,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75201,gel,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75202,spots,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75203,of,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75204,MRP,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75205,.,O,2613.0,The modification sites induced by MR of milk protein were monitored by matrix - assisted laser desorption / ionization time - of - flight mass spectrometry analysis of tryptic - digested gel spots of MRP .
75206,As,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75207,a,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75208,result,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75209,",",O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75210,modification,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75211,and,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75212,their,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75213,localization,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75214,in,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75215,AA,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75216,sequence,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75217,of,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75218,MRP,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75219,was,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75220,identified,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75221,.,O,2614.0,"As a result , modification and their localization in AA sequence of MRP was identified ."
75584,We,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75585,review,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75586,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75587,compare,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75588,trends,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75589,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75590,coronary,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75591,heart,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75592,disease,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75593,(,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75594,CHD,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75595,),O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75596,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75597,stroke,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75598,mortality,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75599,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75600,Spain,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75601,from,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75602,1966,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75603,to,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75604,1990,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75605,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75606,changes,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75607,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75608,food,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75609,consumption,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75610,at,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75611,national,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75612,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75613,regional,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75614,levels,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75615,.,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75709,This,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75710,paradoxical,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75711,situation,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75712,can,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75713,be,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75714,explained,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75715,by,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75716,expanded,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75717,access,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75718,to,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75719,clinical,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75720,care,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75721,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75722,increased,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75723,consumption,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75724,of,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75725,fruit,B-AG.01.h.01,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75726,and,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75727,fish,B-AG.01.d.07,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75728,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75729,improved,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75730,control,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75731,of,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75732,hypertension,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75733,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75734,and,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75735,a,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75736,reduction,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75737,in,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75738,cigarette,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75739,smoking,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75740,.,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
76012,The,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76013,pyramid,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76014,describes,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76015,a,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76016,dietary,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76017,pattern,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76018,that,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76019,is,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76020,attractive,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76021,for,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76022,its,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76023,famous,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76024,palatability,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76025,as,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76026,well,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76027,as,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76028,for,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76029,its,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76030,health,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76031,benefits,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76032,.,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76262,Predictions,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76263,of,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76264,drug,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76265,residues,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76266,in,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76267,milk,B-AG.01.e,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76268,are,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76269,critical,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76270,in,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76271,food,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76272,protection,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76273,and,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76274,are,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76275,a,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76276,major,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76277,consideration,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76278,in,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76279,the,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76280,economics,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76281,of,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76282,treatment,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76283,of,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76284,mastitis,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76285,in,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76286,dairy,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76287,cows,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
76288,.,O,2648.0,Predictions of drug residues in milk are critical in food protection and are a major consideration in the economics of treatment of mastitis in dairy cows .
77187,But,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77188,",",O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77189,environmental,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77190,contamination,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77191,due,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77192,to,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77193,drugs,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77194,or,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77195,medicines,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77196,used,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77197,for,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77198,different,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77199,purposes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77200,in,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77201,humans,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77202,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77203,animals,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77204,goes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77205,unseen,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77206,largely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77207,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77208,can,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77209,affect,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77210,the,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77211,health,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77212,of,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77213,living,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77214,system,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77215,severely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77216,.,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77724,We,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77725,examined,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77726,the,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77727,association,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77728,of,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77729,tea,B-AG.01.ac,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77730,and,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77731,coffee,B-AG.01.ad,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77732,consumption,B-X,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77733,with,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77734,EC,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77735,risk,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77736,among,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77737,"442,143",O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77738,men,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77739,and,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77740,women,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77741,without,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77742,cancer,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77743,at,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77744,baseline,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77745,from,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77746,9,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77747,countries,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77748,of,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77749,the,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77750,European,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77751,Prospective,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77752,Investigation,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77753,into,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77754,Cancer,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77755,and,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77756,Nutrition,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77757,.,O,2697.0,"We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition ."
77758,Tea,B-AG.01.ac,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77759,and,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77760,coffee,B-AG.01.ad,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77761,intakes,B-X,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77762,were,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77763,recorded,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77764,using,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77765,country,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77766,-,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77767,specific,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77768,validated,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77769,dietary,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77770,questionnaires,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
77771,.,O,2698.0,Tea and coffee intakes were recorded using country - specific validated dietary questionnaires .
78040,This,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78041,article,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78042,reviews,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78043,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78044,epidemiologic,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78045,literature,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78046,on,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78047,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78048,relationship,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78049,between,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78050,consumption,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78051,of,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78052,major,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78053,food,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78054,groups,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78055,and,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78056,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78057,risk,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78058,of,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78059,epithelial,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78060,ovarian,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78061,cancer,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78062,(,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78063,EOC,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78064,),O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78065,.,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78308,Diet,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78309,is,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78310,a,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78311,modifiable,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78312,risk,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78313,factor,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78314,for,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78315,breast,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78316,cancer,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78317,",",O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78318,but,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78319,the,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78320,association,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78321,between,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78322,the,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78323,risk,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78324,of,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78325,TNBC,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78326,and,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78327,diet,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78328,has,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78329,not,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78330,been,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78331,studied,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78332,.,O,2716.0,"Diet is a modifiable risk factor for breast cancer , but the association between the risk of TNBC and diet has not been studied ."
78779,The,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78780,association,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78781,between,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78782,estimated,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78783,total,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78784,caffeine,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78785,intake,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78786,and,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78787,risk,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78788,of,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78789,diabetes,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78790,was,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78791,insignificant,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78792,both,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78793,among,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78794,men,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78795,and,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78796,among,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78797,women,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78798,.,O,2731.0,The association between estimated total caffeine intake and risk of diabetes was insignificant both among men and among women .
78974,High,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78975,consumption,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78976,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78977,margarine,B-AG.01.f,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78978,exerted,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78979,a,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78980,significant,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78981,protection,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78982,against,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78983,cancer,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78984,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78985,the,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78986,colon,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78987,whereas,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78988,high,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78989,consumption,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78990,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78991,carrot,B-AG.01.h.02.a,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78992,spinach,B-AG.01.h.02.c,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78993,",",O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78994,whole,B-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78995,-,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78996,grain,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78997,bread,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78998,and,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78999,pasta,B-AG.01.i,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79000,(,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79001,favorably,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79002,),O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79003,and,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79004,red,B-AG.01.d,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79005,meat,I-AG.01.d,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79006,(,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79007,unfavorably,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79008,),O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79009,affected,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79010,rectal,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79011,cancer,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79012,risk,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79013,in,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79014,particular,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79015,.,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79071,Raisins,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79072,are,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79073,dried,B-AG.01.n.08,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79074,grapes,I-AG.01.n.08,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79075,consumed,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79076,worldwide,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79077,that,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79078,contain,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79079,beneficial,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79080,components,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79081,for,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79082,human,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79083,health,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79084,.,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79097,Despite,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79098,a,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79099,60,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79100,%,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79101,sugar,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79102,content,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79103,",",O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79104,several,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79105,studies,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79106,have,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79107,reported,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79108,health,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79109,-,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79110,promoting,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79111,properties,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79112,for,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79113,raisins,B-AG.01.n.08,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79114,and,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79115,this,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79116,review,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79117,compiles,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79118,the,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79119,intervention,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79120,studies,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79121,",",O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79122,as,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79123,well,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79124,as,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79125,the,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79126,cell,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79127,line,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79128,and,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79129,animal,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79130,model,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79131,studies,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79132,carried,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79133,out,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79134,to,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79135,date,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79136,.,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79242,Moreover,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79243,",",O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79244,gut,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79245,microbiota,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79246,could,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79247,be,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79248,affected,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79249,by,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79250,the,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79251,prebiotic,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79252,content,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79253,of,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79254,raisins,B-AG.01.n.08,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79255,.,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79754,Analyses,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79755,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79756,the,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79757,dietary,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79758,pattern,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79759,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79760,the,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79761,diet,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79762,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79763,Crete,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79764,shows,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79765,a,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79766,number,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79767,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79768,protective,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79769,substances,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79770,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79771,such,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79772,as,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79773,selenium,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79774,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79775,glutathione,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79776,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79777,a,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79778,balanced,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79779,ratio,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79780,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79781,(,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79782,n-6):(n-3,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79783,),O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79784,essential,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79785,fatty,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79786,acids,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79787,(,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79788,EFA,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79789,),O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79790,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79791,high,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79792,amounts,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79793,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79794,fiber,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79795,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79796,antioxidants,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79797,(,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79798,especially,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79799,resveratrol,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79800,from,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79801,wine,B-AG.01.y.01.a,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79802,and,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79803,polyphenols,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79804,from,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79805,olive,B-AG.01.f,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79806,oil,I-AG.01.f,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79807,),O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79808,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79809,vitamins,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79810,E,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79811,and,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79812,C,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79813,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79814,some,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79815,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79816,which,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79817,have,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79818,been,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79819,shown,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79820,to,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79821,be,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79822,associated,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79823,with,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79824,lower,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79825,risk,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79826,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79827,cancer,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79828,",",O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79829,including,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79830,cancer,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79831,of,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79832,the,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79833,breast,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
79834,.,O,2763.0,"Analyses of the dietary pattern of the diet of Crete shows a number of protective substances , such as selenium , glutathione , a balanced ratio of ( n-6):(n-3 ) essential fatty acids ( EFA ) , high amounts of fiber , antioxidants ( especially resveratrol from wine and polyphenols from olive oil ) , vitamins E and C , some of which have been shown to be associated with lower risk of cancer , including cancer of the breast ."
80195,Patients,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80196,with,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80197,RA,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80198,frequently,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80199,ask,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80200,their,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80201,doctors,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80202,about,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80203,which,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80204,diets,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80205,to,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80206,follow,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80207,",",O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80208,and,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80209,even,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80210,in,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80211,the,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80212,absence,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80213,of,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80214,advice,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80215,from,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80216,their,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80217,physicians,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80218,",",O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80219,many,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80220,patients,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80221,are,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80222,undertaking,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80223,various,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80224,dietary,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80225,interventions,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80226,.,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80627,High,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80628,consumption,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80629,of,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80630,mustard,B-AG.01.f,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80631,oil,I-AG.01.f,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80632,was,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80633,associated,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80634,with,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80635,GBC,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80636,risk,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80637,in,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80638,both,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80639,high-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80640,and,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80641,low,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80642,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80643,risk,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80644,regions,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80645,(,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80646,OR,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80647,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80648,1.33,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80649,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80650,95,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80651,%,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80652,CI,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80653,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80654,0.99,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80655,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80656,1.78,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80657,;,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80658,OR,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80659,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80660,3.01,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80661,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80662,95,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80663,%,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80664,CI,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80665,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80666,1.66,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80667,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80668,5.45,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80669,),O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80670,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80671,respectively,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80672,.,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80849,In,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80850,the,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80851,present,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80852,study,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80853,",",O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80854,masticated,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80855,samples,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80856,of,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80857,three,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80858,nuts,B-AG.01.h.01.f,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80859,from,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80860,healthy,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80861,adults,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80862,were,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80863,exposed,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80864,to,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80865,a,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80866,static,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80867,model,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80868,of,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80869,gastric,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80870,digestion,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80871,followed,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80872,by,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80873,simulated,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80874,intestinal,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80875,digestion,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80876,.,O,2799.0,"In the present study , masticated samples of three nuts from healthy adults were exposed to a static model of gastric digestion followed by simulated intestinal digestion ."
80877,Primary,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80878,outcomes,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80879,were,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80880,particle,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80881,size,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80882,and,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80883,lipid,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80884,release,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80885,at,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80886,each,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80887,phase,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80888,of,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80889,digestion,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80890,.,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80929,However,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80930,",",O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80931,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80932,masticated,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80933,and,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80934,digesta,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80935,particle,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80936,sizes,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80937,were,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80938,not,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80939,related,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80940,to,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80941,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80942,integrity,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80943,of,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80944,cell,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80945,walls,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80946,or,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80947,lipid,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80948,release,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80949,.,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
81512,This,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81513,implies,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81514,that,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81515,fat,B-AG.01.f,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81516,and,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81517,sugar,B-AG.01.l.02,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81518,addition,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81519,could,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81520,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81521,avoided,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81522,in,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81523,foods,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81524,for,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81525,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81526,without,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81527,having,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81528,an,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81529,impact,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81530,on,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81531,palatability,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81532,",",O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81533,allowing,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81534,the,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81535,energy,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81536,density,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81537,of,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81538,children,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81539,'s,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81540,diet,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81541,to,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81542,be,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81543,limited,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81544,.,O,2825.0,"This implies that fat and sugar addition could be avoided in foods for children without having an impact on palatability , allowing the energy density of children 's diet to be limited ."
81651,Sensitivities,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81652,and,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81653,negative,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81654,predictive,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81655,accuracies,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81656,were,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81657,generally,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81658,high,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81659,with,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81660,egg,B-AG.01.g,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81661,white,I-AG.01.g,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81662,and,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81663,milk,B-AG.01.e,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81664,",",O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81665,but,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81666,low,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81667,with,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81668,egg,B-AG.01.g,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81669,yolk,I-AG.01.g,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
81670,.,O,2829.0,"Sensitivities and negative predictive accuracies were generally high with egg white and milk , but low with egg yolk ."
82103,Vegetarians,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82104,also,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82105,appear,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82106,to,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82107,have,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82108,lower,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82109,low,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82110,-,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82111,density,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82112,lipoprotein,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82113,cholesterol,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82114,levels,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82115,",",O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82116,lower,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82117,blood,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82118,pressure,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82119,",",O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82120,and,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82121,lower,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82122,rates,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82123,of,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82124,hypertension,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82125,and,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82126,type,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82127,2,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82128,diabetes,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82129,than,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82130,nonvegetarians,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82131,.,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82190,The,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82191,variability,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82192,of,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82193,dietary,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82194,practices,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82195,among,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82196,vegetarians,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82197,makes,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82198,individual,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82199,assessment,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82200,of,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82201,dietary,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82202,adequacy,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82203,essential,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82204,.,O,2849.0,The variability of dietary practices among vegetarians makes individual assessment of dietary adequacy essential .
82243,Wine,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82244,may,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82245,cause,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82246,stomach,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82247,irritation,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82248,due,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82249,to,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82250,its,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82251,stimulatory,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82252,effect,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82253,on,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82254,gastric,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82255,acid,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82256,secretion,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82257,",",O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82258,although,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82259,the,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82260,mechanisms,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82261,by,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82262,which,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82263,wine,B-AG.01.y.01.a,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82264,or,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82265,components,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82266,thereof,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82267,activate,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82268,pathways,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82269,of,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82270,gastric,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82271,acid,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82272,secretion,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82273,are,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82274,poorly,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82275,understood,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82276,.,O,2851.0,"Wine may cause stomach irritation due to its stimulatory effect on gastric acid secretion , although the mechanisms by which wine or components thereof activate pathways of gastric acid secretion are poorly understood ."
82316,Between,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82317,both,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82318,beverages,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82319,",",O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82320,red,B-AG.01.y.01.a,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82321,wine,I-AG.01.y.01.a,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82322,showed,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82323,a,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82324,clear,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82325,trend,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82326,for,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82327,being,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82328,more,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82329,active,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82330,in,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82331,stimulating,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82332,gastric,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82333,acid,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82334,secretion,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82335,than,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82336,white,B-AG.01.y.01.a,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82337,wine,I-AG.01.y.01.a,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82338,(,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82339,p,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82340,=,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82341,0.054,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82342,),O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82343,.,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82344,Quantification,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82345,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82346,the,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82347,intracellular,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82348,proton,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82349,concentration,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82350,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82351,human,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82352,gastric,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82353,tumor,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82354,cells,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82355,(,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82356,HGT-1,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82357,),O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82358,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82359,a,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82360,well,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82361,-,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82362,established,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82363,indicator,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82364,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82365,proton,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82366,secretion,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82367,and,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82368,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82369,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82370,turn,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82371,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82372,stomach,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82373,acid,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82374,formation,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82375,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82376,vivo,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82377,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82378,confirmed,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82379,the,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82380,stronger,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82381,effect,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82382,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82383,red,B-AG.01.y.01.a,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82384,wine,I-AG.01.y.01.a,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82385,as,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82386,compared,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82387,to,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82388,white,B-AG.01.y.01.a,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82389,wine,I-AG.01.y.01.a,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82390,.,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82445,However,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82446,",",O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82447,addition,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82448,of,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82449,ethanol,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82450,to,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82451,individual,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82452,organic,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82453,acids,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82454,attenuated,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82455,the,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82456,secretory,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82457,effect,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82458,of,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82459,tartaric,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82460,acid,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82461,",",O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82462,but,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82463,not,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82464,that,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82465,of,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82466,the,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82467,other,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82468,organic,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82469,acids,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82470,.,O,2857.0,"However , addition of ethanol to individual organic acids attenuated the secretory effect of tartaric acid , but not that of the other organic acids ."
82471,It,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82472,was,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82473,concluded,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82474,that,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82475,malic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82476,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82477,for,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82478,white,B-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82479,wine,I-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82480,and,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82481,succinic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82482,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82483,for,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82484,red,B-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82485,wine,I-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82486,are,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82487,key,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82488,organic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82489,acids,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82490,that,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82491,contribute,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82492,to,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82493,gastric,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82494,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82495,stimulation,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82496,.,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82926,Test,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82927,meals,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82928,(,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82929,100,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82930,micrograms,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82931,Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82932,),O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82933,labeled,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82934,with,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82935,59Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82936,were,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82937,fed,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82938,after,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82939,5,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82940,d,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82941,and,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82942,59Fe,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82943,absorption,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82944,determined,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82945,by,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82946,whole,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82947,-,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82948,body,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82949,counting,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
82950,.,O,2871.0,Test meals ( 100 micrograms Fe ) labeled with 59Fe were fed after 5 d and 59Fe absorption determined by whole - body counting .
83240,No,O,2884.0,No significant increased risk was observed for occupational activities .
83241,significant,O,2884.0,No significant increased risk was observed for occupational activities .
83242,increased,O,2884.0,No significant increased risk was observed for occupational activities .
83243,risk,O,2884.0,No significant increased risk was observed for occupational activities .
83244,was,O,2884.0,No significant increased risk was observed for occupational activities .
83245,observed,O,2884.0,No significant increased risk was observed for occupational activities .
83246,for,O,2884.0,No significant increased risk was observed for occupational activities .
83247,occupational,O,2884.0,No significant increased risk was observed for occupational activities .
83248,activities,O,2884.0,No significant increased risk was observed for occupational activities .
83249,.,O,2884.0,No significant increased risk was observed for occupational activities .
83503,Phenolic,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83504,compounds,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83505,-,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83506,namely,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83507,",",O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83508,gingerols,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83509,and,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83510,shoagols,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83511,-,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83512,were,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83513,quantified,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83514,using,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83515,high,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83516,-,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83517,performance,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83518,liquid,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83519,chromatography,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83520,.,O,2894.0,"Phenolic compounds - namely , gingerols and shoagols - were quantified using high - performance liquid chromatography ."
83599,However,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83600,",",O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83601,Western,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83602,consumers,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83603,may,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83604,be,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83605,unlikely,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83606,to,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83607,enjoy,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83608,the,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83609,plain,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83610,flavor,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83611,and,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83612,chewy,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83613,texture,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83614,of,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83615,Seolgitteok,B-AG.01.n.13,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
83616,.,O,2898.0,"However , Western consumers may be unlikely to enjoy the plain flavor and chewy texture of Seolgitteok ."
84226,Consumption,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84227,of,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84228,fruit,B-AG.01.h.01,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84229,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84230,fats,B-AG.01.f,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84231,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84232,fish,B-AG.01.d.07,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84233,",",O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84234,and,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84235,fluids,B-AG.01.y,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84236,was,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84237,substantially,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84238,less,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84239,than,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84240,recommended,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84241,.,O,2920.0,"Consumption of fruit , fats , fish , and fluids was substantially less than recommended ."
84536,Neither,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84537,bile,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84538,acid,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84539,concentrations,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84540,nor,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84541,activities,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84542,of,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84543,the,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84544,bacterial,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84545,enzymes,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84546,beta,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84547,-,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84548,glucosidase,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84549,and,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84550,beta,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84551,-,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84552,glucuronidase,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84553,in,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84554,faecal,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84555,water,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84556,changed,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84557,after,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84558,carrot,B-AG.01.y,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84559,and,I-AG.01.y,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84560,tomato,I-AG.01.y,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84561,juice,I-AG.01.y,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84562,consumption,B-X,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84563,.,O,2933.0,Neither bile acid concentrations nor activities of the bacterial enzymes beta - glucosidase and beta - glucuronidase in faecal water changed after carrot and tomato juice consumption .
84900,Adherence,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84901,to,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84902,a,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84903,diet,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84904,comprising,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84905,mostly,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84906,fruits,B-AG.01.h.01,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84907,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84908,vegetables,B-AG.01.h.02,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84909,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84910,fish,B-AG.01.d.07,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84911,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84912,and,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84913,olive,B-AG.01.f,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84914,/,I-AG.01.f,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84915,sunflower,I-AG.01.f,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84916,oil,I-AG.01.f,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84917,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84918,along,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84919,with,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84920,avoidance,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84921,of,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84922,Western,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84923,-,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84924,type,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84925,foods,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84926,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84927,may,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84928,contribute,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84929,to,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84930,a,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84931,substantial,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84932,reduction,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84933,in,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84934,postmenopausal,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84935,breast,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84936,cancer,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84937,risk,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84938,.,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
85775,Additional,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85776,medical,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85777,complaints,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85778,treated,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85779,with,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85780,chocolate,B-AG.01.n.17.a,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85781,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85782,cacao,B-AG.01,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85783,have,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85784,included,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85785,anemia,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85786,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85787,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85788,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85789,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85790,mental,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85791,fatigue,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85792,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85793,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85794,breast,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85795,milk,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85796,production,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85797,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85798,consumption,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85799,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85800,tuberculosis,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85801,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85802,fever,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85803,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85804,gout,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85805,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85806,kidney,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85807,stones,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85808,",",O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85809,reduced,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85810,longevity,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85811,and,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85812,poor,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85813,sexual,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85814,appetite,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85815,/,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85816,low,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85817,virility,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85818,.,O,2971.0,"Additional medical complaints treated with chocolate / cacao have included anemia , poor appetite , mental fatigue , poor breast milk production , consumption / tuberculosis , fever , gout , kidney stones , reduced longevity and poor sexual appetite / low virility ."
85894,The,O,2975.0,The proceedings are synthesized in this article .
85895,proceedings,O,2975.0,The proceedings are synthesized in this article .
85896,are,O,2975.0,The proceedings are synthesized in this article .
85897,synthesized,O,2975.0,The proceedings are synthesized in this article .
85898,in,O,2975.0,The proceedings are synthesized in this article .
85899,this,O,2975.0,The proceedings are synthesized in this article .
85900,article,O,2975.0,The proceedings are synthesized in this article .
85901,.,O,2975.0,The proceedings are synthesized in this article .
86031,Some,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86032,preclinical,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86033,and,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86034,clinical,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86035,studies,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86036,suggest,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86037,impacts,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86038,of,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86039,mushrooms,B-AG.01.h.02.h,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86040,on,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86041,cognition,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86042,",",O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86043,weight,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86044,management,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86045,",",O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86046,oral,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86047,health,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86048,",",O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86049,and,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86050,cancer,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86051,risk,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86052,.,O,2980.0,"Some preclinical and clinical studies suggest impacts of mushrooms on cognition , weight management , oral health , and cancer risk ."
86744,The,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86745,high,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86746,-,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86747,risk,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86748,areas,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86749,tended,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86750,to,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86751,show,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86752,higher,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86753,consumption,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86754,of,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86755,food,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86756,associated,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86757,with,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86758,elevated,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86759,risk,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86760,(,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86761,traditional,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86762,soups,B-AG.01.n.02,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86763,",",O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86764,cold,B-AG.01.d,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86765,cuts,I-AG.01.d,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86766,),O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86767,and,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86768,lower,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86769,consumption,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86770,of,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86771,foods,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86772,associated,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86773,with,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86774,reduced,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86775,risks,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86776,(,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86777,raw,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86778,vegetables,B-AG.01.h.02,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86779,",",O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86780,citrus,B-AG.01.h.01.a,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86781,fruits,I-AG.01.h.01.a,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86782,",",O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86783,garlic,B-AG.01.h.02.e,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86784,),O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86785,.,O,3006.0,"The high - risk areas tended to show higher consumption of food associated with elevated risk ( traditional soups , cold cuts ) and lower consumption of foods associated with reduced risks ( raw vegetables , citrus fruits , garlic ) ."
86993,Treatment,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86994,with,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86995,camel,B-AG.01.e,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86996,milk,I-AG.01.e,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86997,or,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86998,bovine,B-AG.01.e,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86999,milk,I-AG.01.e,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87000,reversed,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87001,these,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87002,abnormalities,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87003,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87004,resulting,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87005,in,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87006,weight,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87007,gain,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87008,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87009,decreased,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87010,blood,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87011,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87012,levels,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87013,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87014,and,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87015,improved,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87016,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87017,tolerance,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87018,.,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87048,Long,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87049,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87050,term,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87051,administration,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87052,of,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87053,camel,B-AG.01.e,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87054,milk,I-AG.01.e,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87055,or,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87056,bovine,B-AG.01.e,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87057,milk,I-AG.01.e,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87058,counteracted,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87059,streptozotocin,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87060,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87061,induced,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87062,metabolic,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87063,manifestations,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87064,in,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87065,rats,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87066,",",O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87067,maintained,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87068,platelet,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87069,function,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87070,",",O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87071,and,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87072,abolished,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87073,coagulopathy,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87074,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87075,associated,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87076,fibrinogen,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87077,consumption,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87078,.,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87146,To,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87147,compare,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87148,the,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87149,metabolic,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87150,effect,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87151,of,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87152,coingestion,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87153,of,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87154,saturated,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87155,and,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87156,monounsaturated,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87157,fats,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87158,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87159,potato,B-AG.01.h.02.a,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87160,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87161,12,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87162,subjects,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87163,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87164,non,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87165,-,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87166,insulin,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87167,-,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87168,dependent,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87169,diabetes,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87170,mellitus,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87171,(,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87172,NIDDM,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87173,),O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87174,received,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87175,300,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87176,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87177,mashed,B-AG.01.n.09,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87178,potato,I-AG.01.n.09,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87179,alone,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87180,or,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87181,in,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87182,combination,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87183,with,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87184,40,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87185,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87186,olive,B-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87187,oil,I-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87188,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87189,80,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87190,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87191,olive,B-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87192,oil,I-AG.01.f,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87193,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87194,50,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87195,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87196,butter,B-AG.01.e.01,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87197,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87198,or,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87199,100,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87200,g,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87201,butter,B-AG.01.e.01,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87202,",",O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87203,respectively,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87204,.,O,3019.0,"To compare the metabolic effect of coingestion of saturated and monounsaturated fats with potato , 12 subjects with non - insulin - dependent diabetes mellitus ( NIDDM ) received 300 g mashed potato alone or in combination with 40 g olive oil , 80 g olive oil , 50 g butter , or 100 g butter , respectively ."
87501,Foods,O,3028.0,Foods were classified into food categories .
87502,were,O,3028.0,Foods were classified into food categories .
87503,classified,O,3028.0,Foods were classified into food categories .
87504,into,O,3028.0,Foods were classified into food categories .
87505,food,O,3028.0,Foods were classified into food categories .
87506,categories,O,3028.0,Foods were classified into food categories .
87507,.,O,3028.0,Foods were classified into food categories .
87691,Insulin,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87692,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87693,like,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87694,growth,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87695,factor,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87696,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87697,I,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87698,(,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87699,IGF,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87700,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87701,I,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87702,),O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87703,has,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87704,been,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87705,proposed,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87706,as,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87707,the,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87708,link,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87709,between,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87710,diet,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87711,and,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87712,breast,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87713,cancer,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87714,risk,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87715,.,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87716,Due,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87717,to,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87718,their,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87719,estrogen,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87720,-,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87721,like,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87722,structure,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87723,",",O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87724,soy,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87725,isoflavones,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87726,may,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87727,affect,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87728,IGF,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87729,-,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87730,I,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87731,levels,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87732,in,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87733,a,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87734,similar,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87735,way,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87736,as,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87737,exogenous,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87738,estrogens,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87739,.,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87981,These,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87982,findings,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87983,suggest,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87984,that,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87985,a,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87986,diet,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87987,rich,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87988,in,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87989,soy,B-AG.01.h.02.g,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87990,foods,I-AG.01.h.02.g,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87991,and,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87992,low,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87993,in,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87994,meats,B-AG.01.d,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87995,may,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87996,be,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87997,related,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87998,to,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
87999,lower,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88000,IGF,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88001,-,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88002,I,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88003,levels,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88004,",",O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88005,but,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88006,it,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88007,is,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88008,unclear,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88009,whether,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88010,soy,B-AG.01.h.02.g,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88011,or,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88012,other,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88013,characteristics,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88014,of,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88015,diet,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88016,and,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88017,lifestyle,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88018,are,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88019,responsible,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88020,for,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88021,this,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88022,association,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88023,.,O,3046.0,"These findings suggest that a diet rich in soy foods and low in meats may be related to lower IGF - I levels , but it is unclear whether soy or other characteristics of diet and lifestyle are responsible for this association ."
88256,This,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88257,paper,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88258,summarizes,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88259,new,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88260,findings,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88261,concerning,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88262,cocoa,B-AG.01,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88263,effects,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88264,on,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88265,blood,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88266,pressure,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88267,and,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88268,cardiovascular,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88269,health,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88270,",",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88271,focusing,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88272,on,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88273,putative,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88274,mechanisms,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88275,of,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88276,action,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88277,and,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88278,"""",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88279,nutraceutical,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88280,"""",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88281,viewpoints,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88282,.,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88393,Milk,B-AG.01.e,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88394,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88395,meat,B-AG.01.d,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88396,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88397,and,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88398,grains,B-AG.01.i,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88399,supplied,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88400,an,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88401,appreciable,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88402,proportion,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88403,of,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88404,each,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88405,vitamin,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88406,except,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88407,vitamin,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88408,A,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88409,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88410,which,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88411,was,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88412,found,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88413,primarily,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88414,in,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88415,the,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88416,two,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88417,vegetable,B-AG.01.h.02,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88418,groups,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88419,.,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88420,Meat,B-AG.01.d,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88421,and,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88422,grains,B-AG.01.i,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88423,contained,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88424,the,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88425,greatest,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88426,quantities,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88427,of,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88428,minerals,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88429,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88430,but,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88431,milk,B-AG.01.e,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88432,provided,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88433,a,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88434,relatively,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88435,good,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88436,proportion,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88437,of,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88438,potassium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88439,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88440,calcium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88441,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88442,magnesium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88443,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88444,and,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88445,phosphorus,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88446,.,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88457,Women,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88458,exhibiting,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88459,anemia,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88460,consumed,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88461,smaller,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88462,amounts,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88463,of,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88464,vitamins,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88465,studied,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88466,than,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88467,did,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88468,women,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88469,without,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88470,anemia,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88471,.,O,3066.0,Women exhibiting anemia consumed smaller amounts of vitamins studied than did women without anemia .
88897,The,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88898,objective,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88899,of,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88900,this,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88901,experiment,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88902,was,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88903,to,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88904,study,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88905,the,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88906,effects,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88907,of,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88908,incorporating,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88909,lemon,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88910,leaves,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88911,and,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88912,rice,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88913,straw,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88914,into,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88915,the,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88916,compound,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88917,feed,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88918,of,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88919,diets,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88920,for,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88921,dairy,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88922,goats,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88923,.,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
89374,Tobacco,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89375,smoking,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89376,was,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89377,negatively,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89378,associated,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89379,with,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89380,risk,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89381,for,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89382,current,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89383,smokers,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89384,of,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89385,cigarettes,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89386,compared,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89387,to,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89388,non,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89389,-,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89390,smokers,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89391,but,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89392,was,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89393,presumably,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89394,not,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89395,causally,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89396,related,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89397,.,O,3092.0,Tobacco smoking was negatively associated with risk for current smokers of cigarettes compared to non - smokers but was presumably not causally related .
89678,Recent,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89679,technological,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89680,advancements,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89681,in,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89682,the,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89683,separation,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89684,and,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89685,purification,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89686,of,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89687,CGAs,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89688,such,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89689,as,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89690,molecular,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89691,-,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89692,imprinted,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89693,polymer,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89694,technique,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89695,;,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89696,microwave,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89697,-,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89698,assisted,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89699,extraction,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89700,;,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89701,pH,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89702,gradient,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89703,counter,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89704,current,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89705,chromatography,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89706,has,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89707,also,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89708,been,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89709,described,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89710,.,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
90546,The,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90547,samples,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90548,were,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90549,prepared,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90550,using,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90551,3,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90552,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90553,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90554,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90555,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90556,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90557,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90558,rice,B-AG.01.l,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90559,starch,I-AG.01.l,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90560,",",O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90561,with,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90562,10,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90563,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90564,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90565,30,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90566,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90567,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90568,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90569,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90570,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90571,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90572,sugar,B-AG.01.l.02,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90573,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90574,trehalose,B-AG.01.l.02,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90575,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90576,allose,B-AG.01.l.02,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90577,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90578,added,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90579,and,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90580,10,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90581,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90582,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90583,30,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90584,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90585,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90586,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90587,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90588,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90589,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90590,oil,B-AG.01.f,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90591,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90592,canola,B-AG.01.f,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90593,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90594,coconut,B-AG.01.f,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90595,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90596,.,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90620,The,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90621,flow,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90622,behavior,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90623,of,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90624,the,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90625,film,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90626,suspensions,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90627,showed,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90628,shear,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90629,-,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90630,thinning,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90631,behavior,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90632,as,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90633,calculated,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90634,by,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90635,the,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90636,Power,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90637,Law,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90638,model,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90639,.,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90654,The,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90655,breaking,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90656,stress,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90657,of,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90658,the,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90659,films,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90660,blended,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90661,with,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90662,sugar,B-AG.01.l.02,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90663,and,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90664,oil,B-AG.01.f,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90665,was,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90666,less,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90667,than,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90668,that,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90669,of,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90670,control,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90671,.,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90672,On,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90673,preparation,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90674,day,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90675,and,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90676,after,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90677,7,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90678,days,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90679,',O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90680,storage,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90681,",",O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90682,the,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90683,breaking,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90684,strain,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90685,tended,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90686,to,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90687,increase,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90688,more,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90689,with,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90690,the,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90691,addition,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90692,of,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90693,coconut,B-AG.01.f,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90694,oil,I-AG.01.f,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90695,than,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90696,with,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90697,that,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90698,of,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90699,canola,B-AG.01.f,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90700,oil,I-AG.01.f,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
90701,.,O,3142.0,"On preparation day and after 7 days ' storage , the breaking strain tended to increase more with the addition of coconut oil than with that of canola oil ."
91236,During,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91237,the,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91238,adjustment,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91239,period,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91240,",",O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91241,participants,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91242,continued,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91243,to,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91244,follow,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91245,their,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91246,usual,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91247,eating,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91248,patterns,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91249,.,O,3163.0,"During the adjustment period , participants continued to follow their usual eating patterns ."
91863,Nevertheless,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91864,",",O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91865,there,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91866,is,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91867,still,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91868,a,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91869,need,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91870,to,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91871,adapt,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91872,these,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91873,sensors,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91874,to,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91875,special,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91876,requirements,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91877,of,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91878,on,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91879,-,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91880,farm,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91881,utilization,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91882,such,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91883,as,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91884,robustness,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91885,",",O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91886,calibration,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91887,and,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91888,maintenance,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91889,",",O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91890,costs,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91891,",",O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91892,operating,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91893,cycle,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91894,duration,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91895,",",O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91896,and,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91897,high,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91898,sensitivity,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91899,and,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91900,specificity,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91901,.,O,3184.0,"Nevertheless , there is still a need to adapt these sensors to special requirements of on - farm utilization such as robustness , calibration and maintenance , costs , operating cycle duration , and high sensitivity and specificity ."
91902,This,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91903,paper,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91904,provides,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91905,an,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91906,overview,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91907,of,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91908,available,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91909,sensors,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91910,",",O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91911,ongoing,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91912,research,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91913,",",O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91914,and,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91915,areas,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91916,of,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91917,application,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91918,for,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91919,analysis,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91920,of,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91921,milk,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91922,constituents,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91923,.,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91924,Currently,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91925,",",O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91926,the,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91927,recognition,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91928,of,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91929,abnormal,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91930,milk,B-AG.01.e,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91931,and,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91932,the,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91933,control,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91934,of,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91935,udder,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91936,health,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91937,is,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91938,achieved,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91939,mainly,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91940,by,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91941,recording,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91942,electrical,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91943,conductivity,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91944,and,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91945,changes,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91946,in,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91947,milk,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91948,color,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
91949,.,O,3186.0,"Currently , the recognition of abnormal milk and the control of udder health is achieved mainly by recording electrical conductivity and changes in milk color ."
92748,Because,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92749,milk,B-AG.01.e,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92750,is,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92751,not,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92752,necessary,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92753,for,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92754,humans,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92755,after,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92756,weaning,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92757,and,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92758,the,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92759,nutrients,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92760,it,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92761,contains,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92762,are,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92763,readily,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92764,available,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92765,in,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92766,foods,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92767,without,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92768,animal,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92769,protein,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92770,",",O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92771,saturated,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92772,fat,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92773,",",O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92774,and,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92775,cholesterol,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92776,",",O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92777,vegetarians,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92778,may,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92779,have,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92780,healthier,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92781,outcomes,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92782,for,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92783,chronic,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92784,disease,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92785,if,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92786,they,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92787,limit,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92788,or,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92789,avoid,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92790,milk,B-AG.01.e,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92791,and,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92792,other,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92793,dairy,B-AG.01.e,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92794,products,I-AG.01.e,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92795,.,O,3218.0,"Because milk is not necessary for humans after weaning and the nutrients it contains are readily available in foods without animal protein , saturated fat , and cholesterol , vegetarians may have healthier outcomes for chronic disease if they limit or avoid milk and other dairy products ."
92796,Bones,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92797,are,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92798,better,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92799,served,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92800,by,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92801,attending,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92802,to,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92803,calcium,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92804,balance,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92805,and,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92806,focusing,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92807,efforts,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92808,on,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92809,increasing,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92810,fruit,B-AG.01.h,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92811,and,I-AG.01.h,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92812,vegetable,I-AG.01.h,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92813,intakes,B-X,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92814,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92815,limiting,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92816,animal,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92817,protein,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92818,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92819,exercising,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92820,regularly,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92821,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92822,getting,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92823,adequate,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92824,sunshine,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92825,or,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92826,supplemental,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92827,vitamin,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92828,D,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92829,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92830,and,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92831,getting,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92832,approximately,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92833,500,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92834,mg,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92835,Ca,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92836,/,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92837,d,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92838,from,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92839,plant,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92840,sources,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92841,.,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
93393,The,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93394,purpose,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93395,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93396,this,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93397,study,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93398,was,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93399,to,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93400,determine,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93401,the,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93402,effects,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93403,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93404,consumption,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93405,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93406,different,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93407,cocoa,B-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93408,-,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93409,derived,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93410,products,I-AG.01,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93411,on,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93412,uric,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93413,acid,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93414,crystallization,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93415,in,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93416,urine,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93417,of,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93418,20,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93419,healthy,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93420,volunteers,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93421,.,O,3239.0,The purpose of this study was to determine the effects of consumption of different cocoa - derived products on uric acid crystallization in urine of 20 healthy volunteers .
93704,Specific,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93705,IgE,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93706,to,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93707,olive,B-AG.01.h.01.e,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93708,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93709,grass,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93710,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93711,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93712,weed,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93713,pollens,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93714,were,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93715,10.92,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93716,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93717,6.17,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93718,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93719,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93720,2.4,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93721,AU,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93722,/,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93723,ml,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93724,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93725,respectively,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93726,.,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93727,The,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93728,histamine,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93729,release,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93730,test,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93731,was,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93732,positive,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93733,for,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93734,carrot,B-AG.01.h.02.a,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93735,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93736,celery,B-AG.01.h.02.a,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93737,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93738,celeriac,B-AG.01.h.02.a,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93739,",",O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93740,and,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93741,olive,B-AG.01.h.01.e,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93742,pollen,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93743,up,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93744,to,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93745,a,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93746,dilution,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93747,of,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93748,1/10(6,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93749,),O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
93750,.,O,3253.0,"The histamine release test was positive for carrot , celery , celeriac , and olive pollen up to a dilution of 1/10(6 ) ."
94254,Furthermore,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94255,",",O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94256,in,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94257,animals,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94258,fed,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94259,on,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94260,olive,B-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94261,oil,I-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94262,in,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94263,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94264,absence,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94265,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94266,added,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94267,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94268,",",O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94269,plasma,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94270,LDL,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94271,-,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94272,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94273,concentrations,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94274,were,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94275,lower,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94276,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94277,P,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94278,<,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94279,0.05,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94280,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94281,and,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94282,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94283,extent,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94284,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94285,atherosclerotic,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94286,lesions,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94287,was,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94288,reduced,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94289,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94290,P,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94291,<,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94292,0.001,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94293,for,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94294,both,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94295,regions,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94296,of,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94297,the,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94298,aorta,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94299,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94300,compared,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94301,with,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94302,animals,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94303,fed,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94304,on,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94305,coconut,B-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94306,oil,I-AG.01.f,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94307,(,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94308,with,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94309,no,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94310,added,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94311,cholesterol,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94312,),O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94313,.,O,3272.0,"Furthermore , in animals fed on olive oil in the absence of added cholesterol , plasma LDL - cholesterol concentrations were lower ( P < 0.05 ) and the extent of atherosclerotic lesions was reduced ( P < 0.001 for both regions of the aorta ) compared with animals fed on coconut oil ( with no added cholesterol ) ."
94458,We,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94459,conclude,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94460,that,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94461,the,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94462,male,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94463,Golden,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94464,Syrian,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94465,hamster,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94466,represents,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94467,a,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94468,useful,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94469,model,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94470,of,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94471,dietary,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94472,induced,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94473,regression,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94474,as,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94475,well,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94476,as,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94477,progression,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94478,of,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94479,atherosclerosis,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94480,.,O,3277.0,We conclude that the male Golden Syrian hamster represents a useful model of dietary induced regression as well as progression of atherosclerosis .
94625,In,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94626,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94627,other,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94628,group,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94629,(,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94630,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94631,CHO,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94632,group,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94633,),O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94634,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94635,patients,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94636,consumed,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94637,the,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94638,same,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94639,standard,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94640,meal,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94641,plus,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94642,a,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94643,supplement,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94644,of,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94645,300,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94646,kcal,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94647,derived,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94648,from,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94649,different,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94650,types,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94651,of,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94652,CHO,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94653,(,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94654,bread,B-AG.01.n.11,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94655,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94656,coke,B-AG.01.aa,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94657,",",O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94658,fruit,B-AG.01.h.01,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94659,),O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
94660,.,O,3282.0,"In the other group ( the CHO group ) , patients consumed the same standard meal plus a supplement of 300 kcal derived from different types of CHO ( bread , coke , fruit ) ."
95642,A,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95643,calibration,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95644,study,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95645,in,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95646,a,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95647,subsample,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95648,was,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95649,used,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95650,to,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95651,correct,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95652,for,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95653,dietary,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95654,measurement,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95655,errors,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95656,.,O,3315.0,A calibration study in a subsample was used to correct for dietary measurement errors .
95775,There,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95776,was,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95777,no,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95778,association,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95779,between,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95780,total,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95781,or,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95782,specific,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95783,vegetables,B-AG.01.h.02,3318.0,There was no association between total or specific vegetables intake and GC risk .
95784,intake,B-X,3318.0,There was no association between total or specific vegetables intake and GC risk .
95785,and,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95786,GC,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95787,risk,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95788,.,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
96042,Among,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96043,prolamins,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96044,",",O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96045,barley,B-AG.01.i,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96046,exhibited,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96047,higher,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96048,recovery,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96049,compared,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96050,to,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96051,wheat,B-AG.01.i,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96052,and,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96053,rye,B-AG.01.i,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96054,with,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96055,most,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96056,of,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96057,the,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96058,ELISA,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96059,kits,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96060,used,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96061,.,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96676,The,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96677,question,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96678,now,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96679,is,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96680,whether,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96681,wine,B-AG.01.y.01.a,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96682,",",O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96683,particularly,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96684,red,B-AG.01.y.01.a,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96685,wine,I-AG.01.y.01.a,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96686,with,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96687,its,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96688,abundant,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96689,content,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96690,of,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96691,phenolic,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96692,acids,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96693,and,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96694,polyphenols,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96695,",",O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96696,confers,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96697,additional,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96698,health,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96699,benefits,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
96700,.,O,3349.0,"The question now is whether wine , particularly red wine with its abundant content of phenolic acids and polyphenols , confers additional health benefits ."
97560,Nutritional,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97561,intervention,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97562,strategies,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97563,are,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97564,needed,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97565,to,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97566,promote,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97567,more,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97568,frequent,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97569,consumption,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97570,of,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97571,nutrient,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97572,-,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97573,rich,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97574,foods,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97575,and,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97576,less,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97577,frequent,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97578,consumption,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97579,of,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97580,NNDFs,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97581,in,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97582,these,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97583,Arctic,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97584,communities,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97585,.,O,3379.0,Nutritional intervention strategies are needed to promote more frequent consumption of nutrient - rich foods and less frequent consumption of NNDFs in these Arctic communities .
97599,While,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97600,the,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97601,pathogenesis,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97602,of,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97603,dementia,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97604,is,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97605,complex,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97606,and,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97607,incompletely,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97608,understood,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97609,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97610,it,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97611,may,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97612,be,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97613,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97614,at,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97615,least,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97616,to,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97617,a,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97618,certain,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97619,extent,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97620,",",O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97621,the,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97622,consequence,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97623,of,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97624,systemic,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97625,vascular,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97626,pathology,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97627,.,O,3381.0,"While the pathogenesis of dementia is complex and incompletely understood , it may be , at least to a certain extent , the consequence of systemic vascular pathology ."
97907,276,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97908,(,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97909,24,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97910,%,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97911,),O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97912,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97913,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97914,patients,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97915,reported,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97916,some,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97917,kind,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97918,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97919,allergic,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97920,symptoms,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97921,on,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97922,eating,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97923,or,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97924,handling,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97925,various,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97926,foods,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97927,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97928,of,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97929,which,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97930,hazel,B-AG.01.h.01.f,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97931,nut,I-AG.01.h.01.f,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97932,",",O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97933,apple,B-AG.01.h.01.c,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97934,and,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97935,shell,B-AG.01.d.07,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97936,fish,I-AG.01.d.07,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97937,were,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97938,the,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97939,most,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97940,often,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97941,named,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
97942,.,O,3393.0,"276 ( 24 % ) of the patients reported some kind of allergic symptoms on eating or handling various foods , of which hazel nut , apple and shell fish were the most often named ."
98233,Although,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98234,there,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98235,were,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98236,no,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98237,ethnic,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98238,differences,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98239,in,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98240,overall,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98241,saturated,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98242,fat,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98243,/,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98244,cholesterol,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98245,avoidance,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98246,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98247,more,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98248,non,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98249,-,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98250,Hispanic,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98251,whites,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98252,recognized,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98253,milk,B-AG.01.e,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98254,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98255,eggs,B-AG.01.g,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98256,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98257,and,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98258,visible,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98259,fat,B-AG.01.f,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98260,on,I-AG.01.f,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98261,meat,I-AG.01.f,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98262,as,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98263,food,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98264,sources,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98265,to,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98266,avoid,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98267,.,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98268,The,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98269,scale,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98270,described,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98271,in,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98272,this,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98273,paper,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98274,provides,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98275,useful,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98276,information,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98277,about,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98278,the,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98279,specific,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98280,food,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98281,components,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98282,recognized,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98283,as,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98284,dietary,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98285,sources,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98286,of,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98287,saturated,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98288,fat,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98289,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98290,cholesterol,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98291,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98292,helps,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98293,identify,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98294,those,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98295,population,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98296,groups,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98297,that,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98298,would,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98299,benefit,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98300,from,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98301,nutrition,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98302,education,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98303,programs,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98304,.,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98325,The,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98326,impact,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98327,of,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98328,coffee,B-AG.01.ad,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98329,and,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98330,green,B-AG.01.ac,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98331,tea,I-AG.01.ac,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98332,consumption,B-X,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98333,on,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98334,upper,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98335,aerodigestive,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98336,tract,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98337,(,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98338,UADT,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98339,),O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98340,cancer,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98341,risk,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98342,has,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98343,not,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98344,been,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98345,established,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98346,.,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98347,Evaluation,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98348,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98349,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98350,possible,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98351,anticarcinogenic,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98352,properties,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98353,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98354,their,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98355,ingredients,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98356,is,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98357,confounded,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98358,by,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98359,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98360,potential,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98361,increase,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98362,in,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98363,risk,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98364,owing,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98365,to,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98366,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98367,high,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98368,temperatures,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98369,at,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98370,which,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98371,these,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98372,beverages,B-AG.01.y,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98373,are,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98374,generally,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98375,consumed,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98376,.,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98612,Food,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98613,sources,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98614,of,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98615,nutrients,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98616,in,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98617,Mexican,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98618,children,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98619,are,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98620,not,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98621,well,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98622,known,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98623,.,O,3419.0,Food sources of nutrients in Mexican children are not well known .
99379,Overall,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99380,",",O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99381,this,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99382,study,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99383,shows,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99384,that,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99385,supplementation,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99386,of,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99387,GSGME,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99388,did,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99389,not,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99390,influence,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99391,inflammation,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99392,or,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99393,ER,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99394,stress,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99395,in,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99396,the,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99397,liver,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99398,but,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99399,increased,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99400,milk,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99401,yield,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99402,",",O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99403,an,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99404,effect,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99405,that,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99406,could,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99407,be,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99408,due,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99409,to,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99410,effects,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99411,on,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99412,ruminal,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99413,metabolism,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99414,.,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99672,Dietary,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99673,vitamin,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99674,C,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99675,reduced,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99676,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99677,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99678,somatic,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99679,cell,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99680,count,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99681,but,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99682,did,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99683,not,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99684,affect,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99685,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99686,febrile,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99687,response,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99688,or,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99689,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99690,production,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99691,following,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99692,LPS,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99693,infusion,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99694,.,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99768,Thus,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99769,",",O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99770,rice,B-AG.01.k,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99771,flour,I-AG.01.k,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99772,is,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99773,mainly,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99774,used,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99775,for,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99776,the,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99777,manufacturing,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99778,of,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99779,the,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99780,basic,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99781,products,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99782,of,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99783,this,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99784,population,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
99785,.,O,3456.0,"Thus , rice flour is mainly used for the manufacturing of the basic products of this population ."
100054,This,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100055,benefit,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100056,is,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100057,partly,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100058,due,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100059,to,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100060,the,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100061,olive,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100062,oil,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100063,'s,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100064,unequivocal,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100065,cardio,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100066,-,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100067,protective,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100068,role,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100069,.,O,3465.0,This benefit is partly due to the olive oil 's unequivocal cardio - protective role .
100132,These,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100133,health,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100134,benefits,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100135,are,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100136,supported,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100137,by,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100138,strong,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100139,mechanistic,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100140,evidence,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100141,from,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100142,experimental,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100143,studies,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100144,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100145,demonstrating,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100146,that,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100147,specific,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100148,components,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100149,of,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100150,olive,B-AG.01.f,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100151,oil,I-AG.01.f,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100152,have,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100153,antihypertensive,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100154,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100155,antithrombotic,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100156,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100157,antioxidant,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100158,",",O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100159,antiinflammatory,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100160,and,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100161,anticarcinogenic,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100162,action,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100163,.,O,3468.0,"These health benefits are supported by strong mechanistic evidence from experimental studies , demonstrating that specific components of olive oil have antihypertensive , antithrombotic , antioxidant , antiinflammatory and anticarcinogenic action ."
100239,Nutrition,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100240,",",O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100241,particularly,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100242,intake,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100243,of,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100244,vegetables,B-AG.01.h.02,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100245,and,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100246,certain,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100247,plant,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100248,components,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100249,",",O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100250,has,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100251,been,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100252,reported,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100253,to,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100254,have,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100255,a,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100256,major,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100257,role,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100258,in,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100259,cancer,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100260,risk,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100261,reduction,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100262,.,O,3472.0,"Nutrition , particularly intake of vegetables and certain plant components , has been reported to have a major role in cancer risk reduction ."
100287,This,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100288,study,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100289,aims,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100290,to,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100291,review,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100292,scientific,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100293,evidence,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100294,from,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100295,all,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100296,studies,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100297,",",O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100298,published,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100299,from,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100300,1996,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100301,to,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100302,March,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100303,2010,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100304,that,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100305,examined,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100306,the,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100307,protective,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100308,effects,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100309,of,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100310,rosemary,B-AG.01.h.02.i,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100311,on,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100312,colorectal,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100313,cancer,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100314,and,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100315,other,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100316,types,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100317,of,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100318,cancer,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100319,.,O,3474.0,"This study aims to review scientific evidence from all studies , published from 1996 to March 2010 that examined the protective effects of rosemary on colorectal cancer and other types of cancer ."
100659,ED05,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100660,estimates,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100661,ranged,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100662,between,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100663,0.4,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100664, ,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100665,mg,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100666,for,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100667,mustard,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100668,protein,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100669,and,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100670,280,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100671, ,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100672,mg,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100673,for,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100674,shrimp,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100675,protein,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100676,.,O,3488.0,ED05 estimates ranged between 0.4   mg for mustard protein and 280   mg for shrimp protein .
100698,The,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100699,association,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100700,between,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100701,intake,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100702,of,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100703,different,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100704,dairy,B-AG.01.e,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100705,products,I-AG.01.e,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100706,and,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100707,the,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100708,risk,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100709,of,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100710,stroke,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100711,remains,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100712,unclear,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100713,.,O,3490.0,The association between intake of different dairy products and the risk of stroke remains unclear .
100778,Incident,O,3495.0,Incident stroke cases were identified in national registers .
100779,stroke,O,3495.0,Incident stroke cases were identified in national registers .
100780,cases,O,3495.0,Incident stroke cases were identified in national registers .
100781,were,O,3495.0,Incident stroke cases were identified in national registers .
100782,identified,O,3495.0,Incident stroke cases were identified in national registers .
100783,in,O,3495.0,Incident stroke cases were identified in national registers .
100784,national,O,3495.0,Incident stroke cases were identified in national registers .
100785,registers,O,3495.0,Incident stroke cases were identified in national registers .
100786,.,O,3495.0,Incident stroke cases were identified in national registers .
102385,Dietary,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102386,advice,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102387,aims,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102388,to,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102389,reduce,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102390,the,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102391,majority,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102392,of,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102393,lithogenic,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102394,risk,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102395,factors,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102396,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102397,reducing,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102398,the,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102399,supersaturation,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102400,of,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102401,urine,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102402,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102403,mainly,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102404,for,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102405,calcium,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102406,oxalate,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102407,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102408,calcium,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102409,phosphate,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102410,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102411,and,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102412,uric,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102413,acid,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102414,.,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102468,Available,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102469,scientific,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102470,evidence,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102471,agrees,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102472,on,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102473,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102474,harmful,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102475,effects,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102476,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102477,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102478,meat,B-AG.01.d,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102479,/,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102480,animal,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102481,protein,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102482,intake,B-X,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102483,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102484,low,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102485,calcium,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102486,diets,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102487,",",O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102488,whereas,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102489,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102490,content,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102491,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102492,fruits,B-AG.01.h.01,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102493,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102494,vegetables,B-AG.01.h.02,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102495,associated,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102496,with,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102497,a,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102498,balanced,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102499,intake,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102500,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102501,low,B-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102502,-,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102503,fat,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102504,dairy,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102505,products,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102506,carries,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102507,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102508,lowest,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102509,risk,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102510,for,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102511,incident,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102512,kidney,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102513,stones,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102514,.,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102582,Improving,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102583,knowledge,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102584,",",O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102585,attitudes,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102586,",",O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102587,and,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102588,practices,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102589,(,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102590,KAP,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102591,),O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102592,related,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102593,to,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102594,salt,B-AG.01.l.01,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102595,intake,B-X,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102596,in,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102597,the,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102598,general,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102599,population,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102600,is,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102601,a,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102602,key,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102603,component,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102604,of,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102605,salt,B-AG.01.l.01,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102606,reduction,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102607,strategies,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102608,.,O,3560.0,"Improving knowledge , attitudes , and practices ( KAP ) related to salt intake in the general population is a key component of salt reduction strategies ."
102690,Height,O,3564.0,"Height , weight , and blood pressure were measured ."
102691,",",O,3564.0,"Height , weight , and blood pressure were measured ."
102692,weight,O,3564.0,"Height , weight , and blood pressure were measured ."
102693,",",O,3564.0,"Height , weight , and blood pressure were measured ."
102694,and,O,3564.0,"Height , weight , and blood pressure were measured ."
102695,blood,O,3564.0,"Height , weight , and blood pressure were measured ."
102696,pressure,O,3564.0,"Height , weight , and blood pressure were measured ."
102697,were,O,3564.0,"Height , weight , and blood pressure were measured ."
102698,measured,O,3564.0,"Height , weight , and blood pressure were measured ."
102699,.,O,3564.0,"Height , weight , and blood pressure were measured ."
103056,We,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103057,investigated,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103058,associations,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103059,between,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103060,intakes,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103061,of,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103062,11,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103063,nutrients,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103064,(,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103065,thiamine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103066,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103067,riboflavin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103068,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103069,niacin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103070,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103071,pantothenic,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103072,acid,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103073,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103074,vitamin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103075,B6,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103076,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103077,biotin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103078,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103079,folate,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103080,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103081,vitamin,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103082,B12,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103083,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103084,methionine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103085,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103086,choline,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103087,",",O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103088,and,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103089,betaine,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103090,),O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103091,and,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103092,gastric,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103093,cancer,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103094,risk,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103095,.,O,3578.0,"We investigated associations between intakes of 11 nutrients ( thiamine , riboflavin , niacin , pantothenic acid , vitamin B6 , biotin , folate , vitamin B12 , methionine , choline , and betaine ) and gastric cancer risk ."
103140,Dietary,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103141,intakes,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103142,of,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103143,nutrients,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103144,were,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103145,estimated,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103146,at,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103147,baseline,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103148,(,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103149,1990,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103150,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103151,1994,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103152,),O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103153,using,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103154,a,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103155,121,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103156,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103157,item,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103158,food,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103159,frequency,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103160,questionnaire,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103161,.,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103162,Odds,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103163,ratios,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103164,(,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103165,ORs,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103166,),O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103167,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103168,95,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103169,%,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103170,confidence,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103171,intervals,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103172,were,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103173,estimated,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103174,using,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103175,conditional,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103176,logistic,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103177,regression,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103178,models,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103179,adjusting,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103180,for,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103181,Helicobacter,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103182,pylori,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103183,infection,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103184,",",O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103185,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103186,other,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103187,potential,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103188,confounders,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103189,.,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103533,During,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103534,the,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103535,past,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103536,20,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103537,years,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103538,",",O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103539,many,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103540,studies,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103541,have,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103542,focused,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103543,on,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103544,polyphenol,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103545,compounds,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103546,for,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103547,their,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103548,potential,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103549,beneficial,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103550,health,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103551,effects,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103552,.,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103742,The,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103743,aim,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103744,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103745,this,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103746,paper,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103747,is,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103748,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103749,provide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103750,an,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103751,up,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103752,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103753,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103754,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103755,date,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103756,review,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103757,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103758,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103759,latest,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103760,studies,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103761,which,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103762,investigated,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103763,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103764,health,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103765,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103766,promoting,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103767,components,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103768,forming,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103769,upon,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103770,fermentation,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103771,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103772,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103773,main,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103774,food,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103775,matrices,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103776,",",O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103777,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103778,order,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103779,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103780,contribute,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103781,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103782,understanding,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103783,their,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103784,important,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103785,role,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103786,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103787,healthy,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103788,diets,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103789,and,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103790,relevance,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103791,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103792,national,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103793,dietary,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103794,recommendations,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103795,worldwide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103796,.,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103797,Formation,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103798,of,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103799,antioxidant,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103800,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103801,bioactive,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103802,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103803,anti,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103804,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103805,hypertensive,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103806,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103807,anti,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103808,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103809,diabetic,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103810,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103811,and,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103812,FODMAP,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103813,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103814,reducing,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103815,components,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103816,in,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103817,fermented,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103818,foods,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103819,are,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103820,mainly,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103821,presented,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103822,and,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103823,discussed,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103824,.,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103870,Fermented,B-AG.01.e,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103871,milk,I-AG.01.e,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103872,and,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103873,fruit,B-AG.01.ab,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103874,juice,I-AG.01.ab,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103875,were,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103876,found,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103877,to,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103878,have,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103879,probiotic,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103880,activity,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103881,.,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103952,It,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103953,is,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103954,formed,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103955,as,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103956,an,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103957,intermediate,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103958,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103959,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103960,course,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103961,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103962,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103963,conversion,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103964,of,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103965,linoleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103966,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103967,to,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103968,oleic,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103969,acid,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103970,in,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103971,the,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103972,rumen,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103973,.,O,3611.0,It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen .
103974,The,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103975,predominant,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103976,naturally,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103977,occurring,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103978,isomer,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103979,is,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103980,the,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103981,cis-9,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103982,",",O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103983,trans-11,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103984,modification,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103985,.,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
104050,The,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104051,inhibition,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104052,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104053,mammary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104054,tumours,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104055,in,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104056,rats,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104057,is,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104058,effective,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104059,regardless,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104060,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104061,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104062,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104063,carcinogen,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104064,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104065,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104066,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104067,amount,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104068,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104069,dietary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104070,fat,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104071,.,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104589,Okra,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104590,gum,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104591,is,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104592,an,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104593,acceptable,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104594,fat,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104595,replacer,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104596,in,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104597,chocolate,B-AG.01.n.14,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104598,bar,I-AG.01.n.14,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104599,cookies,I-AG.01.n.14,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104600,.,O,3637.0,Okra gum is an acceptable fat replacer in chocolate bar cookies .
104875,Nevertheless,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104876,there,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104877,is,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104878,little,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104879,information,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104880,on,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104881,the,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104882,metabolic,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104883,effects,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104884,of,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104885,conventional,B-AG.01.n.17.a,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104886,chocolate,I-AG.01.n.17.a,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104887,or,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104888,specialized,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104889,formulations,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104890,with,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104891,reduced,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104892,sucrose,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104893,content,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104894,.,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
105153,Isomalt,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105154,appears,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105155,to,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105156,be,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105157,a,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105158,palatable,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105159,alternative,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105160,sweetener,B-AG.01.l.02,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105161,capable,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105162,of,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105163,reducing,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105164,the,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105165,glycaemic,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105166,effect,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105167,of,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105168,diabetic,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105169,confectionary,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105170,.,O,3658.0,Isomalt appears to be a palatable alternative sweetener capable of reducing the glycaemic effect of diabetic confectionary .
105429,Honey,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105430,is,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105431,a,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105432,natural,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105433,product,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105434,",",O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105435,containing,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105436,flavonoids,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105437,and,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105438,phenolic,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105439,acids,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105440,",",O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105441,appreciated,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105442,for,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105443,its,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105444,therapeutic,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105445,abilities,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105446,since,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105447,ancient,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105448,times,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105449,.,O,3666.0,"Honey is a natural product , containing flavonoids and phenolic acids , appreciated for its therapeutic abilities since ancient times ."
105719,Many,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105720,non,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105721,-,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105722,gluten,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105723,cereals,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105724,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105725,starches,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105726,(,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105727,rice,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105728,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105729,corn,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105730,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105731,sorghum,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105732,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105733,millets,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105734,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105735,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105736,potato,B-AG.01.h.02.a,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105737,/,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105738,pea,B-AG.01.l,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105739,starch,I-AG.01.l,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105740,),O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105741,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105742,various,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105743,gluten,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105744,replacers,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105745,(,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105746,xanthan,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105747,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105748,guar,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105749,gum,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105750,),O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105751,have,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105752,been,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105753,used,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105754,for,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105755,retaining,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105756,the,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105757,physical,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105758,-,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105759,sensorial,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105760,properties,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105761,of,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105762,gluten,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105763,-,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105764,free,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105765,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105766,cereal,B-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105767,-,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105768,based,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105769,products,I-AG.01.i,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105770,.,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105908,Lifestyle,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105909,factors,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105910,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105911,including,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105912,nutrition,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105913,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105914,play,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105915,an,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105916,important,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105917,role,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105918,in,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105919,the,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105920,etiology,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105921,of,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105922,Cardiovascular,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105923,Disease,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105924,(,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105925,CVD,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105926,),O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105927,.,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
106941,The,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106942,role,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106943,of,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106944,fat,B-AG.01.f,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106945,intake,B-X,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106946,as,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106947,a,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106948,risk,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106949,factor,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106950,for,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106951,stroke,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106952,remains,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106953,uncertain,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106954,",",O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106955,whereas,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106956,the,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106957,association,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106958,between,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106959,stroke,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106960,and,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106961,cholesterol,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106962,has,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106963,more,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106964,convincingly,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106965,been,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106966,demonstrated,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106967,by,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106968,the,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106969,recent,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106970,intervention,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106971,trials,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106972,using,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106973,statins,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
106974,.,O,3718.0,"The role of fat intake as a risk factor for stroke remains uncertain , whereas the association between stroke and cholesterol has more convincingly been demonstrated by the recent intervention trials using statins ."
107580,Affected,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107581,commodities,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107582,include,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107583,oats,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107584,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107585,wheat,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107586,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107587,maize,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107588,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107589,barley,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107590,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107591,raisins,B-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107592,and,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107593,other,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107594,dried,B-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107595,vine,I-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107596,fruits,I-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107597,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107598,wine,B-AG.01.y.01.a,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107599,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107600,beer,B-AG.01.y.01.b,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107601,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107602,coffee,B-AG.01.ad,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107603,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107604,and,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107605,cocoa,B-FOOD,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107606,.,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107607,Although,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107608,OTA,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107609,has,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107610,been,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107611,shown,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107612,to,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107613,cause,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107614,kidney,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107615,disease,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107616,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107617,including,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107618,kidney,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107619,cancer,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107620,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107621,in,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107622,multiple,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107623,animal,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107624,species,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107625,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107626,the,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107627,impact,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107628,of,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107629,dietary,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107630,OTA,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107631,on,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107632,human,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107633,health,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107634,from,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107635,a,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107636,global,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107637,perspective,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107638,has,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107639,been,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107640,less,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107641,clear,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107642,.,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107715,This,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107716,is,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107717,especially,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107718,true,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107719,in,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107720,the,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107721,light,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107722,of,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107723,increasing,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107724,type,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107725,2,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107726,diabetes,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107727,and,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107728,obesity,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107729,prevalence,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107730,worldwide,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107731,;,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107732,both,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107733,conditions,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107734,frequently,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107735,lead,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107736,to,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107737,chronic,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107738,kidney,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107739,disease,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107740,(,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107741,CKD,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107742,),O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107743,",",O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107744,and,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107745,may,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107746,synergize,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107747,with,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107748,dietary,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107749,OTA,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107750,exposure,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107751,to,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107752,increase,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107753,CKD,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107754,risk,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107755,.,O,3744.0,"This is especially true in the light of increasing type 2 diabetes and obesity prevalence worldwide ; both conditions frequently lead to chronic kidney disease ( CKD ) , and may synergize with dietary OTA exposure to increase CKD risk ."
107772,We,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107773,aimed,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107774,to,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107775,quantify,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107776,the,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107777,association,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107778,between,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107779,dietary,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107780,patterns,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107781,and,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107782,gastric,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107783,cancer,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107784,",",O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107785,by,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107786,location,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107787,and,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107788,histological,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107789,type,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107790,",",O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107791,according,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107792,to,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107793,Helicobacter,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107794,pylori,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107795,infection,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107796,status,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107797,.,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107863,Three,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107864,dietary,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107865,patterns,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107866,were,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107867,identified,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107868,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107869,with,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107870,the,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107871,following,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107872,main,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107873,characteristics,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107874,:,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107875,(,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107876,I,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107877,),O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107878,high,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107879,consumption,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107880,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107881,fruits,B-AG.01.h.01,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107882,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107883,dairy,B-AG.01.e,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107884,products,I-AG.01.e,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107885,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107886,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107887,low,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107888,consumption,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107889,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107890,alcoholic,B-AG.01.y.01,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107891,beverages,I-AG.01.y.01,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107892,;,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107893,(,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107894,II,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107895,),O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107896,low,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107897,consumption,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107898,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107899,fruit,B-AG.01.h.01,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107900,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107901,salads,B-AG.01.h.02.c,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107902,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107903,vegetables,B-AG.01.h.02,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107904,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107905,dairy,B-AG.01.e,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107906,products,I-AG.01.e,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107907,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107908,fish,B-AG.01.d.07,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107909,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107910,meat,B-AG.01.d,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107911,;,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107912,(,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107913,III,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107914,),O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107915,high,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107916,consumptions,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107917,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107918,most,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107919,food,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107920,groups,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107921,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107922,low,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107923,vegetable,B-AG.01.n.02,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107924,soup,I-AG.01.n.02,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107925,intake,B-X,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107926,.,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
108393,Hepatic,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108394,LDL,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108395,receptor,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108396,activity,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108397,may,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108398,be,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108399,regulated,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108400,by,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108401,the,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108402,messenger,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108403,RNA,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108404,concentration,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108405,of,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108406,the,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108407,LDL,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108408,receptor,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108409,.,O,3767.0,Hepatic LDL receptor activity may be regulated by the messenger RNA concentration of the LDL receptor .
108410,The,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108411,decrease,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108412,in,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108413,hepatic,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108414,LDL,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108415,receptor,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108416,activity,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108417,with,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108418,saturated,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108419,fat,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108420,feeding,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108421,is,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108422,associated,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108423,with,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108424,decreased,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108425,hepatic,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108426,sterol,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108427,O,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108428,-,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108429,acyltransferase,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108430,activity,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108431,and,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108432,",",O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108433,therefore,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108434,",",O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108435,a,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108436,reduced,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108437,inert,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108438,pool,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108439,of,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108440,cholesteryl,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108441,ester,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108442,.,O,3768.0,"The decrease in hepatic LDL receptor activity with saturated fat feeding is associated with decreased hepatic sterol O - acyltransferase activity and , therefore , a reduced inert pool of cholesteryl ester ."
108443,A,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108444,putative,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108445,regulatory,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108446,pool,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108447,of,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108448,cholesterol,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108449,is,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108450,increased,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108451,with,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108452,saturated,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108453,fat,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108454,feeding,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108455,and,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108456,suppresses,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108457,LDL,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108458,receptor,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108459,activity,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108460,",",O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108461,possibly,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108462,through,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108463,hepatic,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108464,messenger,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108465,RNA,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108466,regulation,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108467,.,O,3769.0,"A putative regulatory pool of cholesterol is increased with saturated fat feeding and suppresses LDL receptor activity , possibly through hepatic messenger RNA regulation ."
108644,Intake,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108645,of,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108646,vegetables,B-AG.01.h.02,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108647,is,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108648,recommended,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108649,for,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108650,the,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108651,prevention,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108652,of,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108653,myocardial,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108654,infarction,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108655,(,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108656,MI,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108657,),O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108658,.,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108941,Cranberries,O,3789.0,Cranberries contain various types of bioactive components .
108942,contain,O,3789.0,Cranberries contain various types of bioactive components .
108943,various,O,3789.0,Cranberries contain various types of bioactive components .
108944,types,O,3789.0,Cranberries contain various types of bioactive components .
108945,of,O,3789.0,Cranberries contain various types of bioactive components .
108946,bioactive,O,3789.0,Cranberries contain various types of bioactive components .
108947,components,O,3789.0,Cranberries contain various types of bioactive components .
108948,.,O,3789.0,Cranberries contain various types of bioactive components .
109127,©,O,3799.0,© 2018 Society of Chemical Industry .
109128,2018,O,3799.0,© 2018 Society of Chemical Industry .
109129,Society,O,3799.0,© 2018 Society of Chemical Industry .
109130,of,O,3799.0,© 2018 Society of Chemical Industry .
109131,Chemical,O,3799.0,© 2018 Society of Chemical Industry .
109132,Industry,O,3799.0,© 2018 Society of Chemical Industry .
109133,.,O,3799.0,© 2018 Society of Chemical Industry .
109244,Reducing,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109245,milking,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109246,frequency,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109247,from,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109248,twice,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109249,to,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109250,once,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109251,daily,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109252,did,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109253,not,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109254,seem,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109255,to,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109256,have,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109257,any,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109258,effect,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109259,on,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109260,MEC,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109261,loss,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109262,in,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109263,goat,B-AG.01.e,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109264,and,I-AG.01.e,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109265,cow,I-AG.01.e,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109266,milk,I-AG.01.e,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109267,after,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109268,7,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109269,d,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109270,",",O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109271,but,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109272,increased,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109273,MEC,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109274,loss,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109275,per,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109276,day,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109277,in,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109278,goats,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109279,when,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109280,applied,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109281,for,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109282,a,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109283,longer,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109284,period,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109285,.,O,3805.0,"Reducing milking frequency from twice to once daily did not seem to have any effect on MEC loss in goat and cow milk after 7 d , but increased MEC loss per day in goats when applied for a longer period ."
109356,Administering,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109357,prolactin,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109358,inhibitors,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109359,during,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109360,lactation,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109361,or,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109362,at,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109363,dry,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109364,-,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109365,off,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109366,enhanced,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109367,MEC,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109368,exfoliation,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109369,",",O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109370,whereas,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109371,exogenous,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109372,prolactin,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109373,during,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109374,lactation,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109375,tended,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109376,to,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109377,prevent,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109378,the,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109379,negative,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109380,effect,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109381,of,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109382,prolactin,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109383,inhibitors,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109384,.,O,3809.0,"Administering prolactin inhibitors during lactation or at dry - off enhanced MEC exfoliation , whereas exogenous prolactin during lactation tended to prevent the negative effect of prolactin inhibitors ."
109489,Cases,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109490,and,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109491,controls,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109492,were,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109493,recruited,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109494,at,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109495,the,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109496,University,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109497,Hospital,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109498,"""",O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109499,G.,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109500,Rodolico,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109501,"""",O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109502,of,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109503,Catania,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109504,.,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109505,The,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109506,dietary,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109507,habits,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109508,were,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109509,defined,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109510,through,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109511,the,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109512,"""",O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109513,Lifestyle,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109514,Assessment,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109515,Questionnaire,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109516,"""",O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
109517,.,O,3816.0,"The dietary habits were defined through the "" Lifestyle Assessment Questionnaire "" ."
110388,Data,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110389,on,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110390,food,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110391,consumption,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110392,and,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110393,complete,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110394,follow,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110395,-,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110396,up,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110397,for,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110398,cancer,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110399,occurrence,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110400,was,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110401,available,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110402,for,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110403,a,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110404,total,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110405,of,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110406,"478,533",O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110407,participants,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110408,",",O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110409,who,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110410,were,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110411,recruited,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110412,in,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110413,10,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110414,European,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110415,countries,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110416,.,O,3847.0,"Data on food consumption and complete follow - up for cancer occurrence was available for a total of 478,533 participants , who were recruited in 10 European countries ."
110417,Estimates,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110418,of,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110419,rate,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110420,ratios,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110421,were,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110422,obtained,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110423,by,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110424,Cox,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110425,proportional,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110426,hazard,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110427,models,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110428,",",O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110429,stratified,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110430,by,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110431,age,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110432,at,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110433,recruitment,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110434,",",O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110435,gender,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110436,and,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110437,study,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110438,centre,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110439,",",O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110440,and,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110441,adjusted,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110442,for,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110443,total,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110444,energy,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110445,intake,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110446,",",O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110447,smoking,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110448,status,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110449,",",O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110450,duration,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110451,of,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110452,smoking,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110453,and,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110454,lifetime,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110455,intensity,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110456,of,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110457,smoking,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110458,.,O,3848.0,"Estimates of rate ratios were obtained by Cox proportional hazard models , stratified by age at recruitment , gender and study centre , and adjusted for total energy intake , smoking status , duration of smoking and lifetime intensity of smoking ."
110616,Our,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110617,findings,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110618,do,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110619,not,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110620,support,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110621,an,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110622,effect,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110623,of,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110624,fruit,B-AG.01.h,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110625,and,I-AG.01.h,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110626,vegetable,I-AG.01.h,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110627,consumption,B-X,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110628,",",O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110629,combined,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110630,or,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110631,separately,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110632,",",O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110633,on,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110634,bladder,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110635,cancer,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110636,risk,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110637,.,O,3854.0,"Our findings do not support an effect of fruit and vegetable consumption , combined or separately , on bladder cancer risk ."
110922,Discrepant,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110923,data,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110924,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110925,however,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110926,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110927,have,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110928,been,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110929,reported,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110930,for,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110931,India,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110932,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110933,Japan,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110934,and,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110935,Korea,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110936,.,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
111064,Species,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111065,-,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111066,specific,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111067,risk,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111068,factors,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111069,for,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111070,these,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111071,cancers,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111072,are,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111073,compatible,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111074,with,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111075,the,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111076,transmission,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111077,of,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111078,different,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111079,infectious,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111080,factors,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111081,transferred,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111082,via,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111083,meat,B-AG.01.d,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111084,or,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111085,dairy,B-AG.01.e,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111086,products,I-AG.01.e,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111087,.,O,3870.0,Species - specific risk factors for these cancers are compatible with the transmission of different infectious factors transferred via meat or dairy products .
111544,The,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111545,ORs,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111546,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111547,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111548,highest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111549,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111550,relative,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111551,to,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111552,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111553,lowest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111554,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111555,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111556,total,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111557,vegetable,B-AG.01.h,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111558,and,I-AG.01.h,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111559,fruit,I-AG.01.h,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111560,intake,B-X,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111561,were,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111562,0.28,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111563,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111564,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111565,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111566,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111567,0.18,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111568,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111569,0.43,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111570,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111571,and,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111572,0.53,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111573,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111574,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111575,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111576,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111577,0.34,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111578,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111579,0.82,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111580,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111581,",",O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111582,respectively,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111583,.,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111778,injection,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111779,of,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111780,cadmium,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111781,chloride,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111782,(,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111783,1.2,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111784, ,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111785,mg,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111786,/,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111787,kg,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111788,body,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111789,weight,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111790,),O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111791,diluted,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111792,in,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111793,water,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111794,.,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
112082,The,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112083,importance,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112084,of,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112085,the,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112086,proteinaceous,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112087,components,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112088,was,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112089,further,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112090,confirmed,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112091,by,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112092,the,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112093,lower,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112094,activity,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112095,of,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112096,enzymes,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112097,involved,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112098,in,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112099,lipogenesis,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112100,.,O,3914.0,The importance of the proteinaceous components was further confirmed by the lower activity of enzymes involved in lipogenesis .
112472,Therefore,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112473,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112474,we,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112475,aimed,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112476,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112477,evaluate,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112478,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112479,association,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112480,of,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112481,FPS,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112482,with,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112483,excess,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112484,body,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112485,weight,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112486,(,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112487,EBW,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112488,),O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112489,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112490,and,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112491,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112492,monitor,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112493,differences,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112494,in,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112495,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112496,population,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112497,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112498,São,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112499,Paulo,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112500,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112501,Brazil,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112502,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112503,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112504,2003,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112505,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112506,2015,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112507,.,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112689,These,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112690,findings,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112691,could,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112692,support,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112693,future,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112694,interventions,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112695,and,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112696,policies,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112697,for,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112698,optimal,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112699,food,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112700,intake,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112701,in,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112702,Brazil,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112703,.,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112761,An,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112762,interviewer,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112763,-,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112764,administered,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112765,questionnaire,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112766,was,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112767,used,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112768,to,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112769,ascertain,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112770,major,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112771,life,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112772,events,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112773,and,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112774,obtain,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112775,estimates,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112776,of,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112777,consumption,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112778,(,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112779,ever,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112780,-,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112781,never,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112782,),O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112783,and,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112784,frequency,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112785,of,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112786,consumption,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112787,throughout,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112788,life,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112789,.,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
113402,Emerging,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113403,research,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113404,provides,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113405,substantial,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113406,evidence,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113407,to,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113408,classify,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113409,strawberries,B-AG.01.h.01.b,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113410,as,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113411,a,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113412,functional,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113413,food,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113414,with,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113415,several,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113416,preventive,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113417,and,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113418,therapeutic,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113419,health,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113420,benefits,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
113421,.,O,3952.0,Emerging research provides substantial evidence to classify strawberries as a functional food with several preventive and therapeutic health benefits .
114055,In,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114056,others,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114057,(,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114058,eg,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114059,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114060,Scandinavia,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114061,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114062,United,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114063,Kingdom,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114064,),O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114065,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114066,the,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114067,gluten,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114068,-,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114069,free,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114070,diet,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114071,may,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114072,include,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114073,foods,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114074,such,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114075,as,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114076,wheat,B-AG.01.l,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114077,starch,I-AG.01.l,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114078,that,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114079,have,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114080,been,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114081,rendered,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114082,gluten,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114083,free,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114084,but,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114085,nonetheless,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114086,contain,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114087,small,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114088,amounts,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114089,of,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114090,toxic,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114091,prolamins,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114092,.,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114164,Nonetheless,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114165,",",O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114166,the,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114167,Codex,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114168,Alimentarius,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114169,Standard,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114170,for,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114171,gluten,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114172,-,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114173,free,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114174,foods,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114175,allows,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114176,a,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114177,certain,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114178,amount,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114179,of,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114180,prolamin,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114181,in,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114182,foods,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114183,designated,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114184,gluten,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114185,free,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114186,",",O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114187,and,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114188,these,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114189,products,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114190,have,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114191,been,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114192,used,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114193,in,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114194,many,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114195,countries,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114196,for,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114197,several,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114198,decades,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114199,.,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114232,Until,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114233,this,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114234,research,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114235,is,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114236,conducted,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114237,",",O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114238,dietitians,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114239,in,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114240,the,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114241,United,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114242,States,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114243,should,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114244,continue,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114245,to,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114246,advise,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114247,their,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114248,patients,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114249,against,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114250,the,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114251,use,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114252,of,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114253,wheat,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114254,starch,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114255,and,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114256,other,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114257,foods,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114258,rendered,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114259,gluten,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114260,free,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114261,.,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114588,We,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114589,used,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114590,Cox,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114591,proportional,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114592,hazard,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114593,models,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114594,to,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114595,determine,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114596,the,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114597,association,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114598,between,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114599,Med,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114600,-,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114601,style,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114602,diet,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114603,tertiles,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114604,and,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114605,first,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114606,sepsis,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114607,events,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114608,",",O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114609,adjusting,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114610,for,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114611,socio,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114612,-,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114613,demographics,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114614,",",O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114615,lifestyle,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114616,factors,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114617,",",O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114618,and,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114619,co,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114620,-,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114621,morbidities,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114622,.,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114742,Dietary,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114743,modification,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114744,may,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114745,potentially,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114746,provide,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114747,an,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114748,option,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114749,for,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114750,reducing,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114751,sepsis,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114752,risk,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114753,.,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114832,Progressive,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114833,loss,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114834,of,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114835,metabolic,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114836,control,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114837,is,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114838,evident,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114839,from,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114840,a,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114841,blunting,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114842,of,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114843,carbohydrate,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114844,",",O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114845,fat,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114846,and,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114847,protein,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114848,metabolism,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114849,",",O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114850,which,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114851,is,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114852,commonly,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114853,manifested,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114854,through,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114855,decreased,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114856,insulin,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114857,sensitivity,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114858,",",O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114859,inadequate,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114860,glucose,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114861,and,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114862,lipid,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114863,control,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114864,",",O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114865,accompanied,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114866,by,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114867,a,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114868,pro,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114869,-,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114870,inflammatory,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114871,environment,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114872,and,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114873,hypertension,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
114874,.,O,4000.0,"Progressive loss of metabolic control is evident from a blunting of carbohydrate , fat and protein metabolism , which is commonly manifested through decreased insulin sensitivity , inadequate glucose and lipid control , accompanied by a pro - inflammatory environment and hypertension ."
115199,Recent,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115200,syntheses,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115201,of,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115202,labeled,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115203,and,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115204,unlabelled,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115205,hydroxytyrosol,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115206,coupled,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115207,with,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115208,superior,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115209,analytical,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115210,techniques,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115211,have,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115212,enabled,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115213,its,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115214,absorption,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115215,and,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115216,metabolism,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115217,to,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115218,be,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115219,studied,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115220,.,O,4015.0,Recent syntheses of labeled and unlabelled hydroxytyrosol coupled with superior analytical techniques have enabled its absorption and metabolism to be studied .
115303,Well,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115304,-,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115305,planned,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115306,vegetarian,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115307,diets,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115308,are,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115309,considered,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115310,adequate,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115311,for,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115312,all,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115313,stages,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115314,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115315,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115316,life,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115317,cycle,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115318,",",O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115319,despite,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115320,limited,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115321,data,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115322,on,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115323,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115324,zinc,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115325,status,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115326,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115327,vegetarians,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115328,during,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115329,early,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115330,childhood,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115331,.,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115405,However,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115406,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115407,data,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115408,on,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115409,serum,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115410,zinc,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115411,concentrations,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115412,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115413,the,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115414,recommended,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115415,biomarker,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115416,for,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115417,identifying,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115418,population,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115419,groups,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115420,at,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115421,elevated,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115422,risk,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115423,of,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115424,zinc,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115425,deficiency,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115426,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115427,are,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115428,sparse,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115429,and,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115430,difficult,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115431,to,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115432,interpret,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115433,because,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115434,recommended,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115435,collection,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115436,and,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115437,analytic,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115438,procedures,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115439,have,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115440,not,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115441,always,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115442,been,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115443,followed,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115444,.,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115683,To,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115684,investigate,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115685,this,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115686,possibility,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115687,",",O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115688,we,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115689,studied,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115690,dietary,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115691,data,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115692,from,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115693,participants,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115694,in,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115695,the,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115696,Nurses,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115697,',O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115698,Health,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115699,Study,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115700,.,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115728,During,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115729,8,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115730,years,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115731,of,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115732,follow,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115733,-,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115734,up,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115735,",",O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115736,there,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115737,were,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115738,431,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115739,cases,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115740,of,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115741,new,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115742,CHD,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115743,(,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115744,non,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115745,-,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115746,fatal,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115747,myocardial,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115748,infarction,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115749,or,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115750,death,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115751,from,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115752,CHD,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115753,),O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115754,.,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115912,These,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115913,findings,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115914,support,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115915,the,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115916,hypothesis,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115917,that,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115918,consumption,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115919,of,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115920,partially,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115921,hydrogenated,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115922,vegetable,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115923,oils,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115924,may,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115925,contribute,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115926,to,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115927,occurrence,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115928,of,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115929,CHD,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115930,.,O,4037.0,These findings support the hypothesis that consumption of partially hydrogenated vegetable oils may contribute to occurrence of CHD .
115931,Reducing,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115932,sugar,B-AG.01.l.02,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115933,consumption,B-X,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115934,is,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115935,an,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115936,important,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115937,aspect,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115938,in,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115939,the,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115940,prevention,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115941,of,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115942,and,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115943,fight,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115944,against,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115945,obesity,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
115946,.,O,4038.0,Reducing sugar consumption is an important aspect in the prevention of and fight against obesity .
116054,Furthermore,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116055,",",O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116056,chocolate,B-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116057,with,I-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116058,sugar,I-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116059,and,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116060,chocolate,B-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116061,with,I-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116062,tagatose,I-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116063,both,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116064,elicited,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116065,positive,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116066,emotional,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116067,conceptualisations,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116068,whereas,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116069,chocolate,B-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116070,with,I-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116071,stevia,I-AG.01.n.17.a,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116072,elicited,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116073,negative,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116074,emotional,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116075,conceptualisations,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116076,.,O,4044.0,"Furthermore , chocolate with sugar and chocolate with tagatose both elicited positive emotional conceptualisations whereas chocolate with stevia elicited negative emotional conceptualisations ."
116077,In,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116078,conclusion,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116079,",",O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116080,dark,B-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116081,chocolate,I-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116082,with,I-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116083,tagatose,I-AG.01.n.17.a,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116084,did,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116085,not,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116086,significantly,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116087,differ,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116088,from,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116089,sugar,B-AG.01.l.02,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116090,in,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116091,overall,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116092,liking,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116093,",",O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116094,most,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116095,sensory,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116096,attributes,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116097,and,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116098,emotional,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116099,conceptualisation,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116100,.,O,4045.0,"In conclusion , dark chocolate with tagatose did not significantly differ from sugar in overall liking , most sensory attributes and emotional conceptualisation ."
116217,Mechanisms,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116218,of,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116219,action,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116220,are,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116221,being,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116222,elucidated,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116223,by,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116224,modern,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116225,technology,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116226,.,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116619,The,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116620,development,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116621,of,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116622,this,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116623,disease,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116624,is,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116625,influenced,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116626,by,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116627,genetic,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116628,and,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116629,environmental,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116630,factors,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116631,.,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116676,Peptides,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116677,formed,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116678,during,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116679,the,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116680,digestion,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116681,of,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116682,milk,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116683,proteins,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116684,have,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116685,also,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116686,been,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116687,demonstrated,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116688,to,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116689,have,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116690,a,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116691,blood,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116692,pressure,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116693,lowering,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116694,effect,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116695,.,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116696,Other,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116697,components,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116698,in,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116699,milk,B-AG.01.e,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116700,that,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116701,have,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116702,been,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116703,examined,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116704,for,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116705,their,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116706,effects,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116707,on,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116708,blood,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116709,pressure,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116710,have,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116711,been,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116712,less,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116713,promising,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116714,.,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116908,Nuts,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116909,(,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116910,tree,B-AG.01.h.01.f,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116911,nuts,I-AG.01.h.01.f,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116912,and,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116913,peanuts,B-AG.01.h.01.f,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116914,),O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116915,are,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116916,nutrient,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116917,dense,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116918,foods,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116919,with,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116920,complex,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116921,matrices,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116922,rich,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116923,in,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116924,unsaturated,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116925,fatty,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116926,and,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116927,other,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116928,bioactive,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116929,compounds,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116930,:,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116931,high,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116932,-,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116933,quality,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116934,vegetable,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116935,protein,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116936,",",O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116937,fiber,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116938,",",O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116939,minerals,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116940,",",O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116941,tocopherols,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116942,",",O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116943,phytosterols,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116944,",",O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116945,and,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116946,phenolic,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116947,compounds,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
116948,.,O,4079.0,"Nuts ( tree nuts and peanuts ) are nutrient dense foods with complex matrices rich in unsaturated fatty and other bioactive compounds : high - quality vegetable protein , fiber , minerals , tocopherols , phytosterols , and phenolic compounds ."
117120,In,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117121,conclusion,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117122,",",O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117123,nuts,B-AG.01.h.01.f,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117124,are,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117125,nutrient,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117126,rich,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117127,foods,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117128,with,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117129,wide,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117130,-,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117131,ranging,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117132,cardiovascular,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117133,and,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117134,metabolic,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117135,benefits,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117136,",",O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117137,which,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117138,can,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117139,be,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117140,readily,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117141,incorporated,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117142,into,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117143,healthy,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117144,diets,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117145,.,O,4088.0,"In conclusion , nuts are nutrient rich foods with wide - ranging cardiovascular and metabolic benefits , which can be readily incorporated into healthy diets ."
117549,Snacking,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117550,on,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117551,dried,B-AG.01.n.08,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117552,plums,I-AG.01.n.08,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117553,may,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117554,increase,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117555,satiety,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117556,and,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117557,reduce,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117558,the,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117559,subsequent,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117560,intake,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117561,of,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117562,food,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117563,",",O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117564,helping,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117565,to,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117566,control,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117567,obesity,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117568,",",O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117569,diabetes,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117570,",",O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117571,and,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117572,related,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117573,cardiovascular,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117574,diseases,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117575,.,O,4099.0,"Snacking on dried plums may increase satiety and reduce the subsequent intake of food , helping to control obesity , diabetes , and related cardiovascular diseases ."
117832,Strong,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117833,correlations,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117834,between,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117835,the,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117836,mediator,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117837,response,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117838,induced,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117839,by,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117840,several,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117841,fruits,B-AG.01.h.01,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117842,indicate,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117843,common,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117844,allergens,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117845,within,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117846,the,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117847,extracts,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117848,.,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117896,Some,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117897,studies,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117898,showed,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117899,that,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117900,cadmium,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117901,(,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117902,Cd,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117903,),O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117904,was,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117905,among,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117906,the,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117907,most,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117908,significant,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117909,hazards,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117910,in,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117911,kitchen,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117912,garden,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117913,soils,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117914,and,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117915,prolonged,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117916,exposure,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117917,to,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117918,this,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117919,metal,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117920,could,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117921,cause,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117922,deleterious,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117923,health,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117924,effects,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117925,in,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117926,humans,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117927,.,O,4112.0,Some studies showed that cadmium ( Cd ) was among the most significant hazards in kitchen garden soils and prolonged exposure to this metal could cause deleterious health effects in humans .
117928,In,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117929,general,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117930,",",O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117931,most,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117932,risk,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117933,assessment,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117934,procedures,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117935,are,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117936,based,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117937,on,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117938,total,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117939,concentrations,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117940,of,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117941,metals,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117942,in,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117943,vegetables,B-AG.01.h.02,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117944,.,O,4113.0,"In general , most risk assessment procedures are based on total concentrations of metals in vegetables ."
117964,Seven,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117965,vegetables,B-AG.01.h.02,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117966,(,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117967,radish,B-AG.01.h.02.a,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117968,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117969,lettuce,B-AG.01.h.02.c,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117970,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117971,French,B-AG.01.h.02.g,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117972,bean,I-AG.01.h.02.g,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117973,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117974,carrot,B-AG.01.h.02.a,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117975,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117976,leek,B-AG.01.h.02.e,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117977,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117978,tomato,B-AG.01.h.02.f,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117979,",",O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117980,and,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117981,potato,B-AG.01.h.02.a,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117982,),O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117983,were,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117984,considered,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
117985,.,O,4115.0,"Seven vegetables ( radish , lettuce , French bean , carrot , leek , tomato , and potato ) were considered ."
118246,Curcumin,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118247,directly,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118248,interacts,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118249,with,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118250,adipocytes,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118251,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118252,pancreatic,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118253,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118254,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118255,hepatic,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118256,stellate,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118257,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118258,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118259,macrophages,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118260,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118261,and,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118262,muscle,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118263,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118264,.,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118477,The,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118478,present,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118479,comprehensive,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118480,review,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118481,summarized,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118482,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118483,latest,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118484,studies,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118485,on,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118486,shellfish,B-AG.01.d.07,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118487,consumption,B-X,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118488,and,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118489,synthesized,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118490,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118491,available,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118492,evidence,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118493,on,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118494,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118495,potential,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118496,health,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118497,benefits,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118498,or,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118499,risks,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118500,of,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118501,shellfish,B-AG.01.d.07,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118502,consumption,B-X,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118503,.,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118992,Human,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118993,randomized,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118994,controlled,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118995,studies,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118996,were,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118997,selected,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118998,according,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118999,to,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119000,PRISMA,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119001,guidelines,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119002,.,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119490,These,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119491,estimates,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119492,and,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119493,determinants,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119494,serve,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119495,as,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119496,a,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119497,baseline,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119498,for,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119499,comparison,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119500,for,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119501,other,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119502,works,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119503,and,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119504,public,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119505,health,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119506,campaigns,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119507,.,O,4165.0,These estimates and determinants serve as a baseline for comparison for other works and public health campaigns .
119740,In,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119741,the,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119742,comparison,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119743,with,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119744,olive,B-AG.01.f,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119745,oil,I-AG.01.f,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119746,",",O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119747,no,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119748,differences,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119749,in,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119750,effects,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119751,on,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119752,aortic,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119753,cholesterol,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119754,content,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119755,were,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119756,detected,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119757,between,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119758,butter,B-AG.01.e.01,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119759,",",O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119760,lard,B-AG.01.f,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119761,and,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119762,coconut,B-AG.01.f,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119763,oil,I-AG.01.f,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119764,.,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119980,There,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119981,was,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119982,no,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119983,excess,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119984,risk,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119985,of,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119986,pancreatic,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119987,cancer,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119988,among,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119989,those,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119990,who,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119991,had,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119992,ever,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119993,used,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119994,other,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119995,forms,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119996,of,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119997,tobacco,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119998,",",O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
119999,including,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120000,pipe,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120001,tobacco,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120002,",",O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120003,cigars,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120004,and,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120005,chewing,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120006,tobacco,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120007,.,O,4181.0,"There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco , including pipe tobacco , cigars and chewing tobacco ."
120056,To,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120057,evaluate,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120058,the,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120059,possible,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120060,effects,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120061,on,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120062,insulin,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120063,function,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120064,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120065,49,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120066,herb,B-AG.01.h.02.i,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120067,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120068,spice,B-AG.01.l.03,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120069,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120070,and,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120071,medicinal,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120072,plant,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120073,extracts,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120074,were,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120075,tested,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120076,in,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120077,the,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120078,insulin,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120079,-,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120080,dependent,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120081,utilization,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120082,of,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120083,glucose,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120084,using,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120085,a,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120086,rat,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120087,epididymal,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120088,adipocyte,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120089,assay,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120090,.,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120719,Consumption,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120720,of,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120721,constituents,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120722,of,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120723,the,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120724,traditional,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120725,Japanese,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120726,diet,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120727,",",O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120728,such,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120729,as,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120730,rice,B-AG.01.i,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120731,and,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120732,other,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120733,cereals,B-AG.01.i,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120734,",",O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120735,certain,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120736,seasonings,B-AG.01.l.03,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120737,",",O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120738,salted,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120739,and,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120740,dried,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120741,fish,B-AG.01.d.07,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120742,showed,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120743,a,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120744,positive,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120745,association,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120746,with,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120747,SMR,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120748,.,O,4207.0,"Consumption of constituents of the traditional Japanese diet , such as rice and other cereals , certain seasonings , salted and dried fish showed a positive association with SMR ."
120749,Alcoholic,B-AG.01.y.01,4208.0,Alcoholic beverages and cakes also showed a positive association .
120750,beverages,I-AG.01.y.01,4208.0,Alcoholic beverages and cakes also showed a positive association .
120751,and,O,4208.0,Alcoholic beverages and cakes also showed a positive association .
120752,cakes,B-AG.01.n.13,4208.0,Alcoholic beverages and cakes also showed a positive association .
120753,also,O,4208.0,Alcoholic beverages and cakes also showed a positive association .
120754,showed,O,4208.0,Alcoholic beverages and cakes also showed a positive association .
120755,a,O,4208.0,Alcoholic beverages and cakes also showed a positive association .
120756,positive,O,4208.0,Alcoholic beverages and cakes also showed a positive association .
120757,association,O,4208.0,Alcoholic beverages and cakes also showed a positive association .
120758,.,O,4208.0,Alcoholic beverages and cakes also showed a positive association .
120819,A,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120820,case,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120821,-,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120822,control,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120823,study,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120824,to,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120825,evaluate,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120826,risk,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120827,factors,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120828,of,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120829,gastric,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120830,cancer,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120831,was,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120832,carried,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120833,out,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120834,in,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120835,areas,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120836,with,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120837,contrasting,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120838,incidence,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120839,rates,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120840,in,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120841,Sweden,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
120842,.,O,4211.0,A case - control study to evaluate risk factors of gastric cancer was carried out in areas with contrasting incidence rates in Sweden .
121259,GO,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121260,and,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121261,KEGG,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121262,analyses,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121263,indicated,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121264,that,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121265,the,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121266,candidates,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121267,for,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121268,uniquely,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121269,or,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121270,differentially,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121271,expressed,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121272,proteins,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121273,in,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121274,milk,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121275,sEV,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121276,had,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121277,been,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121278,involved,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121279,in,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121280,diverse,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121281,biological,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121282,activities,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121283,including,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121284,metabolic,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121285,processes,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121286,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121287,cellular,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121288,processes,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121289,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121290,respond,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121291,to,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121292,stimulus,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121293,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121294,binding,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121295,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121296,catalytic,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121297,activities,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121298,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121299,cancer,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121300,pathways,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121301,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121302,focal,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121303,adhesion,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121304,",",O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121305,and,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121306,so,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121307,on,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121308,.,O,4227.0,"GO and KEGG analyses indicated that the candidates for uniquely or differentially expressed proteins in milk sEV had been involved in diverse biological activities including metabolic processes , cellular processes , respond to stimulus , binding , catalytic activities , cancer pathways , focal adhesion , and so on ."
121309,Taken,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121310,together,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121311,",",O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121312,the,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121313,present,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121314,findings,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121315,provided,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121316,a,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121317,novel,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121318,insight,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121319,into,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121320,the,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121321,proteomes,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121322,of,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121323,milk,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121324,sEV,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121325,from,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121326,BLV,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121327,-,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121328,infected,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121329,cattle,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121330,.,O,4228.0,"Taken together , the present findings provided a novel insight into the proteomes of milk sEV from BLV - infected cattle ."
121461,Chocolate,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121462,consumers,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121463,(,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121464,81·8,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121465,%,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121466,),O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121467,were,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121468,more,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121469,likely,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121470,to,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121471,be,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121472,younger,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121473,",",O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121474,physically,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121475,active,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121476,",",O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121477,affluent,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121478,people,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121479,with,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121480,higher,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121481,education,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121482,levels,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121483,and,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121484,fewer,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121485,chronic,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121486,co,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121487,-,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121488,morbidities,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121489,.,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121618,Further,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121619,observational,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121620,prospective,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121621,research,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121622,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121623,well,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121624,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121625,designed,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121626,randomised,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121627,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121628,controlled,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121629,studies,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121630,are,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121631,needed,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121632,to,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121633,confirm,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121634,this,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121635,cross,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121636,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121637,sectional,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121638,relationship,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121639,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121640,to,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121641,comprehend,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121642,the,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121643,role,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121644,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121645,mechanisms,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121646,that,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121647,different,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121648,types,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121649,of,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121650,chocolate,B-AG.01.n.17.a,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121651,may,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121652,play,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121653,in,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121654,insulin,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121655,resistance,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121656,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121657,cardiometabolic,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121658,disorders,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121659,.,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121974,They,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121975,received,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121976,by,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121977,force-,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121978,feeding,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121979,7.14,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121980,mL/(kg,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121981,.,O,4249.0,They received by force- feeding 7.14 mL/(kg .
122222,Ethanol,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122223,significantly,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122224,reduced,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122225,AFSA,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122226,by,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122227,60,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122228,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122229,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122230,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122231,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122232,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122233,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122234,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122235,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122236,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122237,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122238,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122239,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122240,or,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122241,62,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122242,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122243,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122244,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122245,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122246,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122247,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122248,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122249,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122250,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122251,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122252,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122253,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122254,.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122255,These,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122256,data,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122257,suggest,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122258,that,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122259,ethanol,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122260,is,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122261,a,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122262,complementary,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122263,component,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122264,of,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122265,phenolics,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122266,in,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122267,the,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122268,benefits,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122269,of,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122270,red,B-AG.01.y.01.a,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122271,wine,I-AG.01.y.01.a,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122272,for,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122273,hamsters,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122274,and,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122275,that,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122276,chronic,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122277,ingestion,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122278,of,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122279,PE,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122280,in,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122281,ethanol,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122282,prevents,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122283,the,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122284,development,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122285,of,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122286,atherosclerosis,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122287,through,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122288,several,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122289,mechanisms,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122290,.,O,4259.0,These data suggest that ethanol is a complementary component of phenolics in the benefits of red wine for hamsters and that chronic ingestion of PE in ethanol prevents the development of atherosclerosis through several mechanisms .
122479,Alcohol,B-AG.01.y.01,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122480,increased,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122481,risk,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122482,only,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122483,when,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122484,consumed,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122485,at,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122486,high,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122487,levels,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122488,(,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122489,over,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122490,3.64,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122491,ounces,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122492,or,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122493,103,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122494,g,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122495,per,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122496,week,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122497,),O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122498,by,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122499,people,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122500,who,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122501,never,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122502,smoked,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122503,cigarettes,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122504,(,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122505,OR,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122506,=,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122507,2.37,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122508,),O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122509,.,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122878,The,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122879,sex,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122880,-,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122881,specific,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122882,correlates,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122883,of,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122884,factor,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122885,analysis,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122886,derived,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122887,DP,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122888,were,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122889,identified,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122890,with,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122891,multivariable,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122892,linear,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122893,regression,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122894,.,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
123082,The,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123083,"""",O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123084,healthy,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123085,"""",O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123086,DP,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123087,explained,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123088,the,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123089,largest,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123090,amount,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123091,of,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123092,variance,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123093,in,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123094,intake,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123095,.,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123841,After,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123842,allowance,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123843,for,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123844,the,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123845,reciprocal,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123846,confounding,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123847,effect,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123848,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123849,various,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123850,dietary,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123851,habits,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123852,",",O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123853,only,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123854,frequent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123855,intake,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123856,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123857,milk,B-AG.01.e,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123858,seemed,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123859,to,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123860,be,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123861,a,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123862,significant,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123863,independent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123864,indicator,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123865,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123866,prostatic,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123867,cancer,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123868,risk,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123869,.,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
124009,The,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124010,presence,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124011,of,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124012,these,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124013,peptides,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124014,is,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124015,reported,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124016,in,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124017,various,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124018,fermented,B-AG.01.e,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124019,milk,I-AG.01.e,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124020,products,I-AG.01.e,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124021,such,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124022,as,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124023,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124024,yoghurt,B-AG.01.e,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124025,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124026,cheese,B-AG.01.e.02,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124027,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124028,sour,B-AG.01.e,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124029,milk,I-AG.01.e,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124030,",",O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124031,etc,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124032,.,O,4322.0,"The presence of these peptides is reported in various fermented milk products such as , yoghurt , cheese , sour milk , etc ."
124497,Red,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124498,blood,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124499,cell,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124500,count,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124501,and,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124502,erythrocyte,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124503,sedimentation,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124504,rate,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124505,(,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124506,ESR,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124507,;,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124508,both,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124509,The,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124510,role,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124511,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124512,various,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124513,life,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124514,style,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124515,factors,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124516,",",O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124517,including,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124518,dietary,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124519,habits,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124520,",",O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124521,in,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124522,the,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124523,etiology,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124524,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124525,non,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124526,-,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124527,Hodgkin,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124528,'s,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124529,lymphoma,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124530,was,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124531,investigated,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124532,using,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124533,data,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124534,from,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124535,a,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124536,case,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124537,-,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124538,control,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124539,study,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124540,conducted,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124541,in,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124542,the,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124543,northeastern,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124544,part,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124545,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124546,Italy,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124547,.,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124658,the,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124659,consumption,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124660,of,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124661,whole,B-AG.01.n.11,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124662,-,I-AG.01.n.11,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124663,grain,I-AG.01.n.11,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124664,bread,I-AG.01.n.11,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124665,and,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124666,pasta,B-AG.01.i,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124667,showed,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124668,a,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124669,protective,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124670,effect,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124671,.,O,4347.0,the consumption of whole - grain bread and pasta showed a protective effect .
124707,Interestingly,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124708,",",O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124709,these,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124710,associations,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124711,are,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124712,in,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124713,agreement,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124714,with,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124715,the,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124716,positive,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124717,correlation,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124718,that,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124719,is,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124720,emerging,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124721,internationally,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124722,between,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124723,the,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124724,consumption,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124725,of,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124726,fat,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124727,and,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124728,proteins,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124729,and,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124730,non,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124731,-,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124732,Hodgkin,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124733,'s,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124734,lymphoma,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124735,.,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124825,For,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124826,instance,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124827,",",O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124828,colorectal,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124829,cancer,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124830,(,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124831,CRC,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124832,),O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124833,metastasizes,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124834,to,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124835,the,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124836,liver,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124837,in,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124838,two,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124839,-,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124840,thirds,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124841,of,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124842,cases,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124843,",",O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124844,and,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124845,CRC,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124846,liver,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124847,metastasis,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124848,is,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124849,the,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124850,leading,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124851,cause,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124852,of,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124853,mortality,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124854,in,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124855,these,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124856,patients,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124857,.,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
125012,Here,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125013,we,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125014,review,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125015,how,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125016,Westernized,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125017,high,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125018,-,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125019,fat,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125020,diets,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125021,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125022,excessive,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125023,alcohol,B-AG.01.y.01,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125024,intake,B-X,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125025,can,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125026,influence,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125027,inflammation,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125028,within,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125029,the,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125030,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125031,microenvironment,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125032,",",O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125033,stimulating,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125034,both,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125035,primary,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125036,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125037,metastatic,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125038,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125039,tumorigenesis,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125040,.,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125299,Among,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125300,men,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125301,",",O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125302,a,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125303,similar,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125304,pattern,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125305,was,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125306,observed,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125307,",",O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125308,but,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125309,the,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125310,associations,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125311,were,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125312,weak,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125313,and,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125314,mostly,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125315,statistically,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125316,non,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125317,-,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125318,significant,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125319,.,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125728,When,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125729,fruits,B-AG.01.h.01,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125730,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125731,vegetables,B-AG.01.h.02,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125732,were,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125733,examined,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125734,separately,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125735,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125736,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125737,who,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125738,consumed,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125739,more,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125740,than,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125741,75,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125742,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125743,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125744,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125745,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125746,fruits,B-AG.01.h.01,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125747,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125748,vegetables,B-AG.01.h.02,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125749,had,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125750,multivariate,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125751,relative,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125752,risk,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125753,of,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125754,0.59,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125755,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125756,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125757,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125758,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125759,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125760,0.27,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125761,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125762,1.25,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125763,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125764,and,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125765,0.60,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125766,(,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125767,95,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125768,%,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125769,CI,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125770,=,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125771,0.31,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125772,-,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125773,1.17,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125774,),O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125775,respectively,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125776,",",O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125777,compared,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125778,to,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125779,those,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125780,consuming,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125781,11,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125782,or,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125783,less,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125784,servings,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125785,per,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125786,month,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125787,.,O,4385.0,"When fruits and vegetables were examined separately , those who consumed more than 75 servings per month of fruits or vegetables had multivariate relative risk of 0.59 ( 95 % CI = 0.27 - 1.25 ) and 0.60 ( 95 % CI = 0.31 - 1.17 ) respectively , compared to those consuming 11 or less servings per month ."
125916,Our,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125917,results,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125918,suggested,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125919,that,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125920,high,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125921,consumption,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125922,of,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125923,fruits,B-AG.01.h.01,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125924,and,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125925,vegetables,B-AG.01.h.02,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125926,might,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125927,be,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125928,associated,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125929,with,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125930,reduced,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125931,risk,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125932,of,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125933,RCC,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125934,.,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125988,We,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125989,also,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125990,determined,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125991,if,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125992,intake,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125993,of,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125994,fiber,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125995,(,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125996,soluble,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125997,and,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125998,insoluble,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
125999,),O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126000,",",O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126001,physical,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126002,activity,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126003,",",O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126004,and,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126005,nonsteroidal,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126006,anti,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126007,-,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126008,inflammatory,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126009,medications,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126010,(,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126011,NSAIDs,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126012,),O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126013,or,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126014,aspirin,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126015,modified,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126016,the,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126017,associations,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126018,between,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126019,fluid,B-AG.01.y,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126020,intake,B-X,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126021,and,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126022,rectal,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126023,cancer,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126024,.,O,4394.0,"We also determined if intake of fiber ( soluble and insoluble ) , physical activity , and nonsteroidal anti - inflammatory medications ( NSAIDs ) or aspirin modified the associations between fluid intake and rectal cancer ."
126627,In,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126628,conclusion,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126629,",",O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126630,irrespective,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126631,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126632,frequency,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126633,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126634,consumption,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126635,at,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126636,age,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126637,30,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126638,yr,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126639,",",O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126640,a,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126641,greater,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126642,reduction,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126643,in,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126644,consumption,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126645,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126646,red,B-AG.01.d,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126647,meat,I-AG.01.d,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126648,and,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126649,a,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126650,larger,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126651,increase,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126652,in,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126653,consumption,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126654,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126655,vegetables,B-AG.01.h.02,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126656,since,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126657,age,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126658,30,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126659,yr,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126660,were,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126661,associated,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126662,with,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126663,a,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126664,decreased,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126665,risk,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126666,of,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126667,colorectal,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126668,adenomas,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126669,later,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126670,in,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126671,life,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126672,.,O,4410.0,"In conclusion , irrespective of frequency of consumption at age 30 yr , a greater reduction in consumption of red meat and a larger increase in consumption of vegetables since age 30 yr were associated with a decreased risk of colorectal adenomas later in life ."
126844,Dairy,B-AG.01.e,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126845,foods,I-AG.01.e,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126846,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126847,ice,B-AG.01.n.17.b,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126848,cream,I-AG.01.n.17.b,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126849,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126850,beef,B-AG.01.d.03,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126851,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126852,other,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126853,meats,B-AG.01.d,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126854,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126855,potatoes,B-AG.01.h.02.a,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126856,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126857,pastry,B-AG.01.n.15,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126858,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126859,nuts,B-AG.01.h.01.f,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126860,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126861,chips,B-AG.01.n,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126862,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126863,snacks,B-AG.01,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126864,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126865,condiments,B-AG.01.l,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126866,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126867,alcohol,B-AG.01.y.01,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126868,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126869,soda,B-AG.01.aa,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126870,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126871,significantly,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126872,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126873,with,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126874,higher,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126875,total,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126876,intake,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126877,over,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126878,the,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126879,day,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126880,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126881,while,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126882,fruit,B-AG.01.h.01,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126883,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126884,soup,B-AG.01.n.02,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126885,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126886,breakfast,B-AG.01.n.10,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126887,cereal,I-AG.01.n.10,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126888,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126889,pasta,B-AG.01.i,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126890,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126891,pizza,B-AG.01.n,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126892,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126893,water,B-AG.01.z,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126894,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126895,coffee,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126896,/,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126897,tea,B-AG.01.ac,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126898,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126899,diet,B-AG.01.aa,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126900,soda,I-AG.01.aa,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126901,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126902,either,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126903,not,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126904,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126905,or,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126906,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126907,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126908,with,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126909,lower,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126910,overall,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126911,intake,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126912,.,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
127372,This,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127373,paper,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127374,studied,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127375,the,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127376,possible,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127377,effect,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127378,of,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127379,folic,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127380,acid,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127381,in,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127382,fortified,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127383,Baladi,B-AG.01.n.11,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127384,bread,I-AG.01.n.11,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127385,on,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127386,the,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127387,prevention,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127388,of,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127389,colon,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127390,cancer,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127391,development,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127392,in,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127393,rats,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127394,.,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127619,Patients,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127620,with,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127621,chronic,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127622,diseases,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127623,",",O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127624,including,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127625,diabetes,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127626,",",O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127627,use,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127628,NHPs,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127629,at,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127630,a,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127631,higher,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127632,rate,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127633,than,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127634,the,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127635,general,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127636,population,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
127637,.,O,4443.0,"Patients with chronic diseases , including diabetes , use NHPs at a higher rate than the general population ."
128466,Granny,B-AG.01.h.01.c,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128467,Smith,I-AG.01.h.01.c,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128468,showed,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128469,more,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128470,positive,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128471,skin,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128472,reactions,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128473,and,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128474,a,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128475,better,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128476,agreement,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128477,with,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128478,clinical,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128479,history,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128480,than,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128481,Golden,B-AG.01.h.01.c,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128482,Delicious,I-AG.01.h.01.c,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128483,",",O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128484,and,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128485,juice,B-AG.01.ab,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128486,was,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128487,superior,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128488,to,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128489,the,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128490,two,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128491,other,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128492,extraction,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128493,procedures,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128494,for,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128495,both,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128496,apple,B-AG.01.h.01.c,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128497,strains,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128498,.,O,4467.0,"Granny Smith showed more positive skin reactions and a better agreement with clinical history than Golden Delicious , and juice was superior to the two other extraction procedures for both apple strains ."
128832,This,O,4481.0,This is also demonstrated in an in vivo human study .
128833,is,O,4481.0,This is also demonstrated in an in vivo human study .
128834,also,O,4481.0,This is also demonstrated in an in vivo human study .
128835,demonstrated,O,4481.0,This is also demonstrated in an in vivo human study .
128836,in,O,4481.0,This is also demonstrated in an in vivo human study .
128837,an,O,4481.0,This is also demonstrated in an in vivo human study .
128838,in,O,4481.0,This is also demonstrated in an in vivo human study .
128839,vivo,O,4481.0,This is also demonstrated in an in vivo human study .
128840,human,O,4481.0,This is also demonstrated in an in vivo human study .
128841,study,O,4481.0,This is also demonstrated in an in vivo human study .
128842,.,O,4481.0,This is also demonstrated in an in vivo human study .
129254,About,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129255,50,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129256,%,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129257,of,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129258,those,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129259,studied,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129260,ate,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129261,meat,B-AG.01.d,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129262,products,I-AG.01.d,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129263,<,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129264,1,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129265,time,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129266,/,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129267,wk,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129268,or,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129269,not,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129270,at,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129271,all,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129272,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129273,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129274,vegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129275,consumed,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129276,more,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129277,tomatoes,B-AG.01.h.02.f,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129278,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129279,legumes,B-AG.01.h.02.g,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129280,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129281,nuts,B-AG.01.h.01.f,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129282,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129283,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129284,fruit,B-AG.01.h.01,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129285,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129286,but,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129287,less,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129288,coffee,B-AG.01.ad,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129289,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129290,doughnuts,B-AG.01.n.13,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129291,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129292,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129293,eggs,B-AG.01.g,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129294,than,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129295,did,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129296,nonvegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129297,.,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129298,Multivariate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129299,analyses,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129300,showed,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129301,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129302,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129303,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129304,beef,B-AG.01.d.03,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129305,consumption,B-X,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129306,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129307,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129308,ischemic,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129309,heart,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129310,disease,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129311,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129312,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129313,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129314,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129315,men,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129316,[,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129317,relative,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129318,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129319,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129320,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129321,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129322,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129323,2.31,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129324,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129325,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129326,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129327,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129328,beef,B-AG.01.d.03,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129329,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129330,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129331,=3,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129332,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129333,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129334,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129335,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129336,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129337,vegetarians,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129338,],O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129339,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129340,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129341,protective,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129342,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129343,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129344,nut,B-AG.01.h.01.f,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129345,consumption,B-X,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129346,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129347,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129348,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129349,nonfatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129350,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129351,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129352,both,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129353,sexes,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129354,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129355,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129356,approximately,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129357,0.5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129358,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129359,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129360,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129361,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129362,nuts,B-AG.01.h.01.f,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129363,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129364,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129365,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129366,5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129367,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129368,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129369,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129370,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129371,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129372,those,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129373,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129374,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129375,nuts,B-AG.01.h.01.f,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129376,<,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129377,1,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129378,time,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129379,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129380,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129381,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129382,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129383,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129384,reduced,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129385,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129386,of,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129387,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129388,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129389,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129390,preferring,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129391,whole,B-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129392,-,I-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129393,grain,I-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129394,to,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129395,white,B-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129396,bread,I-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129397,.,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
130241,Both,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130242,aqueous,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130243,and,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130244,organic,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130245,extractions,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130246,of,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130247,ginger,B-AG.01.l.03,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130248,significantly,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130249,inhibited,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130250,the,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130251,growth,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130252,of,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130253,one,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130254,or,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130255,both,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130256,E.,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130257,coli,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130258,strains,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130259,",",O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130260,respectively,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130261,(,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130262,also,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130263,at,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130264,the,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130265,1:50,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130266,dilution,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130267,),O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130268,.,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130420,Peroral,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130421,challenges,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130422,with,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130423,spices,B-AG.01.l.03,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130424,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130425,gelatin,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130426,capsules,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130427,were,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130428,negative,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130429,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130430,20,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130431,nonselected,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130432,patients,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130433,.,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130988,However,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130989,",",O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130990,the,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130991,effect,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130992,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130993,consumption,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130994,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130995,raw,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130996,tomatoes,B-AG.01.h.02.f,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130997,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130998,tomato,B-AG.01.l.04,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130999,sauces,I-AG.01.l.04,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131000,on,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131001,inflammation,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131002,biomarkers,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131003,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131004,adhesion,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131005,molecules,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131006,related,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131007,to,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131008,atherosclerosis,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131009,remains,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131010,unknown,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131011,.,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131295,Histone,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131296,modification,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131297,is,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131298,controlled,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131299,by,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131300,the,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131301,balance,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131302,between,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131303,histone,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131304,acetyltransferase,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131305,and,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131306,(,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131307,HAT,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131308,),O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131309,and,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131310,histone,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131311,deacetylase,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131312,(,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131313,HDAC,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131314,),O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131315,enzymes,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131316,.,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
132002,Treatments,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132003,did,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132004,not,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132005,affect,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132006,daily,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132007,DM,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132008,intake,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132009,",",O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132010,or,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132011,yield,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132012,of,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132013,energy,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132014,-,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132015,corrected,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132016,milk,B-AG.01.e,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132017,",",O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132018,milk,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132019,fat,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132020,",",O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132021,or,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132022,milk,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132023,protein,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132024,.,O,4588.0,"Treatments did not affect daily DM intake , or yield of energy - corrected milk , milk fat , or milk protein ."
132077,The,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132078,average,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132079,diameter,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132080,of,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132081,milk,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132082,fat,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132083,globules,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132084,was,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132085,significantly,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132086,greater,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132087,in,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132088,milk,B-AG.01.e,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132089,from,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132090,cows,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132091,offered,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132092,low,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132093,de,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132094,novo,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132095,diets,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132096,.,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
